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DETERMINATION OF THE FUNCTIONS OF RAB32, RAB38, AND THEIR EFFECTOR 
MYOSIN VC IN THE BIOGENESIS OF MELANOSOMES 
 
In mammals, pigment produced within specialized cells is responsible for skin, hair, and 
eye coloration.  Melanocytes are specialized cells that produce pigment within an organelle 
known as the melanosome.  Melanosomes are a member of a specialized class of organelles, 
known as Lysosome-related organelles (LRO), which are responsible for a number of critical 
functions in mammals such as pigmentation, blood clotting, lung function, and immune function.  
LROs are related to the ubiquitous lysosome, and are formed using the same molecular 
mechanisms as lysosomes that rely upon the Adaptor Protein complexes -1 (AP-1) and -3 (AP-
3), and the Biogenesis of Lysosome-related Organelles Complex (BLOC)-2 (BLOC-2).  These 
protein complexes are critical for the trafficking of specialized cargoes to melanosomes required 
for proper melanin synthesis.  But, these complexes are also used for the formation of lysosomes, 
and no mechanism is known to distinguish between trafficking to lysosomes and melanosomes.  
The melanosome serves as a model system to study the formation of LROs, and insights from the 
study of melanosomes help explain the biogenesis of other LROs. 
In this dissertation, I present the finding that Rab32 and Rab38 function as melanosome-
specific trafficking factors that allow for the use of AP-3, AP-1, and BLOC-2 in melanosome 
biogenesis.  Using biochemical approaches, I show that Rab32 and Rab38 bind directly to AP-3, 
AP-1, and BLOC-2 on membranes.  In microscopy experiments, I demonstrate that Rab32 and 
Rab38 localize to early endosomal subdomains where AP-3, AP-1, and BLOC-2 function.  Using 
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a combination of biochemical and microscopic approaches, I show that Rab32 and Rab38 serve 
partially redundant functions in trafficking of specialized cargoes to melanosomes.   
I report the discovery that Myosin Vc, a class V myosin motor, interacts with Rab32 and 
Rab38 and serves novel functions in melanosomes trafficking.  I show, using biochemical 
approaches, that Myosin Vc directly binds to several melanosomal Rab proteins and serves as an 
effector of these proteins in melanosome biogenesis.  Using a combination of approaches, I 
demonstrate that depletion of Myosin Vc from melanocyte cells causes defects in the trafficking 
of cargoes to melanosomes, but also causes severe defects in the secretion of mature 
melanosomes.  With biochemical and microscopic approaches, I compare the function and 
localization of Myosin Vc in melanocytes to related proteins Myosin Va and Myosin Vb, and 
provide evidence to suggest that all three of these proteins function in distinct steps of 
melanosome trafficking.   
My results answer outstanding questions about the use of ubiquitous trafficking 
machinery (AP-3, AP-1, and BLOC-2) in trafficking to a specialized organelle.  I provide 
evidence to answer outstanding questions about the mechanism of action of Rab32 and Rab38 in 
melanosome trafficking through my studies with Myosin Vc. I also establish new areas of 
research in the comparison of Myosin Va, Myosin Vb, and Myosin Vc in melanosome 
trafficking.  My results address numerous unknown areas in melanosome biogenesis, expand the 
knowledge of melanosome biogenesis, and provide numerous new avenues of research to 
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The focus of this dissertation is to investigate the molecular mechanisms underlying the 
biogenesis of a specialized organelle known as the melanosome.  Work presented here focuses 
on specific steps that occur in the trafficking of proteins to melanosomes that are required for the 
formation of melanin pigments within the organelle.  Pigment production within melanosomes is 
responsible for skin, hair, and eye pigmentation in mammals.  Melanosomes are members of a 
class of organelles, known as lysosome-related organelles (LROs), which are similar to the 
ubiquitous lysosome.  Lysosomes functions in the degradation of proteins, lipids, and sugars in 
nearly every cell of the human body.  The distinction between a lysosome and a melanosome is 
through the delivery of melanosome-specific proteins to the organelle, which facilitates the 
production of melanin pigments.  Historically, the melanosome is a well-studied system due to 
the ease of identification of genetic mutations that result in defects in melanosome biogenesis 
that manifest as pigmentation disorders. 
The formation, or biogenesis, of melanosomes has thus far been shown to depend upon a 
combination of ubiquitous molecular mechanisms, used in the biogenesis of lysosomes, and a 
number of cell-type specific proteins found in melanocytes, melanosome producing cells.  The 
endo-lysosomal system is composed of a heterogeneous group of organelles ranging from early 
endosomes to lysosomes.  The early endosome is a hub of intracellular protein trafficking for 
both ubiquitous and cell-type specific sorting functions.  A number of proteins required for the 
biogenesis of melanosomes are trafficked through the early endosome.  It is unclear how proteins 
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destined for the lysosome or the melanosome are segregated and sorted to the proper organelle as 
many of these proteins utilize the same molecular machinery for trafficking.   
The specific goals of my dissertation are to understand how ubiquitous and cell-type specific 
proteins functionally interact to distinguish trafficking to these two organelles.  I focus on the 
function of two small GTPases, Rab32 and Rab38, that function as melanosome-specific 
trafficking factors.  The interactions of Rab32 and Rab38 with ubiquitous trafficking machinery 
are investigated to provide a mechanism for how these melanosome-specific proteins function.  
In this dissertation, I report novel findings on the functions of Rab32 and Rab38 with adaptor 
proteins resident on early endosomes and function in the formation of lysosomes and 
melanosomes (Chapter 2).  These findings were published in the Journal of Biological Chemistry 
in 2012 in which I am the first author.  We were also asked to write a commentary on these 
findings, and how they integrate with the state of knowledge in melanosome biogenesis.  This 
commentary, in which I am the first author, was published in the journal Small GTPases in 2012 
(Appendix 1).  I also participated, and am a second author, in the publication of a methods paper 
that established the use of techniques for the biochemical and microscopy study of intracellular 
protein trafficking, which was published in the Journal of Visualized Experiments (JoVE) in 
2011.  I also report the novel discovery that Myosin Vc, an actin-based motor, functions with 
Rab32 and Rab38 in melanosome biogenesis (Chapter 3).  Studies on the function of Myosin Vc 
in melanosome biogenesis have been compiled into a manuscript, which will be submitted to the 
journal Proceedings of the National Academy of Sciences USA in the coming months. 
In order to understand the melanosome-specific trafficking of proteins, it is necessary to 
first understand the mechanisms used in the cargo trafficking and organelle maturation events of 
the endo-lysosomal system.  In the next section I will discuss certain trafficking proteins, 
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mechanisms, and events that are critical to the function of the endo-lysosomal system.  I will 
then discuss the formation and different types of lysosome-related organelles, and diseases 
impacting the biogenesis of lysosome-related organelles.  Specific details about the formation of 
the melanosome and trafficking of melanin synthesizing enzymes will be presented, followed by 
discussion of the current state of knowledge in the field of melanosome biogenesis (Chapter 1). 
A list of acronym and abbreviations used may be helpful for a reading of this text (Appendix 2).  
I will present research findings from experiments I have performed investigating the functions of 
Rab32 and Rab38 (Chapter 2) and their effector Myosin Vc in melanosome biogenesis (Chapter 
3).  Finally, I will conclude with a discussion of the impact and significance that my results have 
on the state of knowledge in the field (Chapter 4).   
 
1.2 Intracellular trafficking of the endo-lysosomal system 
Melanosome biogenesis uses aspects of the common endo-lysosomal system for the 
specialized trafficking of cargoes to the melanosomes.  The endo-lysosomal system is a hub of 
intracellular protein trafficking and specialized trafficking to melanosomes is just one of the 
many trafficking events that occurs in this system.  In order to understand the specialized 
trafficking that occurs for melanosome biogenesis, it is important to first understand the general 
mechanisms used in the endo-lysosomal system of organelles.  For simplicity, important proteins 
and protein complexes that are fundamental to understanding of endosome function are explicitly 
stated by name, but some specific details in the names of proteins – such as the names of specific 
Rab5 effectors discussed below – are omitted for simplicity.  Consultation of the list of acronyms 




1.2.1 General structure and function of endosomes 
Intracellular trafficking can be simply described as the movement of vesicles; small 
membrane-bound structures roughly 70-100 nm in diameter, between organelles, larger 
membrane structures, or the limiting plasma membrane of the cell. Endocytosis, the 
internalization of material from outside the cell, and secretion, the transport of material to the 
outside of the cell, account for the majority of intracellular trafficking events that occur in cells 
and are necessary for numerous cellular functions. Within intracellular trafficking, the 
endosomal system serves as a major intersection between the intracellular and extracellular 
protein environments (1).  Extracellular material, whether bound to transmembrane receptors or 
soluble in the extracellular environment, and integral transmembrane proteins embedded in the 
plasma membrane are internalized via the formation of endocytic vesicles on the cytoplasmic 
side of the plasma membrane.   
Numerous mechanisms exist for the formation and internalization of endocytic vesicles, 
but a common feature of nearly all endocytic pathways is rapid targeting to distinct organelles 
called early endosomes.  Early endosomes serve as a focal point of intracellular trafficking and 
sorting to other organelles or recycling back to the plasma membrane (2).  The early endosomes, 
also known as sorting endosomes, are the first endocytic compartment for cargoes internalized 
from the plasma membrane and are a heterogeneous, dynamic group of organelles that serves as 
a hub between the extracellular environment and intracellular organelles.  They are maintained 
through constant vesicular and organelle trafficking and remodeling events (3).   
Overall, four major routes are used in early endosomal trafficking of non-specialized 
cells: trafficking to the plasma membrane (via recycling endosomes or direct vesicle transit), 
trafficking to other endosomal organelles, retrograde trafficking to the trans-golgi network, or 
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trafficking to the lysosome for degradation (4, 5).  The endosomal system can be classified based 
on lipid identity, morphology, intra-organellar pH, organelle function, and by both lumenal and 
membrane protein composition (5).  The moderately acidic environment of the early endosome, 
~ pH 6.3 – 6.8, allows for dissociation of soluble, intraluminal ligands and integral-membrane 
receptors. Acidification of endosomes, by Vacuolar-type H+ pumps ATPases (V-ATPase) and 
ion channels, can be utilized by endocytosed cargoes: for instance, the iron-transporting 
transferrin-receptor (TfR) uses the increased acidification of endosomes to release bound iron 
ions and allow recycling of the apo-transferrin receptor complex back to the plasma membrane.  
Upon release from endocytosed receptors, the soluble cargoes can be trafficked out of the 
endosomes to other organelles or directly into the cytosol.   
Early endosomes are composed of thin tubular extensions approximately 60 nm in 
diameter and larger vacuolar domains roughly 400 nm in diameter (6).  The morphologically 
distinct domains of early endosomes characterize different trafficking pathways and have 
different protein, lipid, and chemical composition (7, 8).  Tubular domains of early endosomes, 
with a very large surface area to volume ratio, are functionally important in recycling of integral 
membrane cargoes to the plasma membrane, retrograde transport to the Golgi, and trafficking to 
other organelles, such as lysosome-related organelles. The vacuolar domain of endosomes 
contains the majority of soluble content of early endosomes and is associated with degradation 
via endosomal maturation and fusion with lysosomes (8).    
Maturation from early endosomes to late endosomes is characterized by numerous 
changes in both intra-lumenal and membrane protein content in addition to a shift in membrane 
lipid composition, morphology, and function.   Fundamental steps in endosome maturation: Rab 
switch from Rab5 to Rab7 on endosome membrane, formation of intraluminal vesicles (ILV), 
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acidification of lumenal pH, phospho-inositol conversion from PI(3)P to PI(3,5)P2, loss of 
tubular domains from endosomes, loss of recycling to the plasma membrane, gain of lysosomal 
proteins, switch in organelle fusion specificity, switch in organelle motility, and intraluminal ion 
changes are necessary to complete maturation into a late endosome (9). 
 
1.2.2 Rab GTPases are critical members of endo-lysosomal function 
Numerous proteins have defined roles in endosomal maturation, but Rab GTPases are 
important determinants and markers of different organelles and endo-lysosomal maturation 
events.  Rab GTPases compose the largest sub-family of the RAS GTPase superfamily of 
proteins (10).  Rabs are monomeric proteins that localize to specific compartments and 
membrane subdomains and stably associate with membranes by insertion of a lipid moiety into 
the lipid bilayer.  They serve as pathway-specific “molecular switches” that facilitate the 
recruitment and function of numerous effector proteins within intracellular membrane 
trafficking.  Rabs function as “molecular switches” via tight regulation of nucleotide state 
(GTP/GDP), cellular localization, and protein-protein interactions (10).  In the GDP state, Rabs 
are generally bound to a Guanine-dissociation inhibitory protein (GDI) that maintains the Rab in 
a GDP bound state and inhibits binding of other proteins.  Upon specific signaling events, the 
GDI-protein is displaced by a protein with GTP/GDP-exchange factor (GEF) activity and is 
generally concomitant with recruitment of a Rab to a membrane (10). 
Recruitment of Rabs to membranes is coordinated with insertion of lipid moieties on 
modified c-terminal Cysteine residues, conserved in all Rabs.  Geranylgeranyl-transferases result 
in the presence of single or double lipid moieties on the C-terminus of Rabs that allows for stable 
membrane association (10).  Rabs are recruited to membranes primarily by GEFs, although it is 
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also suspected that membrane lipids, SNAREs, and other interacting proteins are also important 
for recruitment (11).   
Upon exchange of GDP for GTP by GEFs, two regions within Rabs, switch I and switch 
II, undergo conformation changes that facilitate binding to different proteins.  In the now 
“active”, GTP-bound membrane-associated state, Rabs can interact with effector-proteins and 
serve as membrane anchors to functionally couple cytosolic proteins to specific membranes (10).  
Inactivation of Rabs occurs either via the slow, self-hydrolysis of GTP to GDP or is facilitated 
by GTPase-activating proteins (GAPs), which also remove GDP-bound Rabs from membranes 
(10).  Now free in the cytoplasm, GDI proteins will bind the Rabs and maintain the inactive state 
until the cycle is repeated.   
 
1.2.3 Function of Rab5 at early endosomes 
Of the more than 60 members of the Rab family, many Rabs have been identified as 
functioning in endosomal domains.  Rab5 is present on endocytic vesicles and early endosomes 
where it interacts with numerous effector proteins to maintain early endosome function and 
dynamics (12-16).  The initial recruitment of Rab5 to vesicle and early endosome membranes is 
dependent on a GEF for Rab5 that is capable of binding to ubiquitinated cargoes, either alone or 
in complex with a Rab5 effector, which interacts with the active form of Rab5 (17, 18).  The 
Rab5 recruitment by its GEF is enhanced by the Rab effector, which creates a positive feedback 
loop that rapidly recruits additional Rab5 molecules to membranes (19) and facilitates the rapid 
recruitment of Rab5 effectors.   
Through interactions with numerous effector proteins, Rab5 is necessary for the 
production of phosphatidylinositol-3-phosphate (PI(3)P) lipids on early endosomes (20-22), 
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homotypic fusion of early endosomes (12), early endosomal signaling pathways (23-25), and 
early endosome movement on actin and microtubules (26).  Many of the Rab5 effectors also bind 
to the PI(3)P lipids on early endosomes and the lipid composition of these organelles is critical 
for proper trafficking in early endosomes (27). 
Early endosomes undergo numerous remodeling events such as tubulation, dynamic kiss-
and-run or stable fusion events, and organelle fission (5). Soluble N-ethylmaleimide-sensitive 
factor attachment protein receptors (SNAREs) are conserved membrane proteins used in the 
fusion of vesicles and organelles in intracellular trafficking events (28, 29).  SNARE proteins are 
unstructured when monomeric, but in a complex with the correct SNARE binding partners 
SNARE motifs in proteins form a compacted parallel four-helix bundle helical structure (30, 31, 
32).  Interaction of the correct SNAREs to form a tetrameric helical complex is restricted to 
specific pairs of SNAREs, and the presence of correct SNAREs on the vesicle (v-SNAREs) and 
on target membranes (t-SNAREs) allows a zipper-like function that pulls two membranes 
together and facilitates membrane fusion (33, 34).  Early endosome fusion is mediated by the 
Rab 5 effector early endosomal antigen-1 (EEA1) in coordination with specific target-SNAREs 
(35-39). Early endosome fusion events occur through the action of EEA1 proteins bound to Rab5 
and PI(3)P on membranes and the interactions of SNAREs.  EEA1 recruits this SNARE 
machinery to early endosomes, and also acts as a tether between two early endosomes by binding 
to Rab5 on one endosome and PI(3)P on another.  The interaction of v-SNAREs and t-SNAREs 
is facilitated by Rab5 effector the CORVET tethering complex (40, 41).  The CORVET complex 
tethers membranes through interactions with Rab5, and activate and “proof-read” SNARE 
assembly into a complex (41). These activities cause the fusion of two early endosomes, after 
which point the SNARE complex dissociates and the SNAREs are recycled (42, 43). 
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Rab5 effectors are also responsible for the movement of early endosomes through 
recruiting microtubule and actin based motors (25, 44).  The recruitment of Kinesin-3 motor and 
dynein-dynactin complex is dependent on interactions with the Rab5 effector PI(3)P-kinase (45, 
46).  Microtubule-based movement is used in the majority of early endosome movement, but a 
Rab5 effector can drive early endosomes toward actin-based movement using Myosin VI and its 
interacting partner (26, 44).   
 
1.2.4 Rab5-Rab7 switch in the conversion of endosomes 
In addition to functioning in early endosome maintenance, Rab5a also functions in the 
maturation from early to late endosomes by recruiting Rab7 to organelles (47).  The conversion 
from early to late endosomes is dependent on the formation of a Rab7 domain on an early 
endosomes, which coexist with Rab5 briefly in a Rab5/Rab7 hybrid organelle (48, 49).  It is 
unclear if early endosomes are directly converted into late endosomes, or if vacuolar regions of 
early endosomes undergo fission to form a new micro-organelle, which can fuse with other late 
endosomes (48, 50, 51).  Rab5 facilitates the recruitment of Rab7 by interacting with the Rab7-
GEF (47, 52), which interacts with both Rab5 and PI(3)P on early endosomes.  In addition to 
functions as a Rab7-GEF function, this protein also disrupts the interaction of the Rab5-GEF 
with Rab5, and thereby removes the Rab5 activation feedback-loop (47).  The accumulation of 
Rab7 on membranes occurs simultaneously with the deactivation of Rab5 by Rab5-GAP, which 
catalyzed the conversion of GTP to GDP by Rab5 and results in a loss of Rab5 localization and 
activity on membranes (53, 54).  Recently, it was shown that BLOC-1, an important component 
for lysosome and melanosome trafficking, regulates the lifetime of Rab5 on membranes through 
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control of the localization of the Rab5-GAP on membranes, and thus serves to regulate the 
maturation of early endosomes (55).   
 
1.2.5 Maturation of endosomes 
With the recruitment of Rab7 and loss of Rab5, the endosome will undergo a series of 
changes in membrane and protein composition, morphology, and chemistry resulting in 
drastically different organelles.  Morphologically, the endosome loses the dynamic tubules that 
are present on early endosomes (48, 56) and increases in the number of intraluminal vesicles 
(ILV) present in the organelle (9, 57).  While small numbers of ILV are present in early 
endosomes (58) the formation and accumulation of ILV occurs primarily in late endosomes, 
which because of the increase in ILV are often known as multivesicular bodies/endosomes 
(MVB/MVE), and is a critical component in late endosome maturation.  In respect to cargoes, 
the formation of ILV effectively reverses the polarity of transmembrane cargoes such that 
functionally what was the cytosolic tail is now inside the ILV vesicle.  ILV formation is critical 
for the silencing of signaling receptors by hiding the cytosolic tails within ILV and for the 
degradation of cargoes by lysosomal hydrolases, which are often unable to digest the highly 
glycosylated luminal domains of transmembrane proteins but are more easily digested on ILV.  
The formation of ILV occurs using both Endosomal Sorting Complex Required for Transport 
(ESCRT)-dependent and an ESCRT-independent mechanism that depends on specific lipids (59-
70).   
The ESCRT machinery is composed of specific types of cytosolic proteins that organize 
into various sub complexes and enable a unique organelle remodeling events with the formation 
of ILV.  These proteins are individually recruited from the cytosol with ESCRT-0 proteins 
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arriving first, followed sequentially by ESCRT-I, -II, and –III, which self-assemble and facilitate 
the formation of inward budding to form ILV.  The sorting of proteins into ILV is thought to be 
regulated, at least in part, by the presence of ubiquitin-modifications on lysine residues and these 
are recognized by ESCRT proteins to facilitate cargo selection into ILV (71-75). After sorting 
into the forming ILV, but before vesicle closure, the ubiquitin-modification is removed by 
ESCRT proteins with deubiquitination activity (76).  
ESCRT complex recruitment to endosomal membranes is controlled by binding to 
ubiquitinated cargo, accessory proteins, clathrin, and specific PI-lipids (9). PIs, found primarily 
on the cytosolic leaflet of organelles, are important in many membrane fusion and fission events 
and serve as anchors for the binding of Rabs, and Rab-effectors like EEA1 and the 
CORVET/HOPS complexes, Vps-C tethering complexes that function in the fusion of early and 
late endosomes-lysosomes respectively.  The maturation of endosomes also encompasses a 
conversion of the PI-lipids present on membranes from PI(3)P, present on early endosomes, to 
PI(3,5)P2 on late endosomes (77, 78).   
The conversion from PI(3)P to PI(3,5)P2 is regulated by a kinase that binds to enriched 
PI(3)P regions on membranes, and forms a semi-stable complex with its activator and the 
PI(3,5)P2 phosphatase that allow for the rapid production and degradation of PI(3,5)P2 (79).  In 
addition to recruitment of the kinase, PI(3)P levels are regulated by the presence of Rab7 on 
membranes, which functionally decreases the stability of PI(3)P and thus facilitates the 
conversion to PI(3,5)P2 on Rab7-positive membranes (80).   
This change in PI-lipids coincides with a shift in SNARE proteins, tethering complexes 
CORVET/HOPS that alter the fusion specificity of endosomes.  While early endosomes undergo 
primarily homo-typic fusion, late endosomes will undergo homo-typic fusion with other late 
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endosomal membranes, and hetero-typic fusion with lysosomes (9).  Like early endosomes, late 
endosomes are a heterogeneous population of organelles composed of different cargo proteins 
and destined for different fates (57).  Fusion events of late endosomes vary, but can be generally 
categorized as fusion with the Lysosome or autophagosome for cargo and organelle degradation, 
fusion with the plasma membrane for the secretion of ILV as exosomes for cell-cell 
communication, or modification of late endosomes into lysosomes or Lysosome-related 
organelles (9).   
 
1.2.6 Lysosome biogenesis 
Lysosomes are cellular organelles that are responsible for the degradation of proteins, 
organelles, waste material, cellular debris, and extracellular pathogens (9).  The various forms of 
the proteasome are responsible for these degradative functions within the cytoplasm are 
physically separate from the contents of vesicles and organelles by membranes.  Therefore, the 
lysosome functions as a separate mechanism for the degradation of cargoes that are embedded in 
the membranes or within the lumen of vesicles and organelles.  Lysosomes function through the 
activity of acid hydrolases, which are only fully functional in the highly acidic environment of 
the lysosome (~pH 5) (9).  Lacking functional lysosomes, cells exhibit severe dysfunction that 
manifests as lysosomal storage disorders such as Tay-Sachs disease, which results in the 
progressive nerve degeneration that ultimately results in mental and physical disability (81, 82).   
 Development of the lysosome occurs through maturation of the early endosomes into 
late endosomes, invagination of intra-lumenal vesicles to form the multi-vesicular body, and 
further development into a degradative lysosome via the delivery of vesicles from the Golgi 
containing the lytic acid hydrolases.  Interestingly, the acid hydrolases are present in the late 
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endosomes and multi-vesicular bodies but are less active than in the lysosome, and are trafficked 
from the Golgi apparatus to late endosomes/lysosomes primarily using a mechanism dependent 
on the mannose-6-phosphate receptor that recognizes the mannose-6-phosphate groups that are 
attached to acid hydrolases within the Golgi network (9).  
Trafficking to the lysosome is directed either by the presence of ubiquitin on endocytic 
cargoes or small peptide motifs, known as sorting signals, on the cytosolic portion of 
transmembrane proteins (83-85).  Two common examples of sorting signals used in lysosomal 
trafficking are (D/E)xxx(L/I)(L/I) (di-leucine sorting signal) or Yxx! (tyrosine sorting signal) 
where “x” can be any amino acid and ! is a bulky hydrophobic amino acid such as valine, 
isoleucine, leucine, or phenylalanine (86).   
Sorting signals themselves do not have active roles in trafficking; signals are recognized 
by adaptor proteins that will bind the sorting signal and recruit other factors needed for vesicle 
formation (86). Clathrin-adaptor proteins, such as Adaptor-Proteins 1 and 3 (AP-1 and AP-3) 
facilitate the formation of a “clathrin coat” by simultaneously binding to tyrosine or di-leucine 
sorting signals on cytosolic portions of transmembrane proteins, membrane lipids, accessory 
proteins, and clathrin (87, 88).  Clathrin-adaptor proteins function as a nexus that facilitates the 
concentration of cargo proteins and the protein machinery required for the formation of a vesicle. 
Clathrin is a large, hexameric (trimer of dimers) coat protein that is capable of self-
oligomerization into a lattice that functions in vesicle formation and invagination in many 
intracellular trafficking events. The AP (AP-1, AP-2, AP-3, AP-4, AP-5) clathrin adaptor 
proteins are hetero-tetramers composed of two large subunits (adaptins) that contain a well-
folded core domain that links to folded ear domains through flexible, unfolded linker domains, 
and medium and small subunits that also compose the well-folded core domain (88).  The overall 
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structure of AP clathrin adaptor proteins is said to resemble “mickey mouse” with a well-folded 
head domain and two ear domains connected via flexible linkers.  The core, head-domain is 
responsible for binding to cargo sorting signals and membrane lipids, while the well-conserved 
"-subunit is responsible for clathrin binding and the variable subunit is responsible for binding 
accessories proteins (88). These transient, multimeric protein complexes facilitate the formation 
of a vesicle that is subsequently released from the endosomal membrane via scission proteins.  
The clathrin and adaptor-proteins bound to the vesicle quickly disassemble while other accessory 
proteins already present or subsequently recruited remain bound to facilitate subsequent 
vesicular trafficking (88). Adaptor proteins function as a critical bridge between transmembrane 
cargoes, or cargo receptors, and other components of the trafficking machinery required for 
downstream movement. 
 
1.3 Lysosome-related organelles 
The function of the lysosome is a ubiquitous requirement of eukaryotes. However, in 
some specialized cell-types a similar organelle is formed to serve specific functions.  These 
lysosome-related organelles (LROs) are specialized organelles found in some cell-types and 
share some characteristics with lysosomes - namely acidic lumen, protein components, and 
aspects of organelle biogenesis.  In addition to lysosomal components, LROs also contain 
specific proteins that are required for the specialized functions that these organelles serve (89, 
90).   Based on similarity to lysosomes and studies on specific LROs, it is known that LROs are 
formed using a combination of ubiquitous lysosome biogenesis machinery and cell-type specific 




Lysosome-related organelles are found in specialized cell types such as melanocytes, 
platelets, lung alveolar type II cells, and some innate and adaptive immune cells (90-94).  LROs 
have critical roles in pigment production, blood clotting, lung surfactant production, lytic activity 
of the innate immune system and antigen-processing of the adaptive system (90-94).  The 
melanosome has served as the prototypic LRO and has been the most studied due to the easy 
identifying of protein components involved in melanosome biogenesis and function that 
manifests as defects in pigmentation (hypopigmentation or hyperpigmentation) in humans, mice, 
and rats. The availability of the pigmented human melanocyte cell line MNT-1 has served as an 
important tool in studying melanosome biogenesis (95) and is heavily utilized in studies of 
melanosome biogenesis.   
Produced within melanocyte cells in skin, and retinal pigmented epithelial cells (RPE) in 
the eye, melanosomes are responsible for the synthesis of photo-protective pigment melanin, 
responsible for hair and skin pigmentation in mammals.  Melanosomes are known to co-exist 
with lysosomes in melanocytes and RPE cells and, in common with lysosomes, are derived from 
endosomal domains (91-94).  Further, like lysosomes, melanosomes have an acidic lumen that 
contains acid hydrolases, and membranes that contain the Lysosome-associated membrane 
proteins (LAMP) 1-3 (89).  Melanosomes contain numerous melanosome-specific proteins 
responsible for organelle biogenesis, pigment production, and organelle secretion (91-94). 
Platelet dense granules are another form of LRO (91-94).  Found in platelets and in 
platelet-producing megakaryocytes, dense granules are a component of hemostatic 
thrombogenesis, better known as blood clotting (91-94).  Platelets contain three organelles that 
serve functions in thrombus (blood clot) formation: #-granules, $-granules (dense or delta 
granules), and lysosomes.  Dense granules contain high concentrations of serotonin, Calcium, 
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ATP, ADP, and polyphosphate (89) and are characterized by their electron dense core, as 
observed in electron micrographs.  All three granules (#-granules, $-granules, and lysosomes) 
are secreted from platelets during thrombogenesis (91-94).  Like the melanosome, dense granules 
co-exist with lysosomes and have similar mechanisms of biogenesis, presence of LAMPs on the 
organelle membrane, but do not to contain acid hydrolases or a strongly acid lumen (91-94).  
Numerous specific ion-channels and pumps are responsible for the concentration of ions and 
small molecules within dense granules, but the identity and trafficking of most of these 
components remains a mystery. 
Type II alveolar cells of the lung are responsible for production of pulmonary surfactant, 
which occurs within another type of LRO the lamellar body (91-94).  Pulmonary surfactant is a 
mixture of lipids and proteins that are produced within lamellar bodies, which are ultimately 
secreted into the alveolar airspaces to assist in proper lung function.  While relatively little is 
known concerning the biogenesis of lamellar bodies, it has been found that many proteins are 
shared between lamellar bodies and other LROs.  Proteomic analysis has found that LROs have a 
high degree of shared components: a 60% identical proteome was found across all LROs, and 
lamellar bodies of the lung and the melanosome have a 38% shared proteome (96). 
Several LROs are present in cells of the immune system.  Lytic granules found in 
cytotoxic T-cells and natural killer cells are an LRO with shared acidic lumen, acid hydrolases, 
LAMPs, and endosomal origin as lysosomes (93, 94).  Basophil granules are another type of 
LRO that has functions in allergy response, and shares the same acid hydrolases and LAMPs as 
lysosomes but may have different biogenesis (93, 94).  Azurophil granules in neutrophils are yet 
another form of LROs of the immune system that also contain lysosomal acid hydrolases, but 
unlike some other LROs do not have many shared protein components with lysosomes (93, 94).  
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Within antigen presenting dendritic cells and B-cells, the major histocompatibility-complex type 
II (MHC-II) compartments where antigens are loaded onto MHC-II complexes are also a type of 
LRO (93, 94).  These compartments also have shared endocytic origin and protein components 
with lysosomes.  Numerous LROs are found in cells of the immune system, but the biogenesis of 
these organelles has not been as highly studied as in other systems, and therefore less is known 
about these LROs.   
As is evident from the presence of both LROs and lysosomes in several cell types, the 
production of LROs within cells does not preclude the ability to also form lysosomes.  In some 
cases, such as the lytic granules in cytotoxic T-cells and natural killer cells, it appears that the 
LRO replaces the lysosome within the cell (93, 94).  This raises interesting questions about the 
mechanisms shared between different types of organelle in the same cells and how the same 
molecular machinery can simultaneously be used for lysosome and LRO biogenesis within 
specialized cells where LROs exist.  
 
1.4 Diseases of Lysosome-related organelles 
Several genetic disorders result in the loss of functional LROs.  Hermansky-Pudlak 
syndrome (HPS), Chediak-Higashi syndrome (CHS), and Griscelli syndrome (GS) result in 
deficiency of at least one type of LRO (89, 97) (Figure 1.1).  In CHS and HPS both lysosomes 
and numerous LRO types are affected (89).  Research on these disorders has demonstrated that, 
in addition to shared biogenesis between lysosomes and individual LROs, several types of LROs 
have common biogenesis mechanisms (94).  However, to this point there have not been any 
genetic disorders discovered that cause defects in formation of all types of LROs.  This fact 
raises several interesting questions. Is there an evolutionary divergence in the biogenesis of 
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different classes of LROs?  What are the proteins and molecular mechanisms responsible for the 
biogenesis of different LROs?  The answers to these questions can be determined, at least in part, 
by a careful evaluation of the genetic disorders that affect LRO biogenesis. 
 
 1.4.1 Hermansky-Pudlak Syndrome 
Hermansky-Pudlak syndrome is a group of recessive autosomal disorders that are 
characterized by hypopigmentation and blood clotting disorders caused by deficiencies in the 
formation melanosomes and platelet-dense granules (92, 94).  Over 15 gene products are 
identified as causing different forms of HPS in humans or mouse models of the disease (92, 94).  
All subtypes of HPS have deficiencies of melanosomes and platelet dense-granules, but some 
HPS forms have additional deficiencies in lung and immune function (92, 94).   These additional 
defects are a result of aberrant LRO biogenesis in lung lamellar bodies, and lytic granules of 
cytotoxic T-cells, natural killers, and perhaps other immune cells (92).  HPS demonstrates that 
single gene mutations can affect the biogenesis or function of at least two distinct organelles.  
Genes that cause subtypes of HPS are therefore likely to have general roles in LRO biogenesis, 





Figure 1. 1 
Classification of mutations resulting in pigmentation disorders.  Many of the proteins associated with 







1.4.2 HPS-associated multi-subunit complexes 
Analysis of HPS subtypes led to the discovery that most of the genes associated with 
HPS are found in four multimeric protein complexes: Biogenesis of Lysosome-related Organelle 
Complexes (BLOC) -1, -2, and -3; and the adaptor complex-3 (AP-3) (Figure 1.1).  The BLOC 
complexes have very little homology with any proteins of known function, and understanding 
about the function of the BLOCs has remained unclear (97).  All of the BLOC complexes are 
found within the cytoplasm of cells and associated with specific endosomal membrane domains 
(91, 94, 97, 99).  The localization of BLOC complexes and the general deficiency in 
melanosomes and dense granules suggest that these complexes serve roles in endosomal 
dynamics or trafficking. 
The BLOC-1 complex is composed of a single copy of eight subunits: Pallidin, 
Cappuccino, Muted, BLOS3, Dysbindin, Snapin, BLOS1, and BLOS2 (100) (Figure 1.1).  Two 
stable sub-complexes are found within the structure of BLOC-1 that are bridged by a single-
chain, unstructured linker giving the complex a flexible elongated structure anticipated to be 
roughly 300Å long and 30Å in diameter (101). The proteins Pallidin-Cappuccino-BLOS1 form 
one sub-complex and dysbindin-Snapin-BLOS2 form the second (101).  BLOC-1 localizes to 
early endosomes and functions in vesicle formation through unknown mechanisms (91, 94, 97, 
99).  The interactions of BLOC-1 with other proteins are consistent with roles in protein 
trafficking (97) as both subunits of the complex and the entire complex are shown to interact 
with endosomal and exosomal SNAREs (102-106).  Further, BLOC-1 is also responsible for the 
recruitment of the Rab5-GAP that serves to regulate the lifetime of early endosomes, and this 
represents a critical regulator in the development of late endosomes, lysosomes, and lysosome-
related organelles (107).   Of all of the BLOC complexes, BLOC-1 deficient mice display the 
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most severe hypopigmentation, which demonstrates that BLOC-1 serves a critical function in 
melanosome biogenesis (90, 92-94). 
The function of the BLOC-2 complex - composed of the proteins HPS3, HPS5, and HPS6 
– is currently unknown (Figure 1.1).  However, some results on BLOC-2 suggests that it may 
function as a clathrin adaptor protein.  BLOC-2 contains a small peptide motif, a clathrin-box, 
that is capable of binding to clathrin and BLOC-2 partially colocalizes with clathrin in live cells 
(108).   Immunogold labeling in electron micrographs demonstrates that BLOC-2 localizes to 
specific tubular domains of early endosomes where vesicle formation is known to occur (99).  
BLOC-2 causes only partial hypopigmentation in mice, far less obvious than BLOC-1 deficient 
mice, but more severe than BLOC-3 deficient mice (90, 92-94).  Unpublished data from our lab 
also demonstrates that BLOC-2 is able to bind to the sorting signals in the cytosolic tails of 
melanosomal cargo proteins.  The ability to bind clathrin and sorting signals is a hallmark of 
clathrin-adaptors, but it is currently unclear if BLOC-2 might function as an adaptor protein, or 
instead serve other functions in intracellular vesicular trafficking.   
BLOC-3, composed of HPS1 and HPS4, is a ubiquitously expressed protein complex that 
exists within the cytoplasm, but also has some degree of membrane localization (89, 109-113) 
(Figure 1.1).  Immunostaining has shown localization in the peripheral regions of cells, but 
electron micrographs have demonstrated that BLOC-3 is present on tubo-vesicular endosomes, 
uncoated vesicles, and on early stage melanosomes (112).  The structure of BLOC-3 has been 
determined as anti-parallel coiled-coil #-helices of HPS1 and HPS4 with well-folded domains on 
both N- and C- terminal regions of the structure and a more disordered central region (114). 
While BLOC-3 deficient subjects have only mild hypopigmentation, lung fibrosis is prevalent in 
BLOC-3 deficient patients and animals and this suggests that BLOC-3 also has important roles in 
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the formation of lamellar bodies in the lung type II epithelial cells (115-117). In fibroblasts, 
deficiency of BLOC-3 results in altered localization of late endosomes and lysosomes (118).    
Unlike the BLOCs, AP-3, the fourth complex affected in HPS, is a well-known protein 
complex with established functions as a clathrin-adaptor protein (88, 94) (Figure 1.1).  As 
previously described for AP complexes in general, AP-3 is a hetero-tetramer composed of a 
small subunit, !3; a medium subunit, µ3; a large, conserved adaptin, "3; and a variable adaptin, # 
(88).  HPS-2 is caused by a mutation in the "3A adaptin subunit of AP-3 (119-122).  Two genes 
encode for isoforms of !3 and the same is true for "3 (88).  Neuronal AP-3, which contains 
neuron specific isoforms "3b and !3a/b, is not affected in HPS2 but is affected in additional HPS 
subtypes in mice caused by a mutation in the # subunit of AP-3.  These mice have numerous 
neurological defects in addition to hypo-pigmentation and bleeding disorders underlying the 
importance of AP-3 in ubiquitous cellular functions (99, 123-127).  Conserved from yeast 
through humans, AP-3 plays a role in cargo selection at early endosomes through interaction 
with specific sorting signals of cargo proteins, and facilitates sorting of cargoes into vesicles for 
trafficking to lysosomes or LROs (128, 129). 
All of the currently known HPS subtypes in humans are caused by mutations in BLOC-
1/2/3 or AP-3 subunits, but additional mouse models of HPS have an additional mutation that 
affects the HOPS tethering complex (90-94) (Figure 1.1).  The buff mouse is caused by a 
mutation in the VPS33A protein, a homologue of a component of the HOPS complex (130).  The 
HOPS complex in yeast is involved in formation of membrane micro domains and membrane 
fusion events with the yeast vacuole through interactions with the yeast homologue of Rab7, and 
also functions in late endosome/Lysosome fusion and fission events in mammals through 
interaction with Rab7 and a late endosome/lysosome SNARE (131-136).  The yeast HOPS 
23 
!
complex is both a GEF and effector for the yeast Rab7 homologue, and acts as a tethering 
complex through simultaneous interactions with the Rab7 homologue, acidic phospholipids, and 
SNAREs (137-140).   
 
1.4.3 Other HPS-associated genes and proteins 
Aside from mouse models of HPS that are caused by defective protein complexes with 
functions in trafficking, several other rodent models of HPS are caused by defects in monomeric 
proteins: a Rab geranyl-geranyl transferase and a small GTPase Rab38  (90, 92, 97) (Figure 1.1).  
The gunmetal mouse, caused by a mutation in the protein RABGGTA that catalyzes the transfer 
of a geranyl-geranyl moiety to the c-terminal cysteines of Rab proteins, which is necessary for 
the stable membrane association and function of GTP-bound, active Rabs (141).  Gunmetal mice 
display hypopigmentation, bleeding disorders, and dysfunctional cytotoxic T-cells, all of which 
are phenotypes of defects in LRO biogenesis (142, 143).  It is likely that RABGGTA is the 
geranyl transferase used by Rabs involved in LRO biogenesis in these cell types.   
The chocolate mouse and fawn-hooded rat are two animal models caused by defective 
Rab38 and are characterized by hypopigmentation and bleeding disorders (144, 145) (Figure 
1.1).  The Rab GTPase Rab38 is a member of the 60+ Rab GTPase family in mammals and its 
closest homologue in humans is Rab32, with approximately 70% sequence identity (143).  
Rab32 and Rab38 are suspected to function in the post-Golgi trafficking to maturing LROs in 
either a redundant or parallel manner (146, 147). These Rabs have been found to colocalize with 
the cargo proteins required for melanosome biogenesis and with melanin pigment in melanocytes 
(146, 147).  Cells deficient in these Rabs display partial hypopigmentation and also defects in the 
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biogenesis of other LROS (144, 145, 146, 148).  It is clear that Rab38, and likely Rab32, are 
functional components in the biogenesis of multiple LROs.   
 
1.4.4 Interactions among BLOCs and AP-3 
The subcellular localization and knowledge of function for proteins underlying HPS 
subtypes suggests that these proteins function in early endosomal trafficking.  Consistent with 
this cellular localization, many of these components have been demonstrated to physically 
interact.  BLOC-1 has been demonstrated to physically interact with both BLOC-2 and AP-3 in 
co-immunoprecipitation experiments (99, 149-153).  However, the BLOC-1-BLOC-2 and 
BLOC-1-AP-3 interacting complexes appear to be distinct as BLOC-2 and AP-3 do not interact 
and are not all mutually co-precipitated (99).  These interactions are likely to occur on early 
endosomal membranes based on the localization of each of these proteins and the observation 
that BLOC-1- BLOC-2 and BLOC-1-AP-3 interactions occur in membrane fractions (99, 152) 
that also contain clathrin (154).  However, BLOC-1 and AP-3 have been demonstrated to have 
somewhat distinct localization on early endosomal domains and function in separate trafficking 
pathways (87, 99, 153, 155).   
 
1.4.5 Interactions among BLOC-3 and Rabs 
It was recently discovered that BLOC-3 functions as a GTP/GDP-exchange factor (GEF) 
for Rab GTPases (52).  BLOC-3 localizes to both endosomes and melanosomes; and, 
furthermore, BLOC-3 is capable of recruiting Rab32 and Rab38, discussed in detail later, to 
membranes and acts as a GEF for these Rabs (52).  This GEF function was discovered through 
analysis of regions of small homology between subunits of BLOC-3 and subunits of the yeast 
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Rab7 GEF Mon1a-Czz1 (52).  BLOC-3 has been demonstrated to physically interact with the 
small GTPase Rab9, which is a known component of endosomal protein trafficking pathways 
(114).  The interaction between BLOC-3 and Rab9 is not using the GEF function of BLOC-3, 
instead BLOC-3 acts as an effector of Rab9 and this interaction may serve to recruit BLOC-3 to 
late endosomal membranes where Rab9 functions (114).  The discovery of BLOC-3 as a GEF 
explains a large amount of observations regarding its function in vesicular trafficking, but still 
leaves many unanswered questions about its interactions with other proteins and role in various 
trafficking pathways.   
 
1.4.6 HPS complexes and overall roles in melanosome biogenesis 
The HPS complexes BLOC-1, -2, -3 and AP-3 appear to serve ubiquitous roles in the 
trafficking and biogenesis of lysosomes, and also serve functional roles in the biogenesis of 
several LROs (90-94).  The function of BLOC-1 is not clear, but it has an important role in 
melanosome biogenesis based on the reduction in melanin pigment produced and trafficking of 
melanosome membrane proteins in BLOC-1 mutant mice (93, 94).  A mechanistic role for 
BLOC-1 is not clear, but it is likely that BLOC-1, BLOC-2, and AP-3 represent different 
functional steps in vesicular trafficking from early endosomes where BLOC-1 functions 
upstream of separate BLOC-2- and AP-3-dependent pathways. 
The role of AP-3 is best understood as it has been demonstrated to have a vital role in 
targeting of lysosomal and LRO membrane proteins (93, 94, 99, 156, 157).  AP-3 mutant mice 
exhibit moderate hypopigmentation, as compared to the severely hypo-pigmented BLOC-1 mice 
(99, 127).   AP-3 facilitates vesicle formation from specific early endosomal domains for 
trafficking of transmembrane proteins to melanosomes and depletion or mutation of AP-3 results 
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in trafficking defects of melanosome membrane proteins and overall melanosome biogenesis (93, 
94, 99). 
Phenotypically, BLOC-2 mutants strongly resemble AP-3 mutant mice and BLOC-2/AP-
3 double mutant mice are more hypo-pigmented than either mutant alone, or these double-mutant 
mice resemble BLOC-1 mutant mice (93, 94, 99).  While the function of BLOC-2 is not clear, 
BLOC-2 mutant mice display several defects including melanosome clumping into multi-
melanosomal structures and accumulation of melanosome-membrane containing vesicles in the 
cytoplasm (158-161).  A role for BLOC-2 has been established that mirrors that of AP-3 in both 
its mutant phenotype and interaction with BLOC-1, but BLOC-2 has not been previously 
established as an adaptor protein (99).  Based on phenotypic data and biochemical evidence, 
discussed in subsequent sections, it appears that BLOC-2 and AP-3 define separate, but partially 
redundant pathways for biogenesis of melanosomes (99). 
BLOC-3 mutant mice display only modest hypo-pigmentation and have severe lung 
fibrosis (93, 94).  The function of BLOC-3 as a GEF and effector of Rabs involved in 
melanosome biogenesis is supported by the similar hypopigmentation observed in the Rab38-
mutant mouse, and it is likely that additional mechanisms are at work in type-II lung alveolar 
cells that account for the more severe phenotype in those cells (52, 94).  BLOC-3 likely functions 
downstream of BLOC-1, BLOC-2, and AP-3, which appear to function primarily at early 
endosomes, based both on the localization of BLOC-3 to melanosomes and functional role of 
BLOC-3 with Rabs that are important in the vesicle-based aspects of transport to melanosomes 
(52, 147).  Consistently, the LRO defect phenotype is more severe in double mutations of 
BLOC-3 with BLOC-2 or AP-3 (99, 117, 162).  BLOC-3 also functions in the movement of 
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lysosomes in cell types lacking LROs, and it is possible that BLOC-3 also functions, either 
directly or indirectly through the actions of Rabs and effectors, in the movement of LROs (110). 
 
1.5 Melanocytes and melanosomes - a model of LRO biogenesis 
1.5.1 Melanocytes and albinism 
In humans, the melanin pigment serves to protect the nucleus of cells from the UV-
induced DNA-damage that is known to cause mutations, and is the leading cause of skin cancers 
(163).  Melanin pigments are produced within a specialized Lysosome-related organelle called 
the melanosome (90-94).  In the skin, melanosomes are produced in specialized skin epithelial 
cells called melanocytes (164).  Within the eye, melanosomes are produced within pigmented 
retinal epithelial cells (93, 94).  The biogenesis and function of eye and skin melanosomes is 
quite similar, but the two systems differ in the storage of melanosomes.  Melanosomes produced 
within retinal epithelial cells reside within the same cells in which there were produced and form 
a cytosolic, pigmented-cap to protect the nucleus of the cell.  Skin melanosomes, on the other 
hand, are produced in the dermal layer of the skin within melanocytes, but are subsequently 
transferred to neighboring keratinocytes residing in epidermal skin layers (165).  A single skin 
melanocyte produces and transfers melanosomes to up to 40 neighboring keratinocytes (165).  
As in the eye, keratinocytes create a cytosolic, pigmented-cap on the nucleus to provide UV 
protection (165). 
The melanin pigments, and the melanosomes themselves, exist for the purpose of UV-
protection, but are also responsible for the hair, skin, and eye pigmentation present in all 
mammals.  Melanin functions by efficiently converting the energy of the light into heat through 
ultrafast internal conversion, rapid conversion of molecules from low-to-high energy states that 
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subsequently releases energy as heat through molecular vibrations (166).  Regulation of melanin 
synthesis, melanosome biogenesis, or melanosome transfer to keratinocytes results in different 
degrees of pigmentations locally, which in mammals allows for pigment variations responsible 
for the wide variety of coat colors observed.  Any dysfunction in regulation or the pathways 
themselves results in coat-color mutants, in most mammals, and albinism, in humans (165).  
Albinism, characterized as a partial or total loss of pigment, can be caused by various mutations 
caused by environmental or genetic disorders.  Defects in melanin production in the eye cause a 
variety of problems with vision, and defects in melanin production in skin increase the risk of 
skin cancer due to UV-exposure (165). The subtypes of albinism are defined based on the 
proteins affected, which results in various severity and localization of hypopigmentation.   
Oculocutaneous albinism affects pigmentation in the hair, skin, and eyes and can be 
caused by mutations in four genes representing four subtypes: OCA1-4 (167).  OCA1 is caused 
by mutation in the TYR gene that produces the enzyme tyrosinase (167).  OCA1 occurs at a 
frequency of approximately 1:40,000 and is the most severe form of albinism as patients are 
unable to produce any pigment (167).  OCA2 is more prevalent than OCA1, roughly 1:15,000, 
but less severe as patients with OCA2 are able to produce some pigment (167).  OCA2 is caused 
by the mutation of a protein OCA2 with no known function in melanin synthesis (167, 168, 169).  
OCA3, caused by mutation in tyrosinase-related protein 1 (Tyrp-1, TYRP1) causes partial 
albinism less severe than OCA1 and is present primarily in patients of African heritage (167).   
OCA4, caused by mutation in the protein SLC45A2 – a multi-pass, trans-membrane that is a 
transporter of unknown cargoes functions in melanosome pH maintenance, is the least common 




1.5.2 Melanin synthesis 
Two melanin pigments are present in humans, eumelanin, a brown-black polymer 
composed of dihydroxyindole carboxylic acids and reduced forms, and pheomelanin, a red-
brown polymer composed of benzothiazine (165).  Both eumelanin and pheomelanin are 
produced within melanosomes by the conversion of tyrosine to melanin polymers through a 
series of oxidation and isomerization reactions that occur spontaneously, or are catalyzed by 
tyrosinase, tyrosinase-related protein-1 (Tyrp-1, 5,6-dihydroxyindole-2-carboxylic acid oxidase), 
and tyrosinase-related protein-2 (Tyrp-2/TYRP2, also called dopachrome tautomerase) (Figure 
1.2).   
The synthesis of melanins begins by the oxidation of L-tyrosine to L-DOPA (L-3,4-
dihydroxyphenylalanine) and subsequent oxidation of L-DOPA to form DOPAquinone (ortho-
quinone of 3,4-dihydroxyphenylalanine), a highly reactive ortho-quinone, by the activity of 
tyrosinase, a copper-dependent enzyme (172, 173) (Figure 1.2).  DOPAquinone can 
spontaneously react with free cysteines to form cysteinylDOPA isomers, 5-S-cysteinyldopa or 2-
S-cysteinyldopa, which are oxidized in a redox reaction with DOPAquinone, and combine to 
form benzothiazine polymers, which compose the yellow-red pheomelanin pigment (173).  As 
the formation of pheomelanin requires no enzymatic activity other than that of tyrosinase, 
pheomelanin synthesis is the default synthetic pathway within melanosomes but is highly 
dependent on the concentration of free cysteines within melanosomes, which is regulated via the 





Figure 1. 2 
Synthesis of Melanin pigments in melanosomes.  Eumelanin and Pheomelanin are produced by the 
enzymatic activity or tyrosinase, Tyrp-1, and Tyrp-2 using several synthetic routes.  Within melanosomes, 
the synthesis of eumelanin and pheomelanin is dependent on the presence of substrates, such as L-
tyrosine and cysteine, catalytic enzymes, and proper intraluminal conditions.  Adapted from Simon and 
Peles, 2010 (192). 
31 
!
In the absence of cysteine, eumelanin are formed following the same initial pathways as 
pheomelanin synthesis: conversion of L-tyrosine into L-DOPA and finally dopaquinone 
oxidation by tyrosinase.  Dopaquinone spontaneously converts to cycloDOPA by intramolecular 
cyclization and is rapidly oxidized in a redox reaction with dopaquinone to form dopachrome.  
The formation of eumelanin from this point can be catalyzed by tyrosinase alone through 
spontaneous rearrangement to 5,6-dihydroxyindole (DHI), which will be further oxidized and 
polymerize to form eumelanin pigments (173).   
A different eumelanin pigment can be formed using a separate pathway with tyrosinase, 
Tyrp-1, and Tyrp-2.  Dopachrome can also rearrange to form to 5,6-dihydroxyindole-2-
carboxylic acid (DHICA), instead of DHI, by the activity dopachrome tautomerase (Tyrp-2).  As 
with DHI, DHICA will be further oxidized and will polymerize to form a different eumelanin 
pigment.  While tyrosinase alone is sufficient for the production of eumelanin and pheomelanin, 
the activities of Tyrp-1 and Tyrp-2 allow for the production of different eumelanin pigments in 
melanosomes that underlie the range of shades of melanin (174-179).  Additionally, the activity 
and stability of tyrosinase increases in the presence of Tyrp-1 and Tyrp-2; and tyrosinase and 
Tyrp-1 have been shown to physically interact in in vitro and in vivo experiments (180).   
Multiple melanin pigments can be created via the different actions of enzymes within 
melanosomes.  It has generally been understood that melanocytes produce one type of melanin at 
a time and alternation between the production of pheomelanin and various eumelanin pigments 
gives rise to pigmentations patterns present in human hair and mammalian coats (181, 182).  
However, production of pheomelanin and both types of eumelanin occur simultaneously within 
melanosomes and it has been proposed that initial melanin production is prevalently the rapid 
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formation of pheomelanin pigments, which are subsequently coated by slower-forming 
eumelanin pigments giving a melanosome a pheomelanin core and eumelanin coat (173). 
The production of eumelanin or pheomelanin is controlled both by the presence of 
melanin-specific enzymes (Tyrp-1/Tyrp-2 for eumelanin, cysteine transporter for pheomelanin) 
within melanosomes; and, at a higher level, by signal transduction pathways of the melanocyte-
stimulating hormone ($-MSH) (183). $-MSH binding to the melanocortin-1 receptor leads to the 
induction of eumelanin synthesis (184).  Conversely, stimulation of the melanocortin-1 receptor 
induces pheomelanin synthesis via the down regulation of proteins necessary for eumelanin 
synthesis, such as Tyrp-1, Tyrp-2, PMEL (Pmel17), and OCA2 (185-191).  Pheomelanin 
synthesis occurs readily in the presence of cysteine, but red is the least common hair color in 
humans and pheomelanin accounts for only 25% of melanin within nature (192) .  Mutations in 
$-MSH signaling or melanocortin-1 receptor underlie the production of red hair in humans and 
other mammals as these mutations inactivate the signaling pathway required for the activation of 
eumelanin synthesis (193, 194).  Red-hair and pale skin has long been correlated with an 
increased prevalence of skin cancers, and it was believed that this was simply a result of 
decreased melanin, and a subsequent decrease in UV-protection.  However, pheomelanin itself 
may be a causative factor in skin cancers and ocular diseases through photo activation of oxygen 
by UV-A light – the lower photo ionization potential of pheomelanin, relative to eumelanin, can 
result in the generation of mutagenic oxygen radicals -and a much higher incidence of cancer in 






1.5.3 Melanosome biogenesis and maturation 
Melanin synthesis within melanosomes is dependent on maintenance of the proper pH, 
enzyme composition, free-amino acids precursor molecules, and structural protein content.   
Melanosomes are characterized by four, morphologically distinct stages as characterized by 
electron micrographs  (91, 95)(Figure 1.3).  Stage I, non-pigmented melanosomes originate from 
an early/late endosomal organelle and are characterized by enlarged intraluminal vesicles and a 
rigid, flat clathrin coat on a portion of the limiting membrane of the melanosome (Figure 1.3).  
These melanosomes are formed by the delivery of the transmembrane, structural protein PMEL, 
which is cleaved by acid hydrolases into smaller forms that oligomerize into amyloid-like fibrils 
within the melanosome.  Stage II melanosomes are also non-pigmented and characterized by 
numerous, large PMEL fibrils that extend along the length of the melanosome giving a 
distinctive striped appearance (Figure 1.3).   
The delivery of melanin-synthesizing enzymes tyrosinase, Tyrp-1, and Tyrp-2, among 
others cargoes, to stage II melanosomes allows for the initial pigment production (Figure 1.3).  
Melanin is synthesized and deposited along the extended PMEL fibrils (Figure 1.3).  Stage III, 
partially pigmented melanosomes are characterized by the deposition of melanin along the 
fibrils.  Further melanin synthesis within stage III melanosomes eventually fills the entire 
intraluminal space thus creating the stage IV, fully pigmented melanosome (Figure 1.3).  The 
biogenesis and maturation of the melanosome is dependent on the proper delivery of specific 






Figure 1. 3 
Melanosome maturation progresses through four morphologically distinct phases.  Stage I melanosomes 
contain the protein Pmel17 on the limiting membrane, in intraluminal vesicles, and in small amyloid-like 
fibrils and a small clathrin lattice.  Stage II melanosomes are distinguished by the presence of non-
pigmented, Pmel17 fibrils that span the length of the organelle.  Delivery of tyrosinase family proteins 
(tyrosinase, Tyrp-1, Tyrp-2) allows for the synthesis of melanin in stage III melanosomes, which is 
deposited upon Pmel17 fibrils and gives the appearance of pigmented striations.  Stage IV melanosomes 
are fully pigmented.  Electron micrographs demonstrate the morphology of melanosomes in different 
stages of development.  Immuno-gold labeling using a 12nm-gold particle clearly shows the presence of 
Pmel17 in stage I and stage II melanosomes, but is masked by melanin pigments in stage III and stage IV 











 1.6 Transmembrane-protein transport to melanosomes 
1.6.1 Biogenesis and trafficking of pre-melanosomes (stage I & II) 
Stage I and stage II melanosomes are often referred to as pre-melanosomes as they do not 
contain the melanin pigment.  The formation of non-pigmented, pre-melanosomes has not been 
definitively characterized, but the pre-melanosome is believed to originate from the vacuolar 
domain of an early endosomal organelle (91).  Studies performed by our lab and other groups 
that have examined lysosomes using lysosomal-specific markers or using fluorescent-labeled 
dextran, a complex polysaccharide that is endocytosed and trafficked to lysosomes where it 
remains un-digested by lysosomal hydrolases, have demonstrated that melanosomes do not 
originate from lysosomes (195).  
A critical component of melanosomes, and a characteristic marker of non-pigmented, 
pre-melanosomes is the premelanosome protein (PMEL).  PMEL is a type I transmembrane 
glycoprotein with a single transmembrane domain and a lumenal domain that is heavily 
glycosylated by N- and O-linked oligosaccharides within the golgi (196).  Trafficking of PMEL 
from the golgi to vacuolar early endosomes most likely occurs after rapid transit through the cell 
surface, followed by endocytosis and trafficking to specific early endosomal domains (196).  
PMEL is subsequently incorporated into intraluminal vesicles (91, 197, 198) using a mechanism 
independent of the Endosomal Sorting Complex Required for Transport (ESCRT), the machinery 
that mediates formation of intraluminal vesicles in Multi Vesicular Bodies (MVBs)/late 
endosomes and defines the ubiquitous degradative/lysosome pathway (91, 197).  In stage I 
melanosomes, PMEL is cleaved into multiple, small fragments by the activity of furin-family 
proprotein convertase, a “sheddase” of the disintegrin and metalloproteinase family, and 
additional melanosome proteases to form the small PMEL fragments that oligomerize to form 
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striated amyloid fibrils (198).  The remaining, non-amyloid PMEL is further cleaved by %-
secretases within stage I and stage II melanosomes (198).  The modification and trafficking of 
PMEL is dependent on interaction with another melanosomal protein, MART-1, that forms a 
complex with PMEL (199).  While MART-1 is also necessary for the proper trafficking of 
OCA1, an L-DOPA transporter, to melanosomes the function of MART-1 itself is unknown 
(199). 
PMEL is observed both on the limiting membrane of stage I melanosomes, in 
intraluminal vesicles, and in small amyloid fibrils within pre-melanosomes (91, 197).  Stage I 
melanosomes differ from MVBs by the presence PMEL proteins and by large, flat, clathrin-
containing coats on their limiting membrane (95, 165). Initial amyloid fibril formation occurs in 
stage I melanosomes, but as fibrils increase in size and span the length of the organelle the 
melanosome is now characterized as a stage II melanosome (91, 95 196, 200).  
 
1.6.2 Trafficking of melanin synthesizing enzymes 
Delivery of the type I, single pass transmembrane enzymes tyrosinase and tyrosinase-
related proteins-1 and -2 (Tyrp-1 and Tyrp-2) is a requirement of the maturation from stage II to 
stage III melanosomes (91, 165)(Figure 1.4).  Transport of newly synthesized tyrosinase and 
Tyrp-1 from the ER to the maturing melanosome requires sorting step at the golgi, where 
enzymes are heavily glycosylated with N-linked oligosaccharides, and to specialized tubular 
domains of early/recycling endosomes, rather than direct transport from the trans-Golgi to the 
melanosome (91, 127, 153, 201, 202). Packaging of the tyrosinase family proteins into transport 
vesicles at early/recycling endosome associated tubules is dependent on ubiquitous Adaptor 
Protein complex (AP)-1 and AP-3 Biogenesis of Lysosome-related Organelles Complex 
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(BLOC)-1 and BLOC-2 (153, 201); and dependent on the specific sorting signals present in these 
cargoes.  
Tyrosinase contains two sorting signals: a conventional di-leucine sorting motif 
(EExxxLL) and a tyrosine motif (YxxL) in the short cytoplasmic tail that are bound by AP-1 and 
AP-3 (87).  Similarly, Tyrp-1 also contains two sorting motifs: an unconventional di-leucine 
motif (DExxxxLL) and tyrosinase motif (YxxL) that are both utilized in the trafficking of the 
protein.  The sorting signals in tyrosinase and Tyrp-1 are recognized by AP-1 and AP-3, which 
facilitate the packaging of tyrosinase and Tyrp-1 into vesicles at specific early endosome tubular 
domains  (87, 99 , 153).  Preliminary data from our lab suggests that BLOC-2 may also be able 
to bind specific sorting signals in the cytosolic tails of tyrosinase and Tyrp-1 (unpublished data 
from our lab).  BLOC-2 has been shown to bind clathrin through its clathrin-box and also 
colocalizes with clathrin in cells (107).  While BLOC-2 has not been accepted to function as a 
clathrin-adaptor protein, BLOC-2 has some functional roles of AP-3 and AP-1 in the trafficking 
of Tyrp-1 (99) and it is possible that BLOC-2 serves an adaptor-like function even if it is not a 
typical clathrin-adaptor protein.  
Several studies have demonstrated that AP-1 and AP-3 define separate, but partially 
redundant trafficking pathways for tyrosinase and Tyrp-1 (87, 99, 153)(Figure 1.4).  Further, 
BLOC-2 and AP-3 also define separate functional trafficking pathways for tyrosinase and Tyrp-1 
(87, 99, 153)(Figure 1.4).  Deficiency of both AP-3 and BLOC-2 complexes causes more severe 
defects in tyrosinase and Tyrp-1 transport and overall pigmentation than either single deficiency 





Figure 1. 4 
Model for the trafficking of tyrosinase family proteins to maturing melanosomes. The trafficking of 
tyrosinase and Tyrp-1 to melanosomes uses multiple pathways at specific early endosomal tubules.  The 
presence of AP-3-dependent and AP-3-independent pathways is clear, but it is not clear if AP-1 and 
BLOC-2 function in the same or in different pathways.  The trafficking of Tyrp-2 is not clear, but may 





Analogously, knockdown of AP-1 or AP-3 alter the transport of tyrosinase, and possibly other 
cargoes, to maturing melanosomes (153).  It is unclear if AP-1 and BLOC-2 function in the same 
pathways, but it is clear that both of these proteins function in a distinct pathway from AP-3.  
These protein complexes – AP-1, AP-3, and BLOC-2 – define two or three separate trafficking 
routes for the trafficking of tyrosinase and Tyrp-1 from early endosomes to melanosomes (Figure 
1.4).  The redundancy of these pathways allows for trafficking of cargoes to the melanosome 
even upon loss of one of the pathways, although the efficiency of trafficking is diminished upon 
loss of function of one pathway.  These pathways are also used for trafficking of cargoes to 
lysosomes, and it is striking that separate redundant pathways are redirected for melanosome 
trafficking (203-206).   
Interestingly, BLOC-1 appears to be necessary for the trafficking of tyrosinase and Tyrp-
1 whether using an AP-3, AP-1, or BLOC-2 dependent pathway (99, 153).  BLOC-1 displays 
early endosomal localization and interacts directly with AP-3 and BLOC-2 (87, 99, 153).  
BLOC-1 either functions “upstream” of these pathways, or may function directly in the AP-3 and 
BLOC-2 dependent pathways for Tyrp-1 trafficking (87, 99, 153).  
The necessity of AP-1, AP-3, BLOC-1, and BLOC-2 in the early endosomal step of 
trafficking of tyrosinase and Tyrp-1 is well accepted, the mechanism by which post-endosomal 
trafficking occurs is an area of debate (87, 99, 153).  Two mechanisms have been suggested for 
post-endosomal trafficking of tyrosinase and Tyrp-1: vesicle trafficking and direct tubulation 
between early endosomes and melanosomes.  The small GTPases Rab32 and Rab38 serve a 
functional role in the post-golgi trafficking of tyrosinase and Tyrp-1, and it appears that these 
Rabs are present on small vesicular structures and melanosomes, which would be consistent with 
a vesicular trafficking step between early endosomes and melanosomes (146).  However, another 
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study using electron microscopy has suggested that the trafficking of these enzymes from the 
early endosome occurs via the extension of a tubule that fuses with the melanosome (207).  This 
study suggests that the endosomal tubules, on which AP-3, AP-1, and BLOC-2 are present, are 
extended from early endosomes and pulled by interaction with Kinesis 13A, a +-end directed 
microtubule motor.  While this model is interesting, it is not an established trafficking 
mechanism and has not been widely adopted as a likely model in the field.  The result of either 
mechanism is the transport of tyrosinase and Tyrp-1 to melanosomes, where these enzymes are 
expected to remain to function in melanin synthesis.  
The trafficking pathways and molecular mechanisms used for the trafficking of Tyrp-2 
remain unclear.  Tyrosinase and Tyrp-1 both have di-leucine motifs, which have been shown to 
be necessary for proper melanosomal trafficking, and tyrosine sorting motifs, which may be used 
for trafficking to melanosomes (153).  Tyrp-2 contains two tyrosine sorting motifs (YRRL and 
YTPL) that are presumably used for trafficking, but it is not well understood which proteins 
function in Tyrp-2 trafficking and it remains understudied (208, 209).  Several studies have 
demonstrated that Tyrp-1 and Tyrp-2 utilize distinct routes in trafficking to melanosomes, but 
that Tyrp-2 is also trafficked through early endosomal compartments (208).  Tyrp-2, like Tyrp-1 
and tyrosinase, is heavily N-glycosylated, and this glycosylation is necessary for proper targeting 
to melanosomes: Tyrp-2 lacking glycosylation is degraded by the proteasome (209).  In 
melanoma cells, Tyrp-2 has been localized to the golgi, melanosome, plasma membrane, and 
other unknown cellular structures, which has led to the model that Tyrp-2 trafficking is more 
similar to PMEL trafficking: secretion from the golgi to plasma membrane, endocytosis, early 
endosome sorting, and subsequent trafficking to melanosomes (209).   
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The trafficking of other melanosome-associated proteins like OCA1, OCA2, Lysosome-
associated membrane proteins (LAMPs), and various small molecule transporters like ATP7A 
and SLC45A2 is less well understood (155, 210-212). OCA2, a melanosomal protein of 
unknown function, is trafficked to melanosome utilizing a BLOC-1/AP-3 dependent pathway 
that is similar, or perhaps identical, with tyrosinase and Tyrp-1 trafficking (168, 213).  LAMPs 
are integral membrane proteins that are highly enriched on the lysosome membrane and serve 
unknown biological functions in lysosome function and movement (214-216). The trafficking of 
LAMPs is dependent on AP-3, AP-1, and BLOC-2 (99, 217-219).  LAMPs contain protein 
sorting signals in the cytosolic tails of the proteins that are bound by AP-1 and AP-3 in the 
trafficking of these cargoes to lysosomes (217).  The trafficking of LAMPs to melanosomes uses 
the same trafficking machinery as lysosome traffic: AP-1, AP-3, and BLOC-2, using the same 
sorting signals as required for lysosomal targeting (99, 217, 220).  BLOC-3 is also associated in 
trafficking of LAMPs and interacts with LAMPs to facilitate lysosomal movement (110, 118).  
The use of the same ubiquitous early endosomal proteins AP-1, AP-3, and BLOCs by numerous 
cargoes for the trafficking to both lysosomes and melanosomes demonstrates that melanosome 
biogenesis relies upon common early endosomal trafficking pathway.  However, it is not clear 
how trafficking to the lysosome and melanosome are differentiated.  While LAMPs are 
simultaneously present in lysosomes and melanosomes, the melanin-synthesizing enzymes 
(tyrosinase, Tyrp-1, etc) are not normally found within lysosomes, emphasizing the presence of 
some mechanisms to regulate the specific trafficking the melanosome (221).  Further, the 
redundant nature of AP-1, AP-3, and BLOC-2 in trafficking of both melanosomal and lysosomal 
cargoes indicates that the melanosome specific trafficking factors must function in multiple 
trafficking pathways.  My work aims at addressing the melanosome specific factors that allow 
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for the differentiation between the ubiquitous and melanosome trafficking and determining how 
these factors function. 
 
1.6.3 Maturation of pigmented melanosomes (Stage III & IV) 
The distinction between Stage II and Stage III melanosomes is based on a small 
accumulation of melanin pigments within Stage III melanosomes (87, 91, 196).  The delivery of 
tyrosinase, Tyrp-1, Tyrp-2, and other proteins directly required for melanin synthesis is likely to 
both stage II and stage III melanosomes.  The mechanisms that differentiate different stages of 
melanosomes and the regulation of melanin synthesis within melanosomes are not clear.  Further 
melanin synthesis produces mature, fully pigmented stage IV melanosomes. 
 
1.6.4 Movement and secretion of mature melanosomes 
The movement of maturing melanosomes is dependent on the activity of microtubule 
based kinesin and dynein motors that act in a tug-of-war model moving the melanosomes toward 
the perinuclear microtubule organizing center, dynein based movement, or toward the cellular 
periphery, kinesin based movement (222).  As is the case for most organelles and vesicles, 
melanosomes are coated with microtubule-based kinesin and dynein motors and with actin-based 
myosin motors that cause the variable speed and directionality of melanosome movement (222).  
This has led to the use of melanosomes as a system to study organelle motility and cooperativity 
of multiple classes of motors (98,212, 223).  
Stage I and II, non-pigmented melanosomes are primarily localized to perinuclear regions 
of the cells, while pigmented melanosomes are observed in peripheral regions.  The maintenance 
of non-pigmented melanosomes in the perinuclear region is dependent on dynein and 
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spectrin/ankyrin activities (224) while the peripheral distribution of pigmented melanosomes is 
dependent on the activity of kinesins and myosins (225).  The speed and directionality of 
melanosome movement is based both on the presence of motors and upon the differential 
regulation of those motors through indirect cAMP-signaling and MAP/ERK kinases (115, 226, 
227, 228).  The retention of stage IV, pigmented melanosomes in the cell periphery is dependent 
on the transition from microtubules into the polarized actin along the cortical edge of cells and 
the activity of a class V Myosin, Myosin Va in mammals, on melanosomes (229).   
The fate of mature, stage IV melanosomes in skin melanocytes, which transfer 
melanosomes to keratinocytes, is different from retinal pigmented epithelial cells in the eye, 
which store melanosomes in cluster that forms a UV-protective perinuclear cap (99, 230).  
Several mechanisms have been proposed for the transfer of melanosomes from melanocytes to 
keratinocytes, including: direct melanocyte-keratinocyte membrane fusion; vesicular transfer of 
individual or multiple melanosomes; secretion of membrane- or non-membrane bound 
melanosomes followed with phagocytosis by keratinocytes; or phagocytosis by keratinocytes of 
melanosome-containing filapodia from melanocytes (231-237).  However, no consensus has 
emerged on which mechanisms of melanosome secretion occur, and it is possible that different 
mechanisms are at play that allow melanosome secretion from perinuclear areas versus the 
secretion of melanosomes from dendrites (238).  Regardless of mechanisms, once in 
keratinocytes melanosomes are transported to the perinuclear region of the cell, where numerous 
melanosomes form a distinctive pigmented cap over the nucleus to minimize UV-induced 





1.7 Role of Rab GTPases in melanosome biogenesis 
The trafficking of structural proteins, transporters, and oxidative enzymes to the maturing 
melanosome occurs using a combination of common lysosomal protein machinery and cell-type 
specific proteins.  This is especially the case with the Rab GTPases, where melanosome 
biogenesis uses both common endocytic and exotic features for melanosome formation and 
subsequent trafficking and secretion (239).  There are two major divisions in the function of Rab 
GTPases with melanosomes: vesicular trafficking of cargoes needed for melanosome biogenesis 
and mature organelle motility; and each is represented through the recruitment of a combination 
of ubiquitous and cell-specific Rabs in each pathway.    
 
1.7.1 Function of Endo-lysosomal Rab7 in melanosome biogenesis 
Much of the trafficking of cargoes to melanosomes occurs through the early endosomal 
subdomains, and the vacuolar domains of early endosomes are also important for the formation 
of stage I melanosomes (91, 196, 197). The early endosomal Rab5s does not appear to function 
directly in the biogenesis of melanosomes or affect trafficking of cargoes (47, 240).  Stage I, 
early endosome derived melanosomes mature into an organelle that resembles the MVB, and 
requires the function of MVB components, including the ESCRT complexes and Rab7 (241, 196, 
242).   The trafficking of cargoes out of early endosomes is dependent on the presence of active 
Rab7 co-localized with tyrosinase, Tyrp-1, and PMEL at early endosomes (242-244).  Rab7 also 
functions indirectly in the movement of non-pigmented melanosomes through a Rab7-effector 
protein that recruits dynein-dynactin motors to melanosomes (245, 246).   The functions of Rab7 
in both early vesicular trafficking and melanosome movement occur simultaneously with the 
ubiquitous functions of Rab7 using similar or identical effector proteins, which necessitates the 
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use of cell-type specific Rab GTPases to separate the melanosomes from the late endosome and 
lysosome pathways. 
 
1.7.2 Post-endosomal trafficking role of Rab32 and Rab38 
Two small GTPase Rab38 and Rab32 are tissue specific Rabs that function in 
melanosome biogenesis and may act as the melanosome specific trafficking factors that function 
with common early endosomal trafficking components.  Rab38 was discovered to have a role in 
melanosome function through examination of coat-color mutants in mice and rats (144, 247, 
248).  The closely related homologue of Rab38, Rab32 functions in the formation of 
melanosome in Xenopus and in Drosophila melanogaster the homologue of Rab38 and Rab32 
functions in pigment formation (249, 250).  The Rab38 mutant rodent models are only mildly 
hypo-pigmented, and no Rab32 mutant model has yet been analyzed (144, 247, 248).  However, 
when melanocytes from Rab38 mutant mice are also subjected to knockdown of Rab32 a more 
severe hypopigmentation is observed (146).  Rab38 and Rab32 are also observed to strongly 
colocalize with each other, and with melanosome cargoes tyrosinase, Tyrp-1, and pigmented 
melanosomes (146), suggesting they function in a post-early endosomal sorting step of 
trafficking.   Both Rab32 and Rab38 are found on tubular early endosomes, vesicles, and 
pigmented melanosomes, in addition to small vesicles containing cargoes transported to 
melanosomes (146).  Such tubules may represent early endosomal sorting domains at which AP-
1, AP-3, and BLOC-2 have been observed to function (99, 146).  Rab32 and Rab38 also display 
a highly cell-type specific expression to cells containing LROs and are also important in the 
formation and function of other LROs (148, 251, 252). The defective trafficking of tyrosinase 
and Tyrp-1 in Rab38 knockout, or Rab32 knockdown cells demonstrates an important function 
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for these two proteins in melanosome trafficking.  Further, these two proteins appear to be 
partially redundant in the trafficking of cargoes, a similar function as is observed with the 
redundant trafficking by early endosome components AP-1, AP-3, and BLOC-2 (99, 146).  It is 
likely that Rab32 and Rab38, therefore, function as LRO-specific biogenesis pathways markers, 
and may function directly with AP-1, AP-3, and BLOC-2. 
It is clear that Rab32 and Rab38 are important for melanosome biogenesis, but the 
functional role for these Rabs is unclear.  The recruitment of Rabs to specific membrane domains 
is a key component in the pathway specificity and regulation of Rabs.  It was recently discovered 
that BLOC-3, a protein complex that functions in the ubiquitous movement of late endosomes 
and lysosomes, acts to recruit Rab32 and Rab38 to specific membranes and acts as the GDP/GTP 
exchange factor (GEF) specifically for Rab32 and Rab38 (52, 118).  Lacking BLOC-3, Rab32 
and Rab38 do not correctly localize to membranes, and defects in the trafficking of tyrosinase, 
Tyrp-1, and Tyrp-2 are observed (52).  BLOC-3 is responsible for the recruitment of Rabs to 
specific membranes, as was demonstrated when BLOC-3 was mis-targeted to mitochondria and 
unmodified Rab32 and Rab38 were found to localize to mitochondria as well (52).   
Interestingly, this function of BLOC-3 as a GEF for Rab32 and Rab38 is independent of 
ubiquitous functions of BLOC-3 in late-endosome and lysosome movement, which is likely 
facilitated by recruitment of BLOC-3 to membrane by endosomal Rab9 (114, 253).  Both Rab32 
and Rab38 use the same GEF, but do not necessarily have common GTPase-activating proteins 
(GAPs).  An effector of Rab9, RUTBC1 serves as a GAP for Rab32 but not Rab38 (255).  In 
combination, the connection of Rab9 effectors as regulators of Rab32 and Rab38 function 
supports a model in which Rab9 and Rab32/38 act in separate, but related pathways in late 
endosome and LRO biogenesis.  However, BLOC-3 mutant mice are less severely hypo-
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pigmented than Rab38 mutant mice, and as Rab38 and Rab32 are partially redundant, suggests 
that BLOC-3 is not solely responsible for the recruitment and function of Rab38 and Rab32 in 
melanosome biogenesis (111, 144).  BLOC-3 serves both ubiquitous and LRO specific functions, 
and facilitates the activation and recruitment of LRO specific Rab32 and Rab38, but may not be 
the only mechanism used to active and recruit these Rabs (255). 
The function of Rabs in trafficking is not through direct action of the Rabs, but instead 
through function as an anchor to attach effector proteins to specific membranes to serve 
trafficking specific functions.  Rab32 and Rab38 have one known effector protein, VPS9-
ankyrin-repeat protein (Varp), which was discovered in a screen using GTP-locked Rab32 and 
Rab38 as bait (256, 257).  Varp, previously characterized as a GEF for Rab21, was found to 
interact specifically with the switch II region of Rab38 and Rab32, Valine 78 and 94 
respectively, that is a common region of binding for Rab effectors because this regions 
undergoes conformational change when in the GDP- or GTP-bound state (258).  Knockdown of 
Varp or use of mutants of Varp or Rab32 and Rab38 that disrupt binding result in the 
mistrafficking of Tyrp-1 to melanosomes and demonstrate that Varp is a functional Rab32 and 
Rab38 effector in melanosome biogenesis (257).   
Further, the Rab32 and Rab38 binding of Varp is required for the formation of dendrites 
in melanocytes, which are suggested to be necessary for secretion of melanosomes to 
keratinocytes (200).  Varp is known to bind to the VAMP7 (Vesicle-associated membrane 
protein 7) a vesicle-SNARE protein, and the recruitment of VAMP7 to vesicles is thought to be 
required for fusion of vesicles carrying Tyrp-1 to melanosomes (200).  Interestingly, the 
regulation of VAMP7 is controlled by binding to Varp with Rab32 or Rab38 (259).  When bound 
by Varp, especially when Varp is also binds to Rab32 or Rab38, VAMP7 is maintained in an 
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inactive state that does not allow interaction with target SNAREs (t-SNAREs) required for 
membrane fusion (259).  The recruitment of VAMP7 to vesicles is necessary for proper 
trafficking of Tyrp-1 between early endosomes and melanosomes, and, though it has not been 
tested, may also be required for proper tyrosinase trafficking (257).  This suggests a mechanism 
in which Varp-Rab32/38 interaction is required for recruitment to vesicles, but that the Varp – 
Rab32/38 interactions must be disrupted to allow for function of VAMP7 in downstream vesicle 
fusion.  It is unclear how this interaction would be maintained, or would impact interaction of 
Rab32 and Rab38 with other, unknown, effectors that would be required for vesicle movement, 
targeting, and fusion with melanosomes.   
 
1.7.3 Trafficking of mature melanosomes via Rab8 and Rab27a 
The biogenesis of the early melanosome and trafficking of melanin-synthesizing enzymes 
to the melanosome is also dependent on Rab GTPases.  The fate of pigmented melanosomes is 
also dependent on the actions of Rabs.  Griscelli syndrome is a rare autosomal disorder 
characterized by hypopigmentation and immune defects (260) (Figure 1.1).  Griscelli syndrome 
is caused by mutation of any of three proteins that function in the trafficking of melanosomes: 
Myosin Va, Rab27a, or melanophilin (167).  Unlike HPS, in which hypopigmentation is a result 
of defects in melanosome formation, Griscelli syndrome causes hypopigmentation due to mis-
localization of mature melanosome in melanocytes that inhibits efficient transfer to keratinocytes 
in skin and hair (167).  Rab27a is also a tissue-specific Rab GTPase and serves functions in 
organelle trafficking and secretion in multiple cell types, and acts in actin-based movement and 
secretion of melanosomes (261, 262, 263). 
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Melanosomes serve as a very nice system to investigate the mechanism that maintains a 
balance between directed microtubule- and actin-based movement through the regulation of 
kinesin, dynein/dynactin, and Myosin V family of motors.  The attachment of motors to 
melanosomes is dependent on the presence and function of several Rab GTPases resident on 
melanosomes at different times.  The complete cadre of Rabs on melanosomes has not been 
determined, and additional Rabs to those already known are likely involved in melanosome 
movement and transport.  The anterograde, kinesin-based movement of melanosomes to the cell 
periphery has been shown to depend on the localization of Rab1A to melanosomes (265).  In 
contrast, the retrograde movement of melanosomes toward the microtubule organizing center in 
the perinuclear region of the cell is dependent on the formation of a complex between Rab7 
effectors and the p150-Glued subunit of the dynactin complex (266).   Both Rab7 and Rab1A are 
likely to be present simultaneously on melanosomes with a tug-of-war balance between kinesins 
and dynein occurring.  Fast, kinesin-based melanosome movement is also correlated with the 
presence of Rab32 and Rab38 on pigmented melanosomes (225).  Analysis of functions of 
different Rabs with melanosome movement has recently been an area of focus as more reagents 
have become available to assess the movement of melanosomes in live cells, and serves as a 
model system to understand organelle dynamics (212, 222, 267, 268). 
Rab32, Rab38, and Rab7 all coexist on stage III melanosomes, but gradually decrease as 
melanosomes mature to fully pigmented stage IV melanosomes, to be replaced by Rab27a on 
mature melanosomes (246, 268).   Rab27a is the best understood Rab to function with 
melanosomes: Rab27a mediates the cortical localization of melanosomes via interaction with 
Myosin Va that is necessary for secretion of melanosomes (246).  Rab27a and, the related 
protein, Rab3A are recruited to mature melanosomes by the previously established GEF for Rab3 
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(269, 270).  In skin melanocytes, Rab27a recruits both melanophilin and Myosin Va to 
membranes, and these proteins comprise a semi-stable tripartite complex that allows for Myosin 
Va to pull melanosomes from microtubules and into the polarized cortical actin (264, 271).  In 
retinal pigmented epithelial cells, where melanosomes are trafficked to apical processes within 
the melanocyte and not secreted, Rab27a recruits Myosin VIIa through a similar tripartite 
complex with effector protein MYRIP (272, 273).  The interactions of Rab27a-Melanophilin-
Myosin Va and Rab27a-MYRIP-Myosin VIIa appear to function similarly, but nuances around 
different functions of Myosins may underlie the differences in the fate of mature melanosomes. 
Rab27a facilitates the tethering of melanosomes to cortical regions of melanocytes, but 
does not function directly in melanosome secretion.  Instead, Rab27a is inactivated on mature 
melanosomes by a specific Rab27a GAP and other Rabs function in melanosome secretion (274, 
275).  Recycling endosomal Rab17 and Rab11a/b appear to function downstream of Rab27a and 
have critical roles in melanosome secretion through regulation of melanocyte filapodia and 
perhaps through a direct trafficking mechanism using Rab11 effectors, such as Myosin Vb (275, 
276, 277).  The recruitment of recycling endosomal Rabs (Rab17 and Rab11) suggest that 
melanosome secretion, like early melanosome formation, may utilize ubiquitous trafficking 
machinery once the specialized organelle is formed by tissue specific factors. 
Interestingly, another recycling endosomal Rab, Rab8, is associated with the actin-based 
movement of melanosomes (278).  Rab8 does not appear to function in the trafficking of cargoes 
to melanosomes, as Tyrp-1 traffics normally in Rab8-siRNA treated cells, but instead Rab8 
depletion impacts melanosome trafficking to dendrite tips (279).  The role of Rab8 in 
melanosome movement is also consistent with a function for Myosin Vb in melanosome 
secretion as both Rab11 and Rab8 are known to recruit Myosin Vb to membranes, and the 
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function of both Rabs in mature melanosome movement strongly suggests a role for Myosin Vb 
(280).  Rab8 and Rab11 may define different aspects of melanosome movement and transfer as 
the Rabs are known to function independently in other trafficking pathways (280-282).  The 
precise role for Rab8 in melanosome biogenesis and function is unknown, and it is, therefore, 
difficult to predict if Rab8 and Rab11 serve similar functions with melanosomes.  The 
association of ubiquitous Rabs from late endosome/lysosome and recycling endosomal pathways 
to melanosomes demonstrates the use of both general and tissue specific machinery in 
melanosome trafficking and underlies the importance of Rabs as organelle markers and 
molecular switches that coordinate and regulate the function of molecular motors (230). 
 
1.8 Role of actin-based Class V Myosin motors in Organelle and vesicle trafficking 
1.8.1 General structure and function of class V myosins 
The long distance movement of vesicles and organelles is generally understood to occur 
along microtubules, but once on the ends of microtubule tracks must switch to actin tracks, or be 
trafficked in a minus-end directed fashion along microtubules.  Currently, the only known 
mechanism for actin-based movement of melanosomes is dependent on the function of Myosin 
Va.  Class V myosins are a non-conventional family of actin-based motors with functions in 
organelle and vesicle movement that is conserved from yeast to humans (283, 284).  There are 
three members of the class V Myosin family in mammals Myosin Va, Vb, and Vc that have non-
redundant functions of vesicle and organelle trafficking (285).  The double-headed class V 
myosins are composed of two heavy chains each of which is characterized by a well-folded actin 
binding ATPase motor domain, a flexible neck region with six IQ motifs for binding of 
calmodulin or light chains, extended coiled-coil alpha helical domains that mediate dimerization, 
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and a well-folded globular tail domain that is necessary for binding to cargoes (283, 286, 
287)(Figure 1.5).   
The ability of class V myosins to efficiently traffic cargoes is a hallmark of their function 
in vesicle and organelle trafficking with long 36-nm steps and high processivity giving rise to 
long run lengths and strong pulling forces that allow single Myosin V motors to travel several 
hundred nanometers on an actin fiber (288-292).  The high processivity of Myosin Vs is thought 
to be a result both from the dimerization of motors and from association of kinesin, bound to the 
same structure as a class V myosin, with actin fibers (293) (Figure 1.5).  Kinesins, which are not 
normally associated with actin binding, are thought to weakly bind to actin fibers and act as 
transient tether, which results in an increased likelihood of Myosin V rebinding to actin (293).  
Kinesins and myosins often coexist on vesicles and organelles, and the presence of both types of 
motors on the same cargo may represent a conserved, general mechanism used to increase 
transport efficiency (293). 
 
1.8.2 Class V Myosins and interacting proteins 
The tail-domain of class V myosins, composed of long coiled-coil domains and a c-
terminal globular tail, are important in the dimerization and attachment of specific cargoes 
(Figure 1.5).  While the motor activity is regulated primarily by association of Ca2+-dependent 
calmodulin light-chain binding to IQ motifs, the primary regulation of Myosin V function is 
dependent on the c-terminal globular tail (284, 294) (Figure 1.5).  The structure of the coiled-coil 
and globular tail domains are highly conserved, and are critical for the recruitment of myosins to 
membranes and for specific cargo binding (Figure 1.5).  Indeed, single amino acid mutations are 
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able to selectively inhibit binding of secretory cargoes and mutations to another region of the 
globular tail can inhibit binding of cargoes for organelle movement (295, 296).   
Interactions between class V myosins and Rabs occur using both the globular tail and 
specific regions of the coiled-coil domain that are important for cargo trafficking (230, 297, 
298).  Tissue specific alternative splicing is a well-established mechanism to generate tissue-
specific functions of proteins, and is used by mammalian Myosin Va and Myosin Vb for tissue 




Figure 1. 5 
General structure of mammalian class V myosin motors.  Functional motors are dimers of monomers that 
have an ATP-binding motor domain (head), six light-chain binding domains (neck), and a tail domain 













Tissue specific isoforms functionally impact binding of Rab GTPases, interaction with other 
trafficking proteins, and subcellular localization of mammalian class V myosins (297, 300-302). 
Specificity in interactions of Rab GTPases with Myosin Va, Vb, and Vc varies based on 
the exon regions used in binding; Rab8 and Rab10 can bind all Myosin Va, Vb, and Vc isoforms 
using the protein region encoded by exon D, but interactions of other Rabs, which are specific to 
a single Myosin, occur in other exon regions (297).  It is intriguing that some Rabs bind to 
multiple Myosin family members, suggesting that some pathways utilize multiple Myosin V 
family members or that a single Rab can operate in more than one pathway.  
 
1.8.3 Yeast Myo2p and Myo4p 
Two class V myosins are known to exist in Saccharomyces cerevisiae, Myo2p and 
Myo4p, each with different functions in trafficking.  Myo2p is primarily associated with the 
movement and polarized localization of the vacuole, peroxisomes, and mitochondria (303-308).  
Myo2p also functions in secretory vesicle trafficking and, as with mammalian class V myosins, 
binds specific Rabs and other motors through interactions with the globular tail (309, 310).  
Interestingly, Myo2p interacts with yeast homologues of Rab11 (Ypt32p) and Rab10 (Sec4p), 
which are both known binding partners for Myosin Va and Vb (Rab11a) or Myosin Va, Vb, and 
Vc (Rab10) (310, 311).  The function of Myo2p as a motor for both organelle and vesicle 
motility and its interaction with well-conserved Rabs demonstrates the importance of this motor. 
The other class V Myosin in yeast, Myo4p functions in the trafficking of specific mRNAs 
through specific regions in the global tail of Myo4p (312, 313). Myo4p traffics more than 20 
different mRNAs associated with polarization to the budding daughter cell through interaction 
with a series of mRNA-binding adaptor proteins She2p and She3p (314-316).  Myo4p is also 
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responsible for the trafficking of cortical endoplasmic reticulum (ER) into the budding daughter 
cell and this ER trafficking uses the same mRNA-binding proteins She2p and She3p, but this 
process occurs completely separate from mRNA trafficking (317).   
Unlike mammalian class V myosins, both Myo2p and Myo4p are non-processive motors 
with relatively low-affinity for actin fibers or bundles (315).  Functionally, however, both Myo2p 
and Myo4p are able to act processively via the presence of multiple motors on the same 
structures; and though Myo4p does not truly dimerize, it functionally homo-dimerizes through 
leucine zipper domains (312, 315, 318).  It appears that Myo2p is a closer functional homologue 
to the mammalian class V myosin motors, and conserved interactions with ubiquitous Rab11 and 
Rab10 suggest that the mammalian Myosin V motors are more closely related evolutionarily to 
Myo2p. 
 
1.8.4 Mammalian class V myosins 
Three class V myosins are present in mammals each with approximately 50% overall 
sequence identity (319).  Interestingly, the tails of the motors are the most divergent regions, and 
the coiled-coil region of the tail in particular shows low sequence identity that allows for 
different binding properties and functions of each motor (297, 299, 319).  Myosin Va is most 
abundant in brain and melanocytes, Myosin Vb is expressed in a broad range of epithelial 
tissues, and Myo5c is expressed broadly but more highly in epithelial and glandular tissues with 
secretory functions (319, 320).  The structure of each of the mammalian class V myosin is very 
similar, and minor differences in the length and structure of the coiled-coil tail domain are the 
greatest structural difference.  The highly conserved motor and neck domains cause equal step 
sizes, and classify each myosin as highly processive (321-324).  However, some in vitro studies 
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have suggested that Myosin Vc may not function processively as an individual motor, but given 
physiological conditions and the presence of multiple Myosin Vc motors on the same structure it 
is predicted that all three myosins are processive in vivo (325-327). 
 
1.8.5 Functions of Myosin Va 
The function of Myosin Va in both neuronal and non-neuronal cells has been an area of 
intense research and has resulted to date in the best understanding of function and regulation of 
any class V myosin (230, 328, 329).  Myosin Va is generally understood to function in the 
capture and dispersal of organelles or vesicles in the cortical actin (329).  Interestingly, Myosin 
Va is capable of specifically localizing to the plus-end of microtubules through indirect binding 
to the microtubule tip-binding protein EB1, which is facilitated by the Myosin Va binding 
partner melanophilin and assists to localize Myosin Va to proper cellular location for function 
(330).  This mechanism, in addition to recruitment to membrane via interaction with Rab 
GTPases, allows for the proper localization of Myosin Va to the polarized cortical actin 
networks.   
In neurons, Myosin Va functions as a point-to-point transporter of IP(3) (inositol 1,4,5-
trisphosphate)-sensitive Ca2+ stores, mRNA, and endoplasmic reticulum (ER) into dendritic 
spines, which is reminiscent of the functions of Myo4p in S. cerevisiae (329, 331, 332).  The 
trafficking of Ca2+ stores, mRNA, and the ER are necessary for dendritic development and 
functional synaptic plasticity and cerebellar motor learning and mice with mutant versions of 
Myosin Va displayed defects in cerebellum-dependent motor learning that could be partially 
rescued by the presence of wild-type Myosin Va (331-334).   
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In neurons and some non-neuronal secretory tissues, Myosin Va also has a role in the 
secretion of secretory vesicles and dense core granules (329, 335, 336).  A neuron specific splice 
variant of Myosin Va with the small, 3 amino acid exon B is necessary for interaction with 
dynein light chains and localization and secretion of neuronal secretory vesicles (335, 337).  
Myosin Va functions in secretory vesicle and granule trafficking, and in secretion by facilitating 
the microtubule/actin-transport switch and maintaining localization in the cell periphery by direct 
binding to the GTP-bound form of Rab3A (338).  The interaction between neuronal specific 
isoform of Myosin Va and Rab3A is directed, but bridging proteins rabphilin-3A and granuphil-
a/b are also necessary for the proper trafficking and secretion of neuronal secretory vesicles and 
secretory granules, respectively (335, 338).  Myosin Va also functions in the secretion of other 
vesicles, such as the high affinity insulin-regulated glucose transporter, GLUT4, in adipocytes 
where Myosin Va functions with Rab10 to facilitate vesicle-plasma membrane docking and 
secretion (339). The presence of tripartite complexes of a Rab, class V myosin, and bridging 
protein may occur in all secretory functions of Myosin Va, including those in which a bridging 
protein has not been discovered such as the Rab10-Myosin Va dependent GLUT4 vesicle 
secretion. 
The function of Myosin Va is best understood in melanocyte cells in the trafficking of 
melanosomes, where loss of Myosin Va results in defects in melanosome trafficking and transfer 
to keratinocytes (340).  Myosin Va knockout mice, dilute, have a pigmentation defect caused by 
inability to properly localize melanosomes to the cell periphery, and in humans mutation of 
Myosin Va underlies Griscelli syndrome type 1 (167).  A tissue specific isoform that contains the 
alternatively spliced exon F of Myosin Va is necessary for melanosome trafficking (341).  When 
exon F is removed melanosome distribution in melanocytes is the same as Myosin Va knockout 
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cells (341).  Myosin Va exon D, another alternatively spliced exon that is present in melanocyte-
specific isoform, is not necessary for melanosome trafficking, but is necessary for the Rab8 and 
Rab10 dependent trafficking of vesicles (280, 339).  The localization of Myosin Va to mature 
melanosomes is dependent on indirect interaction with Rab27a through the bridging protein 
melanophilin in an exon-F dependent fashion (342, 343).  As previously described, the 
Rab27a/melanophilin/Myosin Va complex is necessary for peripheral melanosome distribution 
in melanocyte cells, and a variant of this complex using Rab27a/MyRIP/Myosin VIIa functions 
in a similar fashion in the retinal pigmented epithelial cells (344, 345).  The secretion of 
melanosomes is not directly dependent on the function of Rab27a or Myosin Va/VIIa and may 
use one of the other class V myosins present in melanocytes (277). Melanocytes from Myosin Va 
knockout mice have altered distribution of melanosomes, but no significant change in the 
number of melanosomes consistent with a function in melanosome tethering to the cortical actin, 
but not a direct role in fusion with the membrane and secretion (275, 346). 
 
1.8.6 Functions of mammalian myosin Vb 
Myosin Vb is widely expressed in various epithelial tissues and functions in the 
ubiquitous plasma membrane recycling systems and in formation and maintenance of membrane 
polarization in epithelial cells (347-350).  Myosin Vb is an effector of multiple Rab GTPases 
associated with recycling proteins to the plasma membrane (Rab8a, Rab10, Rab11a); and 
Myosin Vb functions with different Rabs for specific forms of membrane recycling: association 
with Rab11a is required for transferrin-receptor recycling in non-polarized cells, both Rab8a and 
Rab11a are required for apical membrane trafficking in epithelial cells, and Rab8a functions with 
Myosin Vb in the recycling of some cargoes in specialized cells (281, 348).   
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Myosin Vb is also necessary for the recycling of several neurotransmitter receptors in 
post-synaptic neurons (351-355).  Both the ubiquitous and neurotransmitter receptor recycling 
are trafficked through recycling endosomes by Rab11a and Rab11-family interacting proteins 
(Rab11-FIP), which form multi-subunit complexes in a similar fashion as used by 
Rab27a/melanophilin/Myosin Va (352, 355-358).   
Previously, it was unclear if Myosin Vb functions directly in the vesicular trafficking 
from recycling endosomes to the plasma membrane, or in the earlier perinuclear to peripheral 
recycling endosome trafficking (359, 360).  Results from sub-cellular localization studies and 
chemical inhibitors suggest that Myosin Vb functions in the long-range movement of vesicles 
between recycling endosomes and the plasma membrane using a microtubule-independent, actin-
dependent mechanism that constitutes a different mode of long-range trafficking in cells (361). 
 
1.8.7 Functions of mammalian myosin Vc 
Myosin Vc is the least studied member of the mammalian class V myosin family, but is 
the most broadly expressed motor that is highly expressed in numerous tissue types (319).  
Myosin Vc, like Myosin Vb, is expressed in epithelial tissues, but like Myosin Va it is also 
highly expressed in secretory tissues (319). Myosin Vc is important in the Rab8a-dependent, 
ubiquitous transferrin-receptor recycling, but does not function or significantly colocalize with 
Rab11 in transferrin-receptor recycling (319). The recycling of transferrin-receptors is primarily 
dependent on Rab11 and Myosin Vb, and therefore a Rab8a and Myosin Vc dependent recycling 
mechanisms may constitute a separate, non-dominant recycling pathway (319, 348).  However, 
little colocalization with Myosin Vb is observed, suggesting that the Myosin Vb and Myosin Vc 
pathways are not highly overlapping (327).   
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In some secretory cell types, Myosin Vc facilitates the exocytosis and secretion of 
secretory vesicles and granules using Rab8a- or Rab27b- dependent mechanisms (327, 362, 363).  
In these cell types, Myosin Vc shows somewhat polarized localization to specific regions of the 
cell periphery on one side of the cell, and is characterized in three cellular locations: small and 
large perinuclear structures, small peripheral structures with polarized cellular distribution, and 
tubular structures near the basal membrane (327).  Myosin Vc punctae and tubular structures in 
the cell are generally fast moving (327).  These tubular structures also appear to colocalize with 
long actin-bundles near the basal membranes of cells (363), and interestingly nocodazole 
treatment, a microtubule-depolymerizing agent, disrupts the formation and movement of tubules 
but not punctate structures (327).  In the secretory systems studied, Myosin Vc tubules are found 
to strongly colocalize with Rab8a, but punctae strongly colocalize with Rab27b or Rab8a (327, 
363). Interestingly, Myosin Va and Myosin Vc show little colocalization in these secretory cell 
types, and Myosin Va does not appear to function in Myosin Vc-dependent secretory pathways 
in the cell types tested (327).  The functions of Myosin Vc in separate functions, cargo recycling 
and secretion, is also interesting as Rab8 is shown to function with Myosin Vc in both of these 
functions. Motors themselves are unable to distinguish between separate trafficking pathways, 
and are regulated by recruitment to and association with Rabs at specific membranes.  
Regulation of Rabs, therefore, acts as a method to recruit motor activity to different pathways; 
and interactions with ubiquitous or pathways specific Rabs will underlie the function of Myosin 
Vc in trafficking.  Interactions with these Rabs, therefore, may characterize functions of Myosin 
Vc in separate trafficking pathways, which can both be utilized for secretion but uses different 
Rabs.   
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Myosin Va and Myosin Vb are established as functioning in secretion and cargo 
recycling, respectively, and functions of Myosin Vc in both of these types of trafficking suggests 
that Myosin Vc may functionally act as a hybrid of Myosin Va and Myosin Vb.  Myosin Vc 
dependent pathways, however, appear to be distinct from Myosin Va and Myosin Vb dependent 
pathways.  It is notable that Rab8 and Rab10 are capable of interaction with all three mammalian 
Myosin Vs in a conserved exon-dependent fashion, and that these Rab-Myosin interactions result 
in similar functions (trafficking of vesicles to the plasma membrane for either exocytosis or 
recycling) (297).  In several cell types all three classes of mammalian myosin V motors are 
expressed, and often the function of each Myosin in dependent on a Rab that is capable of 
interacting with Myosin Va, Myosin Vb, and Myosin Vc.   It is tempting to suggest that all three 
myosins function cooperatively in a step-by-step, handoff mechanism for the same trafficking 
pathway.  Low degree of colocalization of Myosin Vc with Myosin Va or Myosin Vb, and the 
strong phenotypes observed in Myosin Va or Myosin Vb knockdown suggest that Myosin Vc 
does not serve redundant functions with these motors (167, 348).  The functions of Myosin Vc, 
and the interplay between Myosin Va, Myosin Vb, and Myosin Vc in similar trafficking 
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BLOC-2, AP-3, AND AP-1 FUNCTION IN CONCERT WITH RAB38 AND RAB32 TO 
MEDIATE PROTEIN TRAFFICKING TO LYSOSOME-RELATED ORGANELLES!"!"1 
 
2.1 Summary 
 Lysosome-related organelles (LROs) are synthesized in specialized cell types 
where they largely coexist with conventional lysosomes.  Most of the known cellular transport 
machinery involved in biogenesis are ubiquitously expressed and shared between lysosomes and 
LROs.  Examples of common components are the Adaptor Protein complex-3 (AP-3) and 
Biogenesis of Lysosome-related Organelles Complex (BLOC)-2.  These protein complexes 
control sorting and transport of newly synthesized integral membrane proteins from early 
endosomes to both lysosomes and LROs such as the melanosome.  However, it is unknown what 
factors cooperate with the ubiquitous transport machinery to mediate transport to LROs in 
specialized cells.  Focusing on the melanosome, we show that the ubiquitous machinery interacts 
with cell type specific Rab proteins, Rab38 and Rab32, to facilitate transport to the maturing 
organelle.  BLOC-2, AP-3, and AP-1 coimmunoprecipitated with Rab38 and Rab32 from MNT-
1 melanocytic cell extracts.  BLOC-2, AP-3, AP-1, and clathrin partially colocalized with Rab38 
and Rab32 by confocal immunofluorescence microscopy in MNT-1 cells.  Rab38- and Rab32-
deficient MNT-1 cells displayed abnormal trafficking and steady state levels of known cargoes 
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of the BLOC-2, AP-3, and AP-1 pathways, the melanin synthesizing enzymes tyrosinase and 
tyrosinase-related protein-1.  These observations support the idea that Rab38 and Rab32 are the 
specific factors that direct the ubiquitous machinery to mediate transport from early endosomes 
to maturing LROs.  Additionally, analysis of tyrosinase-related protein-2 and total melanin 




Lysosome-related organelles (LROs) are a group of cell type specific membrane-bound 
compartments with specialized functions (1-4). Examples of LROs include melanosomes, 
platelet dense granules, lamellar bodies of lung type II epithelial cells, and lytic granules of 
cytotoxic T lymphocytes and natural killer cells.  The physiological functions of these organelles 
are diverse, from the production and storage of melanin pigments (melanosomes) and the 
regulation of platelet aggregation (dense granules) to killing virus-infected and tumor cells (lytic 
granules) (1-4).  The LROs share common characteristics with lysosomes such as an acidic 
luminal pH, the presence of lysosome-associated membrane proteins (LAMPs) in their limiting 
membrane, and a common biogenesis pathway (1-4).  The close relationship between lysosomes 
and LROs is further demonstrated by certain human genetic disorders, including the Hermansky-
Pudlak syndrome (HPS), that cause abnormalities in both organelle types (2,4-6).   
HPS is a group of autosomal recessive diseases (OMIM 2033000) that are characterized 
by oculocutaneous albinism (hypopigmentation of eyes and skin) and prolonged bleeding that 
result from defects in the biogenesis of melanosomes and platelet dense granules, respectively 
(2,4-6).  Some HPS patients present additional symptoms due to defects in other LROs, for 
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instance defective lamellar bodies result in fatal pulmonary fibrosis and abnormal lytic granules 
cause immune deficiency (2,4-6).  In humans, different forms of the disease, named HPS-1 
through -9, have been associated with mutations in 9 separate genes (2,4-7).  Orthologues of 
those genes and 7 additional genes cause HPS-like disease in 16 mutant mouse strains (4-9).  
Several of those HPS genes encode proteins that assemble into stable complexes, named Adaptor 
Protein complex-3 (AP-3), and Biogenesis of Lysosome-related Organelles Complex (BLOC)-1, 
-2, and -3 (4-10).  The function of AP-3 in lysosome biogenesis has been well established: it 
characterizes a route for trafficking of integral membrane proteins, such as LAMPs, from early 
endosome-associated tubules to the limiting membrane of late endosomes and lysosomes (11-
13).  The melanosome has served as a prototype for LRO biogenesis studies in part because of 
the availability of both mutant HPS-like mice with obvious coat color phenotype and an 
excellent cell line model system, the MNT-1 pigmented human melanocytic cells (2,4-6,8,9,14-
16) Analogous to its function in lysosome biogenesis, AP-3 mediates the transport of cargo 
integral membrane proteins such as the melanogenic enzyme tyrosinase from early endosome-
associated tubules to maturing melanosomes  (11,14,15,17).  In contrast with AP-3, the function 
of the BLOCs at the molecular level is not well understood.  However, BLOC-1 and -2 also 
localize to early endosome associated tubules and are part of the machinery that mediates 
vesicular transport of integral membrane proteins to lysosomes and melanosomes (7,14,17-19).  
Moreover, BLOC-2 defines a trafficking pathway from early endosomes to maturing 
melanosomes that is parallel to the AP-3-dependent pathway (3,17).  Accordingly, the AP-3 and 
BLOC-2 single mutant mice are moderately hypopigmented but the AP-3/BLOC-2 double 
mutant mice display a severe coat color phenotype (17).  Consistently, epistatic defects were 
observed for the trafficking of a melanosomal cargo protein, tyrosinase-related protein 1 (Tyrp-
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1), in cultured melanocytes isolated from the corresponding single and double mutant mice (17).  
Other studies have shown alternative routes for tyrosinase exiting early endosome-associated 
tubules and presumably leading to maturing melanosomes in MNT-1 cells and mouse 
melanocytes (15).  One such route was defined by AP-3 and the other by another member of the 
AP family, AP-1, which in melanocytes is also involved in a trafficking pathway from early 
endosomes to melanosomes (15,20).  It has not yet been established if the AP-3-independent 
pathways originating from early endosome-associated tubules in the different reports (i.e. 
BLOC-2-dependent and AP-1-dependent) correspond to the same or separate trafficking routes 
(15,17,20). How are LROs formed in relationship with lysosomes? One possibility is that the 
LRO replaces the lysosome in the specialized cell and that expression of cell type-specific 
proteins with lysosomal targeting signals provides the organelle with the LRO function in 
addition to the degradative role of conventional lysosomes.  This may be the case for the lytic 
granule (1).  In contrast, most LROs, including melanosomes and platelet dense granules, coexist 
with conventional lysosomes as distinct organelles in the same cell (21,22).  Therefore, sorting 
mechanisms must exist to segregate newly synthesized LRO and conventional lysosomal 
components (11).  This problem is particularly puzzling because most of the known elements of 
the trafficking machinery such as AP-3 and the BLOCs are shared for the biogenesis of both 
lysosomes and LROs (1,3-7,10,11,17).  Moreover, these common components of the trafficking 
machinery are ubiquitously expressed, as expected for a function in lysosome biogenesis 
(5,10,11).  Thus, an outstanding question is what are the factors that direct the ubiquitous 




Rab proteins are GTPases of the Ras superfamily that confer target and timing specificity 
to vesicle budding, motility, tethering, docking, and fusion within the eukaryotic secretory and 
endosomal pathways (23,24).  Rab38 and its close homolog Rab32 are expressed in a highly 
tissue specific manner, chiefly in LRO producing cells such as melanocytes, platelets, and lung 
type II epithelial cells (24-29).  Rodent models of HPS with mutations in Rab38 display 
hypopigmentation, prolonged bleeding, and lung disease due to defective biogenesis of 
melanosomes, platelet dense granules, and lamellar bodies, respectively (24-32).  The 
pigmentation phenotype elicited by Rab38 deficiency is mild (25).  However, when melanocytes 
isolated from Rab38 mutant mice were subjected to siRNA knock-down of Rab32, the resulting 
phenotype was much more severe and the trafficking of both tyrosinase and Tyrp-1 was altered 
(27).  This result placed Rab38 and Rab32 as key players in LRO biogenesis and implies that 
Rab32 is able to functionally compensate for Rab38, at least in part, or that they operate in 
parallel pathways (27).  This apparently epistatic relationship between Rab38 and Rab32 is 
analogous to the one described between AP-3 and BLOC-2 and raised the exciting possibility 
that these Rabs could be the specificity factors that work in concert with the ubiquitous 
trafficking machinery for transport towards LROs (17,27).  Despite the initial progress made in 
the field with the discovery of Rab38 and Rab32 involvement in LRO biogenesis, several 
questions remain unanswered (27,33).  Where do the Rabs function and who are their partners?  
Can Rab38 functionally compensate for Rab32 deficiency?  Do they have non-redundant roles in 
melanosome biogenesis?   
Using gene silencing, biochemical, and imaging approaches, we show that BLOC-2, AP-
3, and AP-1 interact physically and functionally with Rab38 and Rab32 to mediate melanosome 
biogenesis.  The results indicate Rab38 and Rab32 operate together with the ubiquitous transport 
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machinery in pathways from early endosomal domains towards maturing melanosomes.  
Analysis of the three melanin synthesizing enzymes, tyrosinase, Tyrp-1, and Tyrp-2 and overall 
melanin production show Rab38 and Rab32 have both redundant and non-redundant roles in 
melanosome biogenesis.     
 
2.3 Experimental Procedures 
2.3.1 Plasmids and Antibodies  
The cDNA for Rab32, Rab38 and Rab11 were amplified from total RNA of MNT-1 cells 
by reverse transcriptase-PCR and subsequently cloned in-frame into pGEX-5X-1 and pET-30a+ 
bacterial expression vectors (for expression and purification of GST- and poly-histidine-tagged 
proteins, respectively). Rabbit and rat polyclonal antibodies were generated against purified 
GST-Rab38 or GST-Rab32.  Antibodies were affinity purified from sera using either poly-
histidine-Rab38 or GST-Rab32 covalently coupled to Affi-Gel15 beads (Bio-Rad).  Anti-Rab32 
serum was passed through a GST-Affi-Gel 15 column, to remove anti-GST antibodies.   
Other antibodies used: affinity purified rabbit antibody to HPS6 (HP6D, gift from E. C. 
Dell’Angelica (34)), AP-3 " (Protein Tech); mouse monoclonal antibodies against HPS4 and 
pallidin (gift from E. C. Dell’Angelica (17,35)) AP-3 # (SA4, gift from A. A. Peden (13)), AP-3 
µ (18/p47A, BD), AP-1 % (100/3, Sigma), clathrin heavy chain (X22, Abcam), Tyrp-1 (MEL-
5/TA99, Santa Cruz), tyrosinase (T311, Santa Cruz), Tyrp-2 (C-9, Santa Cruz), SNX1 (clone 51, 
BD), EEA1 (clone 14, BD), $-tubulin (DM1A, Sigma).  Control rabbit IgG was from Southern 
Biotechnology (Birmingham, AL). Alexa-488 and Alexa-546 conjugated secondary antibodies 
were from Invitrogen and horseradish peroxidase (HRP)-conjugated secondary antibodies were 
from GE Amersham. 
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2.3.2 Cell culture   
Human MNT-1 cell line was cultured as described (36). Transfection for siRNA was 
performed using the Nucleofector electroporation system (Lonza) and the NHEM-Neo kit with 
MNT-1 cells sub-cultured 2-3 days before transfection.  Two sequential siRNAs treatments were 
performed on days 1 and 4, cells were analyzed on day 7. Oligonucleotides used for siRNA are 
as follows: # subunit of AP-3 (17), HPS6 subunit of BLOC-2 (Sigma, SASI_Hs01_00035287), % 
subunit of AP-1 (Sigma, SASI_Hs01_00151148), Rab32 (Sigma, SASI_Hs02_00342400), 
Rab38 (Sigma, SASI_Hs01_00247037), HPS4 subunit of BLOC-3 and pallidin subunit of 
BLOC-1 (17). 
 
2.3.3 Biochemical Procedures   
Cytosolic and membrane fractions of MNT-1 cells were prepared by homogenization in 
buffer A (20 mM HEPES, pH 7.4, 50 mM KCl, 1 mM dithiothreitol, 1 mM EGTA, 1 mM 
MgCl2, 250 mM Sucrose) containing a protease inhibitors mixture (34), followed by 
centrifugation at 15,000x g for 10 min and then ultracentrifugation at 400,000x g for 15 min, at 
4°C. The final membrane pellet was solubilized in 1 ml of buffer A containing protease inhibitors 
mixture and 1% (wt/vol) Triton X-100. Triton X-100 was added to the cytosolic fraction to match 
the detergent concentration. Both fractions were cleared by centrifugation for 10 min at 15,000x 
g before immunoprecipitation, which was performed as described above (34) except for the use 
of buffer A in all washing steps, three times with 0.1% (w/v) Triton X-100, and then once 
without detergent. Guanidine nucleotide exchange of GST-Rab fusion proteins and GST 
pulldown assays was performed as described (37). 
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For membrane association experiments, cytosol and membrane fractions were obtained 
from MNT-1 cells by homogenization in buffer B (10 mM HEPES, pH 7.4, 250 mM sucrose, 1 
mM dithiothreitol, 1 mM EGTA, 0.5 mM MgCl2, 0.25 mM GTP%S, and protease inhibitors 
mixture), followed by centrifugation for 5 min at 15,000x g and for 15 min at 400,000x g, at 4°C. 
Immunoblotting was performed as described (38). 
Quantification of immunoblots was carried out by chemifluorescent detection using a 
Storm 860 scanner (Molecular Dynamics) with an excitation wavelength of 450 nm and a 520 
LP emission filter or by scanning films. Integration of the band intensities was performed using 
ImageJ (NIH, USA).  
 
2.3.4 Melanin Content  
 MNT-1 cells were centrifuged at 90x g for 10 minutes to pellet cells.  Cell pellets were 
treated and analyzed as described (39) by a spectrophotometric method at 500nm using purified 
Sepia officinalis melanin (Sigma-Aldrich) as a standard. 
 
2.3.5 Immunofluorescence Microscopy and Antibody Internalization assay  
Immunofluorescence staining, internalization of antibodies, and leupeptin treatment were 
performed as described (17,40,41). Rabbit anti-Rab32 and anti-Rab38 were used in all co-
staining experiments except for co-staining with BLOC-2 (HPS6 subunit) where the 
corresponding rat anti-Rab32 and anti-Rab38 were utilized. For labeling lysosomes with dextran, 
cells were incubated for 15 hours at 37°C in medium containing 50 &g/ml of fixable dextran-
Alexa Fluor 647 (Invitrogen) followed by a 4-hour chase period in medium lacking dextran. 
Immunofluorescence microscopy samples were examined in a temperature controlled chamber at 
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room temperature on an Olympus IX81 spinning disc confocal microscope with Photometrics 
Cascade II camera using a 100x/1.40NA objective.  Images were acquired and analyzed in 
Slidebook v5 software (3i, Denver).  For determination of the percent of colocalization, each 
channel was subjected to a Laplacian 2D filter with a 3x3 kernel [-1, 8, -1] and a binary mask 
was generated using a Ridler-Calvard automated threshold method both on each channel and on 
the overlap between the two individual channels in Slidebook software. Pixel area overlap from 
the overlap mask and each individual mask was used to calculate percent colocalization. 
Negative controls for colocalization were performed with peroxisomal markers (RFP-SKL and 
PMP34-GFP, gift from P. K. Kim) that give a similar distributed punctate staining as proteins of 
interest (42).  The degree of colocalization between AP-3, BLOC-2, Rab32, or Rab38 and the 
peroxisomal markers RFP-SKL and PMP-GFP with this method was below 10%. Antibody 
internalization images were acquired at room temperature using a Nikon Diaphot 300 
microscope with Photometrics Cool SNAP camera using Metamorph software under conditions 
optimized to prevent signal saturation.  Images were analyzed for total fluorescence intensity 
with ImageJ software (NIH, USA) as previously described (17). 
 
2.4 Results 
2.4.1 BLOC-2, AP-3, and AP-1 interact physically with Rab38 and Rab32    
To study endogenous human Rab38 and Rab32, we raised both rabbit and rat polyclonal 
antibodies against purified recombinant GST-Rab38 and GST-Rab32 and affinity purified them 
using the corresponding poly-histidine tagged Rab as a ligand. By immunoblotting analysis, both 
rabbit and rat antibodies to Rab38 recognized the endogenous protein from MNT-1 cell extracts 
and did not cross react with Rab32 or any other protein (Figure2.1). Conversely, both rabbit and 
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rat antibodies to Rab32 recognized the endogenous protein and did not cross react with Rab38 or 
any other protein (Figure 2.1). Notice Rab32 has a slightly slower mobility than Rab38, 
consistent with a 14 residue longer amino acid sequence.  Rabbit anti-Rab38 and anti-Rab32 
antibodies work very well for immunoprecipitation of the corresponding endogenous protein 
from MNT-1 cell extracts (Figure 2.1).  Immunoprecipitated Rab38 was recognized by both 
rabbit and rat anti-Rab38 antibodies by immunoblotting and immunoprecipitated Rab32 was 
recognized by both rabbit and rat anti-Rab32 antibodies.  Importantly, anti-Rab38 antibodies did 
not immunoprecipitate Rab32 and, conversely, anti-Rab32 antibodies did not immunoprecipitate 
Rab38 (Figure 2.1).  As expected, knockdown of Rab38 or Rab32 expression by siRNA 
treatment of MNT-1 cells resulted in a significant decrease of the corresponding polypeptide, 
further demonstrating the specificity of the antibodies (Figure 2.2, lanes 6-8).  
To test for physical association of Rab38 and Rab32 with BLOC-2, AP-3, and AP-1, 
MNT-1 cell extracts were subjected to immunoprecipitation under non-denaturing conditions 
using control IgG, anti-Rab38, or anti-Rab32 antibodies.  The washed immunoprecipitates were 
analyzed by immunoblotting for the presence of BLOC-2, AP-3, and AP-1 using antibodies to 
the HPS6, µ3, and % subunits, respectively (Figure 2.3). As another specificity control, the 
immunoprecipitates were also analyzed for the presence of the endocytic adaptor complex AP-2 
using antibodies to its $ subunit (Figure 2.3).  BLOC-2, AP-3, AP-1, AP-2, and Rab proteins 
exist as both soluble and membrane-associated pools (17,24,27), therefore parallel experiments 





Figure 2. 1 
Immunochemical detection of endogenous Rab32 and Rab38.  A total extract from MNT-1 cells was 
divided into aliquots and immunoprecipitated (IP) using irrelevant rabbit IgG (lane 2) or rabbit 
affinity-purified antibodies against Rab32 (lane 3) or Rab38 (lane 4). Bound proteins, along with a 
total MNT-1 cellular extract (lane 1), were analyzed by immunoblotting (IB) using rabbit or rat 
affinity- purified antibodies against Rab38 (top two panels) or Rab32 (bottom two panels).  Both 
rabbit and rat Rab38 and Rab32 antibodies are sufficiently sensitive to detect the corresponding 
polypeptide in total extracts and recognize only a single band (note that Rab32 mobility is slightly 
slower than Rab38 due to larger size) (lane 1). Immunoprecipitated Rab32 (lane 3) is detected only in 
immunoblots for Rab32 and not in Rab38 blots. Similarly, immunoprecipitated Rab38 (lane 4) is 
detected only in immunoblots for Rab38 and not for Rab32. * indicate bands from the rabbit antibody 







Figure 2. 2 
siRNA treatment in MNT-1 cells efficiently and specifically silenced the corresponding targets. The 
following targets were knocked down in MNT-1 cells by siRNA nucleofection: the % subunit of AP-1 
(lane 2), the # subunit of AP-3 (lane 3), the HPS6 subunit of BLOC-2 (lane 4), Rab32 (lane 6), Rab38 
(lane 7), and both Rab32 and Rab38 (lane 8). Control 1 (lane 1) represents mock nucleofected cells 
and Control 2 cells nucleofected with an irrelevant siRNA (lane 5). Total extracts were normalized 














Figure 2. 3 
Rab32 and Rab38 coimmunoprecipitate with BLOC-2, AP-3, and AP-1, but not with AP-2. MNT-1 
cells were homogenized in the absence of detergents and the homogenate was centrifuged to yield 
cytosolic and membrane fractions.  The membrane fraction was solubilized in buffer containing 1% 
Triton X-100 and the same concentration of detergent was added to the cytosol to match the buffer 
compositions (see Materials and Methods). Both cytosolic and solubilized membrane fractions were 
divided into aliquots and subjected to immunoprecipitation (IP) using irrelevant IgG, anti-Rab32, or 
anti- Rab38 rabbit antibodies.  The immunoprecipitates, together with an aliquot of the input extracts 
corresponding to 1% of the material available for IP, were analyzed by immunoblotting (IB) using 








As shown in Figure 2.3, BLOC-2, AP-3, and AP-1 were detected in the Rab38 and Rab32 
immunoprecipitates obtained from solubilized membrane extracts, but not from those obtained 
from cytosolic extracts.  Importantly, AP-2 was not detected in the Rab38 or Rab32 
immunoprecipitates obtained from solubilized membranes or cytosolic extracts.  These results 
suggest that endogenous Rab38 and Rab32 interact, directly or indirectly, with BLOC-2, AP-3, 
and AP-1. The finding that it is the membrane-bound form of the Rabs that participates in the 
interaction suggests a role of the GTP-bound form of the Rabs. We confirmed the interaction of 
Rab32 and Rab38 with BLOC-2, AP-3, and AP-1 using pulldown assays. GST-Rab32 and GST-
Rab38 were immobilized on glutathione-Sepharose and their bound nucleotide exchanged for 
GDP or GTP%S, a more stable analog of GTP. Subsequently, each Rab was incubated with 
MNT-1 cytosolic extract – as a source of free BLOC-2, AP-3, and AP-1 – supplemented with 
GDP or GTP%S, respectively. As controls, GST and GST-Rab11 were analyzed in parallel 
following the same procedure. By immunoblotting we observed that BLOC-2, AP-3, and AP-1 
bound to GST-Rab32 and GST-Rab38 but not to GST or GST-Rab11 (Figure 2.4).  Furthermore, 
BLOC-2 and AP-3 bound almost exclusively to the GTP%S form of Rab32 and Rab38 compared 
with the GDP forms (Figure 2.4).  
AP-1 also showed a preference for the GTP%S form of Rab32 and Rab38, but less 
dramatic than BLOC-2 or AP-3 (Figure 2.4). As an additional specificity control we tested for 
AP-2 which did not bind to either GST-Rab regardless of the nucleotide form (Figure 2.4). These 
experiments suggest BLOC-2, AP-3 and AP-1 are effectors of Rab32 and Rab38 and that the 






Figure 2. 4 
GTP-dependent interaction of Rab32 and Rab38 with BLOC-2, AP-3, and AP-1. GST pulldown using 
cytosolic extracts from MNT-1 cells and ~ 20 &g each of GST, GST-Rab11, GST-Rab32, or GST-
Rab38 immobilized on glutathione-Sepharose and loaded with GDP or the stable GTP analog, GTP%S. 
The washed glutathione-Sepharose beads, together with an aliquot of the input cytosol corresponding to 
1% or 20% of the material available for pulldown, were analyzed by immunoblotting (IB) using 
antibodies to the HPS6, "3, %, and $ subunits of BLOC-2, AP-3, AP-1, and AP-2, respectively. The 










Figure 2. 5 
Rab38 association to membranes is altered by AP-3 and BLOC-2 deficiency but only BLOC-2 knock 
down affects Rab38 stability. A, MNT-1 cells deficient for AP-1, AP-3, or BLOC-2 together with 
control cells were subjected to a quick homogenization and ultracentrifugation procedure to yield 
postnuclear membrane (M) and cytosolic (C) fractions (see Materials and Methods). The samples were 
analyzed by immunoblotting (IB) using antibodies to Rab32 or Rab38. The graph shows the percentage 
of total Rab38 or Rab32 that was found in the membrane fraction in at least three independent 
experiments (means ± SD). For each Rab protein, the data corresponding to AP-1, AP-3, or BLOC-2 
deficient cells was compared with that of control cells by means of a t test. B, Quantification of the total 
amount of Rab32 and Rab38 present in extracts of MNT-1 cells treated with the indicated siRNAs 
relative to control cells. Bars represent means ± SD of at least three independent experiments. One 
sample t test was used to compare the results obtained from depleted cells with the reference value of 1 
set for control cells. C, MNT-1 cells deficient for Rab32 or Rab38 together with control cells were 
processed as described in (A). The samples were analyzed by immunoblotting using antibodies to 
BLOC-2. The graph shows the percentage of total BLOC-2 that was found in the membrane fraction in 
three independent experiments (means ± SD). The data corresponding to Rab32 and Rab38 deficient 
cells was compared with that of control cells by means of a t test. *p < 0.05; **p < 0.01. 
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2.4.2 BLOC-2 and AP-3 regulate the Rab38 association with membranes  
In order to perform functional studies we first optimized the conditions to achieve 
significant knockdown of the targets of interest in MNT-1 cells by siRNA (Figure 2.2).  The 
most efficient gene silencing was obtained using the Nucleofector system for oligonucleotide 
transfection and subjecting the cells to two sequential siRNA treatments (see Materials and 
Methods for further details) (43).  To address the biological significance of the observed physical 
interactions of BLOC-2, AP-3, and AP-1 with Rab38 and Rab32, we tested whether membrane 
association of each Rab was affected by deficiencies in their interacting partners.  To this end, 
cytosolic and membrane fractions were obtained from control MNT-1 cells or cells deficient for 
BLOC-2, AP-3, or AP-1, and the relative amounts of endogenous Rab38 or Rab32 in the 
membrane fraction were determined by quantitative immunoblotting (17).  About 60% of Rab38 
and 95% of Rab32 were found in the membrane fractions of control MNT-1 cells, indicating a 
stronger Rab32-membrane association at steady state (Figure 2.5A).  Interestingly, the relative 
amounts of Rab38 recovered from membranes were reduced to about 25% in AP-3-deficient 
cells and to less than 10% in BLOC-2- deficient cells (Figure 2.5A).  Deficiency of AP-1, 
however, did not have a statistically significant effect in the fraction of Rab38 recovered from 
membranes.  The relative amount of Rab32 recovered from membranes was somewhat decreased 
by deficiency in AP-3 or BLOC-2 compared to control cells, but the difference did not reach 
statistical significance (Figure 2.5A). Deficiency of AP-1 had no effect on the Rab32 membrane-
associated pool.  In several replicates of these experiments, the overall amount of Rab38 was 
noticeably reduced in BLOC-2 deficient cells. Hence, quantitative immunoblotting analysis of 
the total amount of Rab38 was carried out in extracts from control MNT-1 cells or cells deficient 
for AP-1, AP-3, BLOC-2 or double deficient for AP-3 and BLOC-2. 
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The total amount of Rab38 was significantly reduced in cells deficient for BLOC-2 or 
both BLOC-2 and AP-3, but not in AP-1 or AP-3 deficient cells (Figure 2.5B).  A similar 
analysis for Rab32 showed only a marginal decrease in BLOC-2 deficient cells (Figure 2.5B).  
Together, the data suggest that both AP-3 and BLOC-2 regulate or stabilize the Rab38 
association with membranes and that BLOC-2 also regulates overall stability of Rab38. The 
stronger link between Rab38 and BLOC-2 prompted us to examine the converse relationship, i.e. 
if the association of BLOC-2 with membranes was affected by deficiency of Rab38.  Indeed, the 
relative amounts of BLOC-2 recovered from membrane fractions decreased from about 40% in 
control cells to 20% in Rab38 deficient cells (Figure 2.5C).  In contrast, deficiency of Rab32 did 
not have any statistically significant effect on the relative amounts of BLOC-2 recovered from 
membrane fractions (Figure 2.5C).  Overall the data suggests a stronger connection between 
Rab38 and the ubiquitous components of trafficking machinery (AP-3, BLOC-2), compared to 
Rab32. 
 
2.4.3 BLOC-2, AP-3, and AP-1 partially colocalize with Rab38 and Rab32  
It is well established that the bulk of both AP-3 and AP-1 localize to clathrin coated buds 
on early endosome-associated tubules in MNT-1 and other melanocytic cells (15,17,20).  This 
has been shown by immunoelectron microscopy and immunofluorescence microscopy with 
antibodies to the endogenous complexes (15,17,20).  Endogenous BLOC-2 was also localized to 
MNT-1 early endosome-associated tubules by immunoelectron microscopy (17).  Given the 
observed physical association and effect on recruitment to membranes (Figs. 2.3-2.5), we sought 
to determine whether AP-3, AP-1, and BLOC-2 colocalize with Rab38 and Rab32 in MNT-1 
cells.  Confocal immunofluorescence microcopy was carried out using the same antibodies to 
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AP-3, AP-1, or BLOC-2 as in previous reports (15,17,20), and our new antibodies to Rab38 and 
Rab32 (Figure 2.1 and 2.2).  Analysis of untreated cell stainings revealed that Rab38 has more 
cytosolic distribution compared to Rab32 and that Rab32 stains more structures which is 
consistent with the biochemical evidence of membrane associated fractions for these Rabs 
(Figure 2.5A, 2.6, and 2.7).  An examination of subcellular distribution of endogenous Rab38 
and Rab32 showed that both proteins are mainly found in small punctae in perinuclear and 
peripheral regions of MNT-1 cells (Figure 2.6 and 2.7).  Specificity of the staining with Rab38 
and Rab32 antibodies was demonstrated by the drastic signal reduction observed upon siRNA 
knockdown of the corresponding Rab protein (Figure 2.8).  A significant degree of colocalization 
was observed between the adaptor proteins AP-3 (48 ± 2 %) or AP-1 (57 ± 2 %), and Rab38 in 
several independent experiments analyzing at least 45 cells (see Materials and Methods for 
further details) (Figure 2.6).  There is no discernible difference between AP-3 and AP-1 
structures labeled by Rab38 and those without Rab38 and both types of structures are seen 
throughout the cell.  AP-3 and AP-1 also partially colocalized with Rab32 albeit to a lower 
extent than with Rab38 (35 ± 1 % and 37 ± 1 % respectively) (Figure 2.6 and 2.7), which 
suggests that the adaptor proteins may function more closely associated with Rab38 than with 
Rab32.  Interestingly, a significant amount of colocalization was observed between clathrin and 
Rab38 or Rab32 (Figure 2.6 and 2.7).  Paralleling the relative levels of colocalization with the 
adaptors, a higher degree of colocalization was observed between clathrin and Rab38 (49 ± 3 %) 




Figure 2. 6 
Rab38 partially colocalizes to proteins required in the trafficking from specialized early endosomal 
domains to melanosomes.  MNT-1 cells were fixed/permeabilized and costained with antibodies against 
Rab38 (A, D, G, J) and the # subunit of AP-3 (B), the % subunit of AP-1 (E), the HPS6 subunit of 
BLOC-2 (H), or the clathrin heavy chain (K). Cells were imaged by confocal fluorescence microscopy 
and Rab38 was found both on small structures and in diffuse staining distributed throughout the cells.  A 
significant number of AP-3 (B), AP-1 (E), BLOC-2 (H), and Clathrin (K) labeled structures show 
colocalization with Rab38 in the merged images (C, F, I, and L). Boxed areas are shown in the 




Figure 2. 7 
Rab32 partially colocalizes to proteins required in the trafficking from early  
endosomes to melanosomes.  MNT-1 cells were fixed/permeabilized and costained with antibodies 
against Rab32 (A, D, G, J) and the # subunit of AP-3 (B), the % subunit of AP-1 (E), the HPS6 subunit of 
BLOC-2 (H), or the clathrin heavy chain (K). Cells were imaged by confocal fluorescence microscopy 
and Rab32 was mainly found on small structures distributed throughout the cells.  Numerous AP-3 (B), 
AP-1 (E), BLOC-2 (H), and Clathrin (K) labeled structures show colocalization with Rab32 in the 
merged images (C, F, I, and L), although to a lesser extent than with Rab38. Boxed areas are shown in 





Figure 2. 8 
Validation of antibodies against Rab32 and Rab38 for immunofluorescence microscopy.  MNT-1 
cells were subjected to Rab32 or Rab38 siRNA treatment, fixed/permeabilized, and stained with 
affinity-purified antibodies against Rab32 or Rab38 generated in both rat and rabbit.  Cells were 
imaged by confocal fluorescence microscopy and the Slidebook software was used to generate 
automated masks covering numerous individual cells and total fluorescence intensity was quantified 











Together the data indicates Rab38 and Rab32 are likely recruited to early endosomes during the 
vesicle budding process before the clathrin coat has disassembled.  The relative levels of 
colocalization of AP-3, AP-1, and clathrin with each Rab showed a consistent difference, 
perhaps indicating Rab38 is recruited earlier than Rab32 during coat formation. In addition, 
BLOC-2 labeled structures also showed partial colocalization with Rab38 or Rab32 but to a 
similar extent (Figure 2.6 and 2.7).  Although the molecular function of BLOC-2 is not clear, it 
has been suggested to operate both at early endosome associated tubules and also in downstream 
transport intermediates (14,17,18).  It is possible that the Rabs are recruited to nascent vesicles, 
where they interact with AP-3, AP-1, or BLOC-2, and then remain associated with the vesicles 
along with BLOC-2.    
The above data is compatible with a role of Rab38 and Rab32 in a pathway from 
specialized early endosome associated tubules – defined by AP-3, AP-1, and BLOC-2 – to 
maturing melanosomes (Fig. 2.9). As a control for colocalization between the Rabs and other 
early endosomal domains, we tested for colocalization with EEA1 and the retromer complex 
subunit SNX1 which label the vacuolar domain of early endosomes and a retrieval pathway to 
the trans-Golgi network, respectively (Figure 2.10). Rab38 showed a very low level of 
colocalization with EEA1 (4 ± 1 %) and SNX1 (4 ± 1 %) (Figure 2.10) that was comparable with 
the colocalization of Rab38 and peroxisomal markers used as negative controls and quantified 
with the same image analysis procedure (see Materials and Methods for further details). 
Likewise, Rab32 displayed very low level of colocalization with EEA1 (4 ± 1 %) and SNX1 (5 ± 




Figure 2. 9 
Model for AP-3, AP-1, and BLOC-2 cooperation with Rab38 and Rab32 to mediate transport to 
maturing melanosomes.  Rab38 and Rab32 interact with AP-3, AP-1, and BLOC-2 at early endosome 
membrane domains where cargo such as the tyrosinase family proteins are concentrated and packaged 
into transport intermediates.  Upon budding, some components of the coat (AP-3, AP-1, clathrin) 
dissociate from the vesicle but others remain bound (Rab32, Rab38, and possibly BLOC-2) to mediate 
further transport, tethering, and fusion with maturing melanosomes.  During melanosome biogenesis, 
transition between stage II and stage III occurs upon incorporation of the melanogenic enzymes with 
the concomitant beginning of melanin synthesis, thus vesicles defined by Rab32 and Rab38 likely 
target this melanosome maturation stage. Deficiency in different components of these pathways elicits 
cargo accumulation in the early endosomes that eventually leaks into other pathways such as the 
recycling pathway towards the plasma membrane or the late endosome/multi vesicular body (MVB) 






Figure 2. 10 
Rab38 and Rab32 do not colocalize to proteins that label early endosome vacuolar domains or the 
retrieval pathway to the trans-Golgi network.  MNT-1 cells were fixed/permeabilized and costained with 
antibodies against Rab38 (A, G) or Rab32 (D, J) and Early Endosome Antigen 1, EEA1 (B, E), or the 
retromer subunit Sorting Nexin 1, SNX1 (H, K). Cells were imaged by confocal fluorescence microscopy 
and only background levels of colocalization were detected in the merged images (C, F, I, and L). Boxed 






We also tested for colocalization between each of Rab38 and Rab32 with melanosome and 
lysosome markers.  We used Tyrp-1 as a well-established melanosomal marker that at steady 
state primarily labels stage III and IV melanosomes and internalized dextran chased for 4 hours 
to label mature lysosomes (Figure 2.11). Both Rab38 and Rab32 showed partial colocalization 
with Tyrp-1 (36 ± 7 % and 36 ± 6 %, respectively) and negligible colocalization with 
internalized dextran (1 ± 2 % and 2 ± 2 %) (Figure 2.11). 
 
2.4.4 Melanocytes deficient for Rab38 and Rab32 display abnormal cargo trafficking and steady 
state levels    
In cells deficient for the ubiquitous components of the trafficking machinery, such as AP-3, AP-1 
and BLOC-2, newly synthesized integral membrane protein cargo are not properly sorted and 
accumulate in early endosomes.  This has been shown both for lysosomal cargo such as LAMP-1 
in non-specialized cells and for melanosomal cargo such as tyrosinase and Tyrp-1 in 
melanocytes (3,11,13-15,17-20,40,44).  Cargo accumulated in early endosomes can subsequently 
leak into the recycling pathway to the plasma membrane or enter into the ESCRT-dependent 
multivesicular body (MVB) pathway for degradation (Figure 2.9) (3,11,13-15,17-20,40,44).  
Therefore, as a consequence of disrupting the normal early endosome to melanosome transport, 
cargo proteins exhibit increased traffic via the plasma membrane and/or are subjected to 
degradation (3,11,13-15,17-20,40,44).  Melanocytes isolated from AP-3 or BLOC-2 deficient 
mice showed both phenotypes (recycling through the plasma membrane and degradation) when 
endogenous Tyrp-1 was analyzed (17). Melanocytes from AP-3/BLOC-2 double mutant mice 




Figure 2. 11 
Rab38 and Rab32 partially colocalize to melanosomes but not to lysosomes.  MNT-1 cells were 
fixed/permeabilized and costained with antibodies against Rab38 (A) or Rab32 (D) and the 
melanosomal protein Tyrp-1 (B, E). Alternatively, cells were allowed to internalize dextran-Alexa-
647, followed by a chase period of 4 hours to ensure specific labeling of mature lysosomes (H, K), 
fixed/permeabilized and stained with antibodies against Rab38 (G) or Rab32 (J). Cells were imaged 
by confocal fluorescence microscopy and both Rab38 and Rab32 were found to partially colocalize 
with the melanosome marker Tyrp-1 (C, F) but not with lysosomes (I, L) in the merged images.  





Here, we sought to determine if Rab38 and Rab32 deficiency also elicits such phenotypes.  Live 
MNT-1 cells subjected to siRNA treatment targeting each Rab alone or both simultaneously 
were incubated with antibodies to the luminal domain of Tyrp-1 for 20 minutes and then 
fixed/permeabilized and processed for fluorescence microscopy.  The total fluorescence intensity 
signal per cell (internalized antibody) was determined for numerous cells per treatment (48 to 
231 cells per treatment), averaged, and normalized to that of control cells (Figure 2.12). 
Deficiency of either Rab38 or Rab32 produces a statistically significant but modest recycling 
phenotype. 
Simultaneous deficiency of both Rabs elicits a more pronounced recycling phenotype 
than either Rab alone.  Thus, these results suggest Rab38 and Rab32 are involved in Tyrp-1 
transport from early endosomes to maturing melanosomes.  In order to compare the relative 
severity of the Tyrp-1 recycling phenotype, similar experiments were carried out in parallel with 
cells deficient for AP-3 or AP-1 (Figure 2.12).  The level of Tyrp-1 recycling in Rab deficient 
cells was comparable to that observed in AP-1 deficient cells but less severe than in AP-3 
deficient cells assayed under the same conditions.   
A possible caveat with the antibody internalization assay is that the observed surface 
expression of Tyrp-1 could be secondary to increases in total Tyrp-1 expression.  This possibility 
was addressed by quantitative Tyrp-1 immunoblotting analysis of crude extracts from MNT-1 
cells subjected to the corresponding siRNA treatment (Figure 2.13A).  Single Rab38 or Rab32 
deficiency caused a marginal decrease in the total levels of Tyrp-1, compared to control cells.  
Deficiency in both Rabs caused a more marked decrease in overall Tyrp-1 levels (Figure 2.13A).  




Figure 2. 12 
Knockdown of Rab32 or Rab38 cause mistrafficking of Tyrp-1.  Live MNT-1 control cells or cells 
deficient for AP-3, AP-1, Rab32, Rab38, or both Rab32 and Rab38 were incubated in media containing 
a mouse anti-Tyrp-1 antibody for 20 minutes at 37°C and subsequently fixed, permeabilized, and 
immunostained with an Alexa-488 conjugated anti-mouse IgG. Cells were imaged using an 
epifluorescent microscope and the relative amounts of internalized anti-Tyrp-1 antibody was estimated 
as the average fluorescence intensity per cell determined with ImageJ and normalized to control cells 
(means ± SD). Result from at least three independent experiments, N > 48 for each treatment, were 
compared with control cells (or between the Rab32/Rab38 double knockdown and the corresponding 









Figure 2. 13 
Rab32 and Rab38 are required for normal steady state levels of tyrosinase, Tyrp-1, and Tyrp-2 and are 
not fully redundant in overall melanosome biogenesis. A, Immunoblotting analysis of total cell extracts 
from control MNT-1 cells and cells deficient for Rab32, Rab38, or both Rab32 and Rab38 was performed 
and quantified to determine the total abundance of tyrosinase (black), Tyrp-1 (grey), and Tyrp-2 (white) 
relative to control cells. Results correspond to three independent experiments normalized to number of 
cells, and compared using the t test, * p<0.05, ** p<0.01.  B, Melanin was extracted from MNT-1 control 
cells or cells deficient for AP-1, Rab32, Rab38, or both Rab32 and Rab38 and quantified by a 
spectrophotometric method. Results correspond to at least three independent experiments normalized to 










an overall increase in Tyrp-1 expression.  Moreover, a lower steady state level of Tyrp-1 in Rab 
deficient cells would be consistent with a scenario in which the melanogenic enzyme cannot 
properly traffic from early endosomes to maturing melanosomes, thus accumulating in early 
endosomes and leaking into the degradative MVB pathway (Figure 2.9).  Following the same 
approach, extracts from MNT-1 cells deficient for each Rab or both simultaneously were 
analyzed for the total amounts of tyrosinase and Tyrp-2, the other two enzymes responsible for 
melanin synthesis in melanosomes.  Tyrosinase was somewhat reduced in Rab38 or Rab32 
deficient cells and more so in the double deficient cells, compared to control cells (Figure 
2.13A). Tyrosinase and Tyrp-1 followed a similar trend although the defect was more marked for 
tyrosinase. 
Notably, Tyrp-2 showed a very strong reduction in Rab32 deficient cells but normal 
levels in Rab38 deficient cells (Figure 2.13A).  The steady state levels of tyrosinase, Tyrp-1, and 
Tyrp-2 in single and double Rab-deficient cells were partially rescued by incubation with the 
lysosomal protease inhibitor leupeptin in agreement with mistrafficking to the degradative 
pathway in the absence of Rab32/Rab38 (Fig 2.14). Taken together, these results are consistent 
with a model in which the Rabs function in the traffic of all three tyrosinase family members 
from early endosomes to maturing melanosomes.  In addition, these results underscore 
similarities and differences between the Rabs in melanosome biogenesis.  On the one hand, both 
Rabs appear to be involved in the transport of tyrosinase and Tyrp-1 in an epistatic fashion such 
that deficiency in one Rab is not severe because the other Rab can still carry out transport, but 
deficiency in both Rabs results in a more important phenotype.  On the other hand, Rab32 is 
strictly necessary to maintain normal Tyrp-2 steady state levels, suggesting Rab32 has unique 




Figure 2. 14 
Partial rescue of tyrosinase, Tyrp-1, and Tyrp-2 steady state levels by leupeptin treatment on Rab32- 
and Rab38-deficient cells.  Control MNT-1 cells and cells deficient for Rab32, Rab38, or both Rab32 
and Rab38 were incubated with leupeptin for 6 hours, total cell extracts were prepared, and the total 
abundance of tyrosinase (black), Tyrp-1 (grey), and Tyrp-2 (white) analyzed by immunoblotting.  
Results correspond to three independent experiments normalized to number of cells, represented 
relative to control cells, and compared using the t test, *p<0.05, ** p<0.01. Notice the higher 
abundance of tyrosinase, Tyrp-1, and Tyrp-2 (rescue) compared to knockdown cells not treated with 










2.4.5 Rab32 and Rab38 functions in melanosome biogenesis are partially redundant  
Another unresolved matter concerns the relative overall relevance of each Rab for 
melanosome biogenesis (27,33).  Are they able to functionally compensate for each other?  The  
fact that the Rab38 mutant mice, chocolate, is hypopigmented indicates that Rab32 cannot fully 
compensate for Rab38 deficiency (25).  Is the converse also true? Analysis of the cargo enzymes 
suggests partial functional compensation between the Rabs for tyrosinase and Tyrp-1 traffic to 
maturing melanosomes but Rab32 appears to be strictly necessary for normal Tyrp-2 traffic 
(Figs. 2.12 and 2.13). 
Analysis of particular cargo proteins gives important clues but also has its limitations and 
we do not yet know the identity or roles of all the cargo proteins involved in melanosome 
formation (45).  Therefore, overall melanin production is probably the most faithful and 
quantitative measure of proper melanosome biogenesis and an adequate way to determine to 
what extent a particular component is needed (9,17,20,46).  By visual inspection, we consistently 
noticed that Rab32 deficient MNT-1 cells were significantly hypopigmented, even more so than 
cells deficient for Rab38.  This was particularly apparent after collecting the cells by 
centrifugation.  To test whether the observed differences were significant, total melanin was 
extracted and quantified from MNT-1 control cells or cells deficient for Rab38, Rab32, or 
simultaneously both Rab38 and Rab32.  Several independent replicates were carried out and AP-
1 deficient cells were also analyzed for comparison.  Consistent with the mild hypopigmentation 
of chocolate mice, Rab38 deficiency caused a moderate loss of melanin in MNT-1 cells (Figure 
2.13B). Importantly, Rab32 deficient MNT-1 cells contained less melanin than control cells (and 
Rab38 or AP-1 deficient cells) (Figure 2.13B).  This result suggests Rab32 is a critical 
component for mature melanosome biogenesis and that Rab38 cannot fully compensate for 
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Rab32 deficiency. Consistent with a significant role for Ra32 in overall melanosome biogenesis, 
Rab32/Rab38 double deficiency did not significantly worsen the phenotype elicited by Rab32 
single deficiency (Figure 2.13B).  One trivial explanation for these results is that MNT-1 cells 
may express substantially more Rab32 than Rab38 but we found comparable amounts of both 
Rabs by quantitative immunoblotting of total cell extracts.  In fact, Rab38 is expressed at slightly 
higher rather than lower levels compared to Rab32 (130 versus 89 pg of Rab per µg of total 
proteins) (Figure 2.15).  Additionally, no compensatory up-regulation of Rab32 was observed 
upon siRNA knockdown of Rab38 or vice versa (Figure 2.2). Taken together, these results imply 
that the Rabs cannot fully functionally compensate for each other during biogenesis of mature 
melanosomes.  
 
2.4.6 Melanocytes deficient for BLOC-3 but not BLOC-1 display abnormal Tyrp-2 steady state 
levels 
To test the possibility that Tyrp-2 transport depends on BLOC-1 or BLOC-3, we carried 
out quantitative Tyrp-2 immunoblotting analysis of crude extracts from MNT-1 cells subjected to 
the corresponding siRNA treatment (Figure 2.16).  MNT-1 cells deficient for BLOC-3 displayed 
a statistically significant decrease in Tyrp-2 steady state levels, while BLOC-1 deficiency had no 






Figure 2. 15 
MNT-1 cells express similar amounts of Rab32 and Rab38. MNT-1 total extracts (77 &g) were 
analyzed by immunoblotting using the corresponding rabbit anti-Rab32 or anti-Rab38 antibodies 
together with His-Rab32 or His-Rab38 samples containing the indicated mass of protein. The 
intensity of the bands was determined by chemifluorescent detection and the amount of Rab32 and 
Rab38 in MNT-1 total extract was calculated by comparison with the His-Rab32 and His-Rab38 











Figure 2. 16 
Cells deficient for BLOC-3 display abnormal Tyrp-2 steady state levels. Immunoblotting analysis of 
total cell extracts from control MNT-1 cells and cells deficient for BLOC-3, or BLOC-1 was performed 
and quantified to determine the total abundance of Tyrp-2 relative to control cells. Results correspond 
to three independent experiments normalized to number of cells, and compared using the t test, * 












The finding that cell type specific Rab38 and Rab32 are involved in the biogenesis of LROs 
raised the possibility that these proteins could operate together with the ubiquitous trafficking 
machinery for transport towards LROs in specialized cell types (24-31).  However, no evidence 
has been reported for a link between the BLOC or AP complexes involved in LRO biogenesis 
and Rab38 or Rab32.  In this study, we demonstrate that AP-3, AP-1, and BLOC-2 interact 
physically and functionally with Rab38 and Rab32 to mediate transport of integral membrane 
proteins from specialized early endosomal domains to maturing melanosomes.  
We show that endogenous Rab38 and Rab32 can associate with AP-3, AP-1, and BLOC-
2 into macromolecular assemblies that are stable enough to allow detection by 
coimmunoprecipitation (Figure 2.3).  Our results show the interactions between the Rabs and 
AP-3, AP-1 and BLOC-2 occur on membranes but not in the cytosol, suggesting a role of the 
GTP-bound form of the Rabs. Indeed, in GST-Rab pulldown experiments the interactions 
showed a strong preference for the GTP form of the Rabs. Since cytosolic AP-3, AP-1, and 
BLOC-2 presumably represent the “free form” of these complexes, their interaction with purified 
GST-Rab38 and GST-Rab32 are likely direct, although the possibility of a bridging protein 
cannot be ruled out. Consistent with these physical interactions a significant degree of 
colocalization was observed between AP-3, AP-1, and BLOC-2 and the Rabs (Fig 2.6 and 2.7).  
The bulk of AP-3 and AP-1 has been shown to localize to coated structures budding off from 
distinct tubular early endosomes or vesicles in MNT-1 and other melanocytic cells (Figure 2.9) 
(15,17,20).  In line with these observations clathrin partially colocalized with the Rabs but 
markers of other endosomal domains, EEA1 and the retromer complex, did not. Moreover, 
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clathrin partially colocalized with Rab38 and Rab32 to a similar degree as the clathrin adaptors 
AP-3 and AP-1, suggesting that the Rabs are recruited in the budding process.  
In support of the idea that the interactions of AP-3, AP-1, and BLOC-2 with the Rabs are 
biologically relevant, we show that knockdown of either Rab38 or Rab32 or both simultaneously 
elicits the same phenotypes as deficiency in AP-3, AP-1, or BLOC-2.  On the one hand, 
deficiency in the Rabs causes enhanced Tyrp-1 recycling through the plasma membrane, a defect 
previously observed in primary melanocytes from AP-3 and BLOC-2 mutant mice and also 
detected here in MNT-1 cells deficient for AP-3 or AP-1 (Figure 2.12) (17).  On the other hand, 
Rab deficiency elicits reduced overall levels of the tyrosinase family members paralleling the 
results obtained with melanocytes from AP-3 and BLOC-2 mutant mice, or from HPS patients 
with mutations in AP-3 and BLOC-2 (Figure 2.13A) (17,47,48).  These cargo trafficking data, 
together with the physical interactions and colocalization results, are most consistent with a 
model in which the Rabs function in pathways from early endosome associated tubules to 
maturing melanosomes (Figure 2.9).  Such a location fits well with the established model for AP-
3-, AP-1-, and BLOC-2-dependent transport of tyrosinase and Tyrp-1 from early endosomes to 
maturing melanosomes and places the Rabs as acting downstream of the early endosome with 
potential roles in vesicle motility or fusion events (3,14,15,17,18,20,44).  This model also 
provides a satisfactory explanation to the observed cargo phenotypes.  Disruption of transport 
from early endosomes towards melanosomes causes accumulation of the cargo in early 
endosomes and leakage into the recycling pathway to the plasma membrane and/or into the 
degradative MVB/lysosomal pathway.  This model is also compatible with a previous electron 
microscopy study that found overexpressed GFP-Rab38 in both MNT-1 cells and mouse 
melanocytes localized to tubules, vesicles and melanosomes (27).  These three structures 
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(tubules, vesicles, and melanosomes) contained tyrosinase and Tyrp-1 and would correspond to 
the model donor compartment, transport intermediate, and target organelle, respectively (Figure 
2.9). In fact we also found that both endogenous Rab38 and Rab32 partially colocalize with 
melanosomes, thus supporting the proposed model (Figs. 2.9 and 2.11). Finally, this model is 
consistent with the recently discovered interaction between the Rab38/32 effector protein Varp 
and VAMP7 (46,49).  Varp plays a role in Tyrp-1 transport to the melanosome and VAMP7 is a 
well-known vesicle SNARE protein of the AP-3- and BLOC-1-dependent pathway involved in 
vesicle fusion with late endosomes/lysosomes (11,19).  Alternatively or in parallel, Rab32 and 
Rab38 might participate in a post-Golgi route that goes from the trans-Golgi Network (TGN) 
directly to the maturing melanosomes – without an early endosome step in between the TGN and 
melanosomes (27). For all the reasons discussed above we favor the early endosome route as the 
main Rab32/Rab38-dependent pathway to maturing melanosomes.   
The Tyrp-1 recycling phenotype found in AP-3 depleted MNT-1 cells (Figure 2.12) 
recapitulates a similar observation made with melanocytes from AP-3 mutant mice using the 
same approach (17).  This result seems to be at variance with that of a previous article reporting 
a relatively normal steady state localization of Tyrp-1 in fixed melanocytes from patients with 
AP-3 deficiency (48).  However, we note that the Tyrp-1 immunofluorescence staining shown in 
that report in AP-3–deficient melanocytes appears to be significantly less intense than in normal 
melanocytes (48), thus in agreement with our previous results with melanocytes from AP-3 
mutant mice (17) and results presented here with MNT-1 cells.  It is likely that in AP-3 deficient 
cells a proportion of Tyrp-1 molecules eventually reach the melanosomes using the AP-1/BLOC-
2 route(s) thus explaining the fixed cell analysis in the earlier report (48). The recycling assay 
with live cells is designed to detect molecules transiently exposed at the cell surface with high 
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sensitivity that would be difficult to appreciate at steady state by confocal fluorescence or thin 
section electron microscopy.  A complete understanding of adaptor requirement for transport of 
each tyrosinase family member will require further elucidation. 
Results presented here shed light on aspects of Rab38 and Rab32 that were previously 
unexplored (33).  Our findings suggest Rab38 and Rab32 have functional similarities and 
differences in melanosome biogenesis.  For instance, both Rabs interact with AP-3, AP-1, and 
BLOC-2 however the connection with Rab38 is stronger than with Rab32 and our data suggests 
it is possible that Rab38 operates earlier than Rab32 in the pathways from early endosomes to 
maturing melanosomes.  First, AP-3, AP-1, and clathrin display a higher degree of colocalization 
with Rab38 than with Rab32 (Figure 2.6 and 2.7).  Second, Rab38 association with membranes 
is decreased after knockdown of AP-3 or BLOC-2, but Rab32 is only marginally affected (Figure 
2.5A).  The functional relationship between Rab38 and BLOC-2 is particularly strong.  BLOC-2 
deficiency affected most severely the Rab38 association with membranes and also compromised 
the overall Rab38 stability (Figure 2.5A and 2.5B).  Conversely, Rab38 (but not Rab32) 
deficiency affected BLOC-2 association with membranes (Figure 2.5C).  This level of 
interdependence between BLOC-2 and Rab38 resembles the one observed between subunits of 
the same BLOC or AP complex (10,40).  For instance absence of a BLOC-2 subunit such as 
HPS3 causes a destabilization (although not complete absence) of the other 2 subunits (HPS5 
and HPS6) (50).  Further confirming the strong Rab38-BLOC-2 connection, the coat color of the 
chocolate mouse (with a Rab38 mutation) is very similar to the BLOC-2 mutant strains, cocoa 
(HPS3), ruby-eye (HPS6) and ruby-eye-2 (HPS5) (25,29,50).  Nevertheless, the Rab38 
association with BLOC-2 is likely transient rather than as components of a stable complex.  
Unlike AP-3 and AP-1, the molecular function of BLOC-2 is unknown.  The tight association 
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with Rab38 discovered here will help future elucidation of BLOC-2 function at the molecular 
level.  
Our results show additional similarities and differences between Rab38 and Rab32 in 
terms of their requirement for trafficking of specific cargoes and overall relevance for 
melanosome biogenesis.  Single deficiency in each Rab causes similar and relatively modest 
Tyrp-1 recycling phenotype or decrease in the steady state levels of tyrosinase and Tyrp-1 
(Figure 2.12, 2.13A).  In contrast, we observed drastically different effects for Tyrp-2 steady 
state levels, which were severely reduced in Rab32-deficient cells but not affected in Rab38-
deficient cells.  In addition, tyrosinase and Tyrp-1 trafficking phenotypes are more severe in cells 
simultaneously deficient for both Rabs, compared to single deficient cells (Figure 2.12, 2.13A).  
Thus, Rab32 appears to more clearly cooperate with Rab38 in pathways utilized by cargo such as 
tyrosinase and Tyrp-1, which are also known to depend on AP-3, AP-1, and BLOC-2 
(4,11,14,15,17,18,20,47,48,51).  Interestingly, the trafficking of Tyrp-2 has been far less 
characterized compared to that of tyrosinase and Tyrp-1.  Our data suggests Tyrp-2 utilizes a 
pathway in which Rab32 is strictly necessary and that it is at least partially different from those 
of tyrosinase and Tyrp-1 (Figure 2.13A). This result is consistent with the finding that Tyrp-1 but 
not Tyrp-2 associates with tyrosinase in murine melanocytes in vivo (52). This apparently 
Rab38-independent pathway towards melanosomes utilized by Tyrp-2, and perhaps other 
melanosome components would provide an explanation for the incomplete compensation by 
Rab38 in Rab32 deficient cells as assessed by melanin content (Figure 2.13B). Conversely, 
incomplete compensation by Rab32 in Rab38 deficient MNT-1 cells (Figure 2.13B) is consistent 
with the pigmentation defect of the chocolate mouse (25). Therefore the emerging picture is one 
in which the Rabs are only partially redundant for melanosome biogenesis. 
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An interesting question is how does Rab32 carry out its unique, non-Rab38 redundant 
functions in melanosome biogenesis such as Tyrp-2 traffic? As stated above, this trafficking 
route appears to be different from the routes used by tyrosinase and Tyrp-1, which are also 
known to depend on AP-3, AP-1, and BLOC-2 (4,11,14,15,17,18,20,47,48,51). It is possible that 
such Tyrp-2/Rab32 route is dependent on other components of the ubiquitous machinery 
involved in melanosome biogenesis, such as BLOC-1 or BLOC-3. Analysis of MNT-1 cells 
deficient for BLOC-3 showed significantly decreased steady state levels of Tyrp-2, while BLOC-
1 deficiency had no effect (Figure 2.16). The Tyrp-2 phenotype caused by BLOC-3 deficiency 
resembles that elicited by Rab32 deficiency (Figure 2.13A). This result raises the possibility that 
Rab32 participates in a separate route to melanosomes that is dependent on BLOC-3 and used by 
cargo such as Tyrp-2. The molecular function of BLOC-3 is unknown. Our results suggest a 
framework for the Rab32 unique functions (non-redundant with Rab38) and will be important for 
future studies aimed at elucidating the function of BLOC-3.  Rab32 may have additional unique 
functions unrelated to LRO biogenesis as it was also reported to modulate the mitochondrial-
associated membrane properties (53).  
In conclusion, our results point to a novel mechanism for directing the ubiquitous 
trafficking machinery from early endosomes towards maturing melanosomes and likely other 
LROs.  Tissue specific Rab proteins, Rab38 and Rab32, interact with AP-3, AP-1, and BLOC-2 
and likely identify specialized early endosomal domains for budding of transport intermediates 
destined to maturing melanosomes.  It is possible that an ubiquitous Rab could define analogous 
early endosomal domains for transport of membrane proteins to conventional lysosomes.  This 
could be the function of Rab7, which is involved in transport to lysosomes and has recently been 
shown to be co-recruited with AP-3 to artificial membranes containing the endosomal 
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phospholipid phosphatidylinositol-3 phosphate (54).  We also obtained evidence that the Rabs 
have both overlapping and exclusive functions for overall melanosome biogenesis and traffic of 
specific cargoes.  Further study is needed to dissect the mechanisms by which Rab38 and Rab32 
execute redundant and unique functions in trafficking to LROs. 
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NOVEL FUNCTION OF MYOSIN VC IN MELANOSOME BIOGENESIS THROUGH 
INTERACTIONS WITH MELANOSOMAL RAB GTPASES #"#"2 
 
3.1 Summary 
Class V myosins are actin-based motors with conserved functions in vesicle and 
organelle trafficking.  Myosin Vc, the third member of the mammalian Myosin V family, 
functions in secretory trafficking and ubiquitous recycling functions in specific cell types. 
 Herein, we report the novel discovery of a function for Myosin Vc in melanosome biogenesis as 
an effector of melanosome-associated Rab GTPases.  We demonstrate direct physical interaction 
between GTP-bound Rab7a, Rab8a, Rab32, and Rab38 and the tail of Myosin Vc in yeast 2-
hybrid assays and GST-pulldowns.  The binding of Rab32 and Rab38 to Myosin Vc depends on 
residues in the switch II region of the Rabs, and Rab binding is mapped to specific, partially 
overlapping regions of the coiled-coil tail domain of Myosin Vc.  Knockdown of Myosin Vc in 
MNT-1 melanocytes causes defects in the trafficking of Tyrp-1 and Tyrp-2 to melanosomes, but 
also significantly increases the abundance of pigmented melanosomes.  Fractionation of MNT-1 
cells demonstrates that Myosin Vc is not abundant on mature melanosomes and likely functions 
in vesicle trafficking, as opposed to Myosin Va and Myosin Vb that are both present on 
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melanosomes.  A comparison of the localization of Myosin Va, Myosin Vb, and Myosin Vc 
suggests that these motors function in different aspects of melanosome biogenesis and secretion. 
 
3.2 Introduction 
The pigmentation of tissues is responsible for the formation of hair and skin coloration in 
mammals, and serves the underlying function of protecting from UV-induced DNA damage.  In 
skin melanocytes, specialized cells responsible for pigment production, melanins are formed in a 
specialized lysosome-related organelle known as the melanosome.  Melanosomes, like all 
lysosome-related organelles, are similar to the ubiquitous lysosome; and the biogenesis of 
melanosomes uses similar mechanisms as the formation of lysosomes (1, 2, 3).  The melanosome 
is derived from an endosomal organelle through a combination of organelle remodeling and 
vesicular trafficking events that transport melanosome-specific proteins toward maturing 
melanosomes (4).   
The development, or maturation, of melanosomes is known to depend on discrete 
trafficking events and can be characterized into four distinct stages.  The least mature 
melanosomes, stage I, are formed by an unknown organelle remodeling event from an 
endosomal membrane.  Stage I melanosomes are characterized by the presence of the structural 
protein Pmel17 on the organelle limiting membrane and in intraluminal vesicles within the 
organelle, and by a distinctive clathrin lattice on the limiting membrane (4).  Within the 
environment of stage I melanosomes, Pmel17 proteins are cleaved by acid hydrolases (5, 6, 7).  
In stage II melanosomes, these Pmel17 fragments oligomerize and form amyloid-like fibrils that 
span the length of the melanosome, and are clearly evident in electron micrographs (8, 9).  The 
delivery of enzymes tyrosinase, Tyrp-1, and Tyrp-2 is needed for the synthesis of melanin and 
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facilitates the production of melanin pigments that coat the Pmel-fibrils to form partially 
pigmented stage III melanosomes (10).  Additional melanin synthesis generates fully pigmented 
stage IV melanosomes (10).  In skin, the stage IV melanosomes are transferred to keratinocytes, 
using unclear mechanisms, where they remain and form a pigmented cap around the keratinocyte 
nucleus (11, 12). 
In endosomal trafficking, Rab GTPases serve numerous functions in organelle 
remodeling and in vesicle trafficking; and serve as specific markers to distinguish endosomal 
trafficking pathways (13). Melanosome biogenesis is known to utilize a combination of 
ubiquitous endosomal Rabs and cell-type specific Rabs for different stages of melanosome 
maturation (4).  Cell-type specific Rab27a functions in the regulation of the sub-cellular 
distribution of melanosomes through interaction with the actin-based motor Myosin Va, in a 
tripartite complex with melanophilin (14, 15). Other cell-type specific proteins, Rab38 and 
Rab32 are important in the biogenesis of melanosomes and function in the vesicle trafficking of 
tyrosinase, Tyrp-1, and Tyrp-2 from early endosomes to melanosomes.  Rab32 and Rab38 act as 
tissue-specific proteins that allow for the trafficking of cargoes to the melanosome using 
ubiquitous early endosomal trafficking components AP-3, AP-1, and BLOC-2 (16, 17).  Less is 
known about the mechanisms used by ubiquitous Rabs, such as Rab7a, Rab8a, Rab17, and 
Rab11a/b that are known to function in cargo and organelle trafficking, that have been 
implicated with functions on melanosomes (18, 19, 20, 21, 22).   
The most clearly understood mechanism used by Rabs in melanosome biogenesis is the 
movement of stage IV melanosomes by the semi-stable complex composed of Rab27a, 
melanophilin, and Myosin Va.  Class V myosins are a well-conserved family of processive actin 
motors that function in vesicle and organelle trafficking events (23).  In melanocytes, the long-
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range movement of melanosomes is dependent on the functions of microtubule-based kinesin 
and dynein motors, but the proper transport of melanosomes to keratinocytes also depends on the 
actin-based transport of melanosomes using Myosin Va.  A cooperative capture model has been 
used to describe the movement of melanosomes as they are pulled off of microtubule tracks and 
into the cortical actin meshwork at the cell periphery by Myosin Va (24, 4).  In wild-type 
melanocytes, pigmented melanosomes accumulate along the plasma membrane of cells, and are 
especially enriched within dendritic projections that have been shown to be sites of melanosome 
transfer to keratinocytes (25). Lacking functional Myosin Va, Rab27a, or melanophilin 
pigmented melanosomes accumulate in perinuclear regions of cells and transfer to keratinocytes 
is diminished (14, 25, 26).  The other members of the mammalian class V Myosin family, 
Myosin Vb and Myosin Vc, function in the ubiquitous recycling of endocytic cargoes, such as 
the transferrin-receptor, and in some polarized trafficking and secretion functions in specialized 
cell types (27, 28, 29, 30).  Additional recycling endosomal Rabs, Rab17 and Rab11a/b have 
been implicated in melanosome biogenesis and secretion, but to date no direct evidence has 
demonstrated that other recycling endosomal machinery is required for normal melanosome 
trafficking (22). 
Here we report the novel discovery that Myosin Vc functions as an effector of Rab7a, 
Rab8a, Rab32, and Rab38 in the biogenesis and secretion of melanosomes.  Myosin Vc serves 
multiple functions in both the trafficking of cargoes to melanosomes and in the secretion of 
mature melanosomes, but interestingly is not abundant on mature melanosomes.  Further, we 
demonstrate that Myosin Vb is enriched on melanosomes, and that all three mammalian class V 




3.3 Results and Discussion 
3.3.1 Interaction of Myosin Vc with melanosome-associated Rab GTPases 
Previous work has identified Rab32 and Rab38 as key components in the biogenesis of 
lysosome-related organelles (16, 17, 31), but the mechanisms of action of these Rabs remains 
unclear.  To better understand the functions of Rab38, a yeast 2-hybrid screen was performed 
using the constitutively-active GTP-locked Rab38-Q69L mutant against a whole bone marrow 
library to identify Rab38 effector proteins.  Among the candidates, Myosin Vc appeared as a 
strongly interacting binding partner and was further tested for Rab38 binding. Myosin Vc is 
found to interact preferentially with the constitutively-active, GTP-locked mutants of Rab38 and 
with GTP-locked Rab32, but not with wild-type proteins (Figure 3.1A).  
Interestingly, Myosin Vc also interacts with constitutively-active Rab7a, and both the 
wild-type and constitutively-active Rab8a (Figure 3.1A).   A function for Myosin Vc as an 
effector of multiple Rabs in melanosome biogenesis is an interesting possibility.   However, 
controls for specificity of the interaction of Rabs with Myosin Vc are necessary to validate 
functional interactions.   Two obvious controls for binding are Rab11a and Rab27a, known 
binding partners of Myosin Vb and Myosin Va (27, 14).  Neither Rab11a, nor Rab27a interact 
with Myosin Vc (Figure 3.1A), suggesting that interactions between melanosome-associated 





Figure 3. 1 
Interaction of early melanosomal Rabs with Myosin Vc.  Yeast 2-hybrid assays with the full-tail of 
human Myosin Va (aa.908 –1855), Myosin Vb (aa.905-1848), and Myosin Vc (aa.898-1742) binding to 
human Rab GTPases associated with melanosome biogenesis in the GTP-locked, constitutively active 
state (Q-L mutations).  Cell growth in panels lacking histidine indicates physical interaction between 
Myosin V and Rabs.  Growth in higher concentrations of 3-amino-1,2,4-triazole (3-AT) demonstrates 
higher affinity binding.  (A) Myosin Vc binds to constitutively active Rab7a, Rab8a, Rab32, and Rab38, 
but not with Rab11a or Rab27a.  (B) Specificity of Rab interactions with class V Myosins.  Rab32 and 
Rab38 bind only to Myosin Vc, but Rab7a and Rab8a bind other class V myosins. (C,D) In vitro GST-
pulldowns demonstrate the direct binding of specific Rabs to His-Myosin Vc(aa.1121-1350). (E) 
Mapping binding of Rab8, Rab32, and Rab38 to Myosin Vc tail. (F) Rab7a independently binds to the 




In addition to the specificity of Myosin Vc binding, the specificity of Rab binding to 
other human class V myosins was tested (Figure 3.1B).  Rab7a has the least specificity in 
binding and is observed to weakly bind to Myosin Va, Myosin Vb, and Myosin Vc (Figure 
3.1B).  Rab8a, previously demonstrated to function in separate trafficking pathways with either 
Myosin Vb or Myosin Vc, is observed to interact with Myosin Vb and Myosin Vc, but not 
Myosin Va (Figure 3.1B).  Interestingly, Rab38 and Rab32 have the most specific binding to 
Myosin Vc, and neither Rab38 nor Rab32 bind Myosin Va or Myosin Vb (Figure 3.1B). Rab11a 
binds only Myosin Vb, as expected; and Rab27a shows no direct binding to any of the Myosins 
tested, which is expected based on the known necessity of melanophilin for Rab27a-Myosin Va 
interaction (32).  The specificity of constitutively active Rab32 and Rab38 binding to only 
Myosin Vc strongly suggests that Myosin Vc functions as an effector protein for these Rabs.  
Does Myosin Vc interact with multiple Rabs present in the same trafficking pathway?  Rabs are 
known to bind the globular tail and coiled-coil domains of class V myosins (33).  The globular 
tail of Myosin Vc alone does not interact with Rab38 and Rab32 and this region of the tail is not 
the binding site for these two Rabs.  To test the binding of these Rabs to Myosin Vc, in vitro 
GST-pulldowns were performed using purified GST-Rab fusion proteins and His-tagged Myosin 
Vc coiled-coil tail domain (aa.1121 – 1350) (Figure 3.1C, 3.1D).  GST-Rab38, GST-Rab32, 
GST-Rab8a, and GST-Rab7a are found to bind directly to the coiled-coil region of Myosin Vc 
only when the Rabs are pre-loaded with GTP-%-S, a non-hydrolysable analogue of GTP (Figure 
3.1C).  Rab32 appears to bind most strongly to Myosin Vc, while Rab7a shows the weakest 
binding (Figure 3.1C).  Consistent with yeast 2-hybrid assays (Figure 3.1A), GST-Rab11a and 
GST-Rab27a do not bind to the portion of Myosin Vc coiled-coil that binds Rab7a, Rab8a, 
Rab32, and Rab38 (Figure 3.1D).   
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Tissue specific alternative splicing of Myosin V-tail exons in the coiled-coil domain are 
prevalent and important for regulating specific Rab interactions (33).  In melanocyte cells, 
Myosin Va exists as an alternatively splice isoform containing exon F that is required for 
localization to melanosomes (34). Rab8a binding to Myosin Vc has been shown to dependent on 
the presence of exon D in the coiled-coil tail (33), but is this region also important for binding of 
Rab38, Rab32, and Rab7a?  Candidate exons in the tail of Myosin Vc were removed from the 
full-length tail and tested in yeast 2-hybrid assays with Rab7a, Rab8a, Rab32, and Rab38 (Figure 
3.1E).   Rab8a and Rab38 have partially overlapping binding sites that both utilize exon E 
(Figure 3.1E).  Similarly, Rab38 and Rab32 have partially overlapping binding sites with exon F 
(Figure 3.1E).  The binding of Rab7a is not mapped to these exons, but Rab7a is capable of 
binding both the coiled-coil and globular tail domains in the tail of Myosin Vc (Figure 3.1C, 
3.1E, 3.1F).  In MNT-1 melanocytes, the only isoform of Myosin Vc detected contained all of 
the exons D, E, and F - naming based on alignment with Myosin Va and Myosin Vb (29).  The 
possibility exists that Myosin Vc could simultaneously bind to specific Rabs with non-
overlapping binding sites (Figure 3.1E), but this cannot be determined by these experiments and 
will be an area of focus of future research.   
 
3.3.2 Myosin Vc binding depends on the switch II region of Rab38 and Rab32  
Previous studies investigating Rab-effector binding have found that exposed hydrophobic 
residues in the switch I, switch II, and hydrophobic triad of Rabs are important for interactions of 
Rabs with effectors (35, 36, 37).  Further, the only previously known effector of Rab38 and 
Rab32, Varp, interacts with specific residues in the switch II region of these Rabs (38).  Alanine-
based mutagenesis was performed for amino acids in the switch I, switch II, and hydrophobic 
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triad regions and a sub-family specific loop, shared by Rab9a, Rab38, and Rab32, was deleted 
(Figure 3.2A), and these mutants were tested for ability to interact with Myosin Vc (Figure 
3.2B).  Only mutation of the tyrosine residues present in the switch II regions of Rab38 (Y79A) 
and Rab32 (Y95A) disrupt the interaction with Myosin Vc (Figure 3.2B).  As both Varp and 
Myosin Vc bind to the switch II region, we mutated residues important for Rab interactions with 
Varp to determine if the same site is used to interact with Myosin Vc (Figure 3.2C, 3.2D).  Yeast 
2-hybrid experiments were performed with a longer growth period to detect subtle defects in 
binding of Rab mutants.  Mutation of adjacent valine residues individually in the switch II region 
does not appear to significantly decrease binding of Rab38 or Rab32 with Myosin Vc, but 
combined mutation of valine and tyrosine results in a loss of interaction with Myosin Vc (Figure 
3.2A, 3.2C). In vitro GST-pulldowns show that mutation of adjacent valine and tyrosine residues 
in the switch II region significantly decreases the binding of Rab32 and Rab38 to Myosin Vc 
(Figure 3.2D).  Therefore, Varp and Myosin Vc both act as Rab38 and Rab32 effectors that 
utilize the same binding site, but the functional implications of both effectors binding to the same 






Figure 3. 2 
Mapping Myosin Vc binding sites on Rab32 and Rab38. (A) Homology modeling of Rab32 onto the 
crystal structure of Rab4a (PDB 2bme).  Residues in pink are not required for the binding to Myosin Vc.  
Green residue, Valine94, is required for the binding of Rab32 effector Varp.  Yellow residue, Tyrosine95, 
is critical for the binding of Myosin Vc. (B) Yeast 2-hybrid assay with alanine mutants of constitutively 
active Rab38 and Rab32.  Mutation of Rab38Q69L-Y79 and Rab32Q85L-Y95 specifically disrupt 
interaction with Myosin Vc tail. (C) Yeast 2-hybrid assays with mutations that disrupt interactions with 
Rab38 and Rab32 effectors Varp and Myosin Vc. (D) In vitro GST-pulldowns with Rab double mutants 







3.3.3 Myosin Vc knockdown alters melanosome secretion 
The interaction between Rab38 and Rab32 with Myosin Vc is intriguing, but it is unclear 
if this interaction has any functional importance in melanosomes, or if Myosin Vc serves any 
functions in melanosome biogenesis.  To determine if Myosin Vc functions in melanocytes, 
siRNA-mediated knockdown against Myosin Vc was performed and cells analyzed after two 
siRNA treatments.  Importantly, the siRNA oligonucleotide found to cause significant 
knockdown of Myosin Vc does not knockdown related proteins Myosin Va or Myosin Vb 
(Figure 3.3A).  Rather, knockdown of Myosin Vc, but not scrambled siRNA oligonucleotide, 
results in a significant increase in the abundance of Myosin Va and Myosin Vb (Figure 3.3A).  
Further, knockdown of Myosin Vc causes a significant increase in the amount of melanin in 
MNT-1 melanocytes (Figure 3.3B).  Transmission-electron micrographs of control and Myosin 
Vc knockdown cells demonstrate that the increase in melanin is due to an increase in the 
abundance of pigmented stage III and IV melanosomes suggesting a role of Myosin Vc in 
secretion (Figure 3.3C).  As Myosin Va is found on mature melanosomes, the increase in Myosin 
Va and Myosin Vb may be caused by the increased melanosome content.  Alternatively, the 
increase in Myosin Va and Myosin Vb might reflect compensation for the loss of Myosin Vc 
functions by up regulation of Myosin Va and Myosin Vb.  The latter possibility would suggest 
that some degree of redundancy exists in the functions of Myosin Vc with Myosin Va or Myosin 
Vb.  Myosin Va knockdown results in perinuclear clustering of melanosomes without 
significantly affecting melanosome number or cell morphology (24, 39). Myosin Vc knockdown 
shows no obvious defects in melanosome localization or cellular morphology of MNT-1 cells, 
but significantly increases the number of pigmented melanosomes (Figure 3.3C).  Pigmented 
melanosomes are frequently observed in close proximity to the plasma membrane (Figure 3.3C).  
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The distinct phenotypes of Myosin Va and Myosin Vc knockdown suggest that Myosin Vc 
functions independently from Myosin Va in melanocytes.  
Consistent with increased abundance of pigmented melanosomes, Myosin Vc knockdown 
also causes an accumulation of some melanosome proteins (Figure 3.4A). The melanin 
synthesizing enzymes tyrosinase and Tyrp-1 are necessary for the production of melanin pigment 
within melanosomes, and these proteins are highly enriched in Myosin Vc knockdown samples 
(Figure 3.4A).  The SNARE VAMP7, thought to be a component of melanosome biogenesis or 
trafficking (38) is also enriched in knockdown samples (Figure 3.4A).  Does this enrichment of 
melanosome proteins reflect an increase in the number of pigmented of melanosomes (Figure 
3.3C), or is it an indirect result of up regulation of melanosomal production resulting from 
Myosin Vc knockdown?   Immunogold labeling of Pmel17 in electron micrographs of MNT-1 
cells demonstrates that knockdown of Myosin Vc results in an increase in the number of 
pigmented melanosomes, but has no effect on the abundance of less mature, striated 
melanosomes, which should have been increased if Myosin Vc knockdown was causing an 
increase in melanosome production (Figure 3.4C).  The increase in melanosomal proteins, 
therefore, reflects an increase in the abundance of pigmented melanosomes and is not a result of 
up regulation of melanosome production, and suggests that the accumulation of pigmented 





Figure 3. 3 
Myosin Vc knockdown causes accumulation of pigmented melanosomes. (A)  Immunoblotting of MNT-1 
extracts subjected to control or Myosin Vc siRNA knockdown.  Myosin Vc is highly depleted upon 
siRNA treatment, but Myosin Va and Myosin Vb are enriched in Myosin Vc depleted extracts. (B) 
Myosin Vc knockdown increases melanin content in MNT-1 detected in a spectroscopic method based on 
absorbance at 500 nm. (C) Myosin Vc knockdown results in accumulation of pigmented, stage III and IV, 
melanosomes in MNT-1 cells by ultra-thin Transmission Electron Microscopy.  Error bars represent 





Figure 3. 4 
Myosin Vc knockdown disrupts trafficking of specific melanosomal cargoes. (A) Immunoblotting of 
extracts from siRNA control and Myosin Vc treated MNT-1 cells.  Depletion of Myosin Vc results in an 
accumulation of melanin synthesizing enzymes tyrosinase and Tyrp-1, but a severe reduction in Tyrp-2. 
Pmel17 is highly enriched in Myosin Vc depleted samples. (B) Myosin Vc depletion results in 
mistrafficking of Tyrp-1 at early endosome exit sites in a Tyrp-1 recycling assay. (C) Electron 
micrographs (20,000x magnification) and analysis of Pmel17-immunogold (12mm) labeled melanosomes.  
“Pigmented melanosomes” reflects any pigmented organelle and “Striated melanosomes reflects any 
organelle structure labeled with Pmel17 that has visible striations.   Error bars represent standard error, * 




3.3.4 Myosin Vc knockdown causes defects in cargo trafficking to melanosomes 
In addition to defects in melanosome secretion, Myosin Vc depletion also causes defects 
in the trafficking of cargoes to melanosomes.   The trafficking of Tyrp-1 is disrupted, as detected 
in a recycling assay that demonstrates trafficking deficiency from early endosomes to 
melanosomes, by Myosin Vc knockdown (Figure 3.4B) (3, 17).  Further, Tyrp-2 abundance is 
severely decreased upon Myosin Vc knockdown (Figure 3.4A).  Previously it was shown that 
knockdown of Rab38 or Rab32 cause mistrafficking of Tyrp-1 (Figure 3.4B), and that Rab32 
knockdown reduces Tyrp-2 levels (17).  Interestingly, knockdown of Myosin Vc results in 
increased levels of multiple Rabs, including Rab32 (Figure 3.4A).  Therefore, the cargo 
mistrafficking phenotypes of Myosin Vc knockdown suggest functions of Myosin Vc in Tyrp-1 
and Tyrp-2 trafficking pathways that might depend on interaction with Rab32. 
The trafficking of Tyrp-2 is believed to utilize a different route than the trafficking of 
tyrosinase and Tyrp-1, which relies on transport through recycling endosomes (40, 41).  Defects 
in the trafficking pathways used by Tyrp-1 and Tyrp-2 suggests that Myosin Vc may function at 
a recycling or early endosomal trafficking step, in addition to defects in melanosome secretion 
observed in Myosin Vc knockdown (Figure 3.3). Nevertheless, sufficient trafficking to 
melanosomes occurs to allow the production of pigmented melanosomes (Figure 3.3B, 3.3C).  
The bimodal phenotypes in Myosin Vc knockdown may reflect dual functions in melanosome 
biogenesis and trafficking, or instead may be due to defects in the trafficking of components 
necessary for melanosome secretion.   
Based on the severe melanosome secretion defect and cargo mistrafficking observed by 
Myosin Vc knockdown it is clear that Myosin Vc serve an important function in these trafficking 
pathways.  Is there a functional connection between Myosin Vc and the melanosome-associated 
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Rabs (Rab7a, Rab8a, Rab32, Rab38) to which it binds?  Knockdown of Rab38 and Rab32 can 
partially recapitulate defects in cargo trafficking observed in Myosin Vc knockdown (Figure 
3.4B) (17), but do interactions of Myosin Vc with Rab7a or Rab8a account for the melanosome 
secretion defects?  Melanosome-associated Rabs were knocked down and cells were assayed for 
the abundance of melanosome proteins observed to be altered by Myosin Vc knockdown (Figure 
3.5).  Knockdown of Rab7a, Rab8a, or Rab32 demonstrate a mistrafficking of Tyrp-2 (Figure 
3.5).   Accumulation of Pmel17 is also observed in Rab8a knockdown, but not significantly from 
knockdown of any other Rabs tested (Figure 3.5).  Knockdown of Rab27a, while only partially 
depleted, does not demonstrate the same phenotypes as observed with Myosin Vc knockdown, 
and reinforces a distinct phenotype of Myosin Vc knockdown than observed for Myosin Va.  
Knockdowns of multiple Rabs are able to partially recapitulate the phenotypes observed with 
Myosin Vc knockdown (Figure 3.5).  Notably, knockdown of some Rabs causes both the up 
regulation and down regulation of other Rabs: Rab7a knockdown appears to results in increased 
abundance of Rab8a and decreased abundance of Rab32; Rab8a knockdown results in increased 
Rab7a abundance; and Rab27a knockdown increases Rab7a and Rab8a abundance (Figure 3.5).  
This connection between Rabs may reflect redundancy and interdependence in the function and 
recruitment to melanosomes.  Myosin Vc may function in multiple steps in the biogenesis and 
secretion of melanosomes through interactions with different Rabs.    Myosin Vc functions as a 
Rab effector with functions in melanosome biogenesis (Ra7a, Rab8a, Rab32, and Rab38), and 





Figure 3. 5 
Knockdown of melanosome-associated Rabs demonstrates divergent effects in melanosome biogenesis 
and secretion.  Immunoblots of extracts from siRNA-treated MNT-1 cells demonstrate that depletion of 
melanosome-associated Rabs have different effects in the trafficking and abundance of melanosome 
cargoes tyrosinase, Tyrp-1, Tyrp-2, and Pmel17.  Depletion of several Rabs partially recapitulates the 
effects observed upon depletion of Myosin Vc.  Only knockdown of Rab8a results in Pmel17 







Tyrp-1 and Tyrp-2 cargo trafficking defects suggest that Myosin Vc functions at early 
endosomes, where the other Rab38/32 effector Varp functions.  Therefore, both effectors may 
function in the same step of trafficking between early endosomes and melanosomes.  
Surprisingly, knockdown of Myosin Vc results in decreased Varp abundance (Figure 3.4A).  
Such an effect is observed for proteins that functionally interact on membranes and form 
transient complexes, such as BLOC-2 and Rab38 (17).  It is unclear if Myosin Vc and Varp 
function in the same trafficking steps to melanosomes or if they interact with Rab38 and Rab32 
during discreet steps, but these two effectors appear to be functionally connected. 
 
3.3.5 Myosin Va and Myosin Vb are present on melanosomes but Myosin Vc is associated with 
vesicles 
To determine on which structures Myosin Vc functions in melanosome biogenesis, the 
subcellular distribution of Myosin Vc was assayed using sucrose gradient fractionation of 
untreated MNT-1 cells (Figure 3.6).  Melanosomes are concentrated in fractions 6-10 based on 
the fractionation patterns of melanosome proteins tyrosinase, Tyrp-1, Tyrp-2, and Pmel17 
(Figure 3.6).  SNARE VAMP7 and melanosome Rabs are also enriched in these fractions (Figure 
3.6).  Rabs also are highly enriched in fractions 1-2, which represent cytosolic and small vesicle 
fractions.  Interestingly, Myosin Vc is not abundant in melanosome fractions 6-10, but rather is 
enriched in fractions 1-2, and to some degree in fractions 3-5, which suggests that Myosin Vc 
functions primarily in a vesicle or endosomal trafficking step in melanosomes biogenesis instead 
of residing on melanosomes (Figure 3.6).  Myosin Va is primarily abundant in melanosome 
fractions 6-10, but also exists in some less dense fractions 4-5 that may correspond to other 
endosomal organelles (Figure 3.6).  Surprisingly, Myosin Vb is also present in dense 
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melanosome fractions 7-9, but is found most in vesicle fraction (fraction 2) and fractions that 
may correspond to recycling endosomes (fractions 5-6).  The resolution of this technique is not 
sufficient to fully differentiate between different endosomal organelles, but it does clearly 
demonstrate that Myosin Va and Myosin Vb are present on melanosomes while Myosin Vc is 
primarily present in vesicle and cytosolic fractions (Figure 3.6).   
It is also interesting to note that Varp and Myosin Vc have partially overlapping 
fractionation patterns.  Both Myosin Vc and Varp are present in cytosolic and vesicles fractions 
(fractions 1-2), and have partially overlapping distribution in less dense endosomal fractions 
(fractions 3-6).  However, it does not appear as Myosin Vc and Varp have identical distribution 
in endosomal fractions (fractions 3-6) and the identity of organelles in these fractions is not clear 
(Figure 3.6).  Based on the fractionation pattern of recycling endosomal Rab11a (fractions 1-5) 
and Myosin Vb (fractions 5-6), which are similar to the distribution of Myosin Vc, and suggests 
that Myosin Vc may also be present on recycling endosomes (Figure 3.6), as has previously been 
shown for other cell-types (29, 30).  Myosin Vc is not abundant on mature melanosomes, but 
rather appears to function in vesicles and at a less-dense endosomal membrane (Figure 3.6).  The 
defect in melanosome secretion observed from Myosin Vc knockdown is likely to occur through 
an indirect mechanism and be the result of mistrafficking of proteins to melanosomes that are 
required for melanosome secretion.    
 
3.3.6 Non-redundant functions of Myosin Va, Myosin Vb, and Myosin Vc in melanosomes? 
Previous studies have shown that Myosin Va is necessary for the peripheral localization 
of mature melanosomes, but that Myosin Va is not required for melanosome secretion (25).  The 




Figure 3. 6 
Myosin Vc is not abundant in melanosome-enriched cellular fractions.  20-55% sucrose gradients with 
ultracentrifugation at 55,000xg (?) were used to separate non-detergent treated MNT-1 extracts.  
Melanosome markers tyrosinase, Tyrp-1, Tyrp-2, and Pme17 should be primarily present in melanosomes 
at steady state.  Gradient fractions 6-10 are enriched in melanosome markers, and melanosome-associated 
Rabs Rab7a, Rab8a, Rab32, Rab38, and Rab27a.  Myosin Va is highly enriched in fractions 6-10, 
consistent with localization to mature melanosomes.  Myosin Vb is present in several fractions, including 
fractions enriched for melanosome markers.  Alternatively, Myosin Vc is present primarily in fractions 1-





Vb might also be involved in the melanosome movement and secretion (Figure 3.6).  Myosin Vc 
knockdown causes an accumulation of many proteins resident on melanosomes (Figure 3.3, 3.4, 
3.6).   Both Myosin Va and Myosin Vb are enriched in Myosin Vc knockdown extracts 
suggesting that Myosin Vb may also be present on melanosomes.   
An examination of the cellular distribution of Myosin Va, Myosin Vb, and Myosin Vc 
demonstrates that these three proteins exhibit partial colocalization, but have distinct distribution 
in MNT-1 cells (Figure 3.7A, 3.7B, 3.7C, 3.7D).  Colocalization of Myosin Va, Myosin Vb, and 
Myosin Vc is observed in some perinuclear clustered structures (Figure 3.7F).  Myosin Vb also 
strongly colocalizes with Myosin Va in dendrite projections of cells, which are known sites of 
melanosome secretion (Figure 3.7B, 3.7C, 3.7D, 3.7E) (25).  Myosin Vb partially colocalizes 
with Rab27a in dendrite projections and in some large Myosin Vb structures near the plasma 
membrane that are not in dendrites (Figure 3.8H), and may correspond to non-dendritic 
structures at which melanosome secretion has been shown to occur (25).  A role of recycling 
endosomes in melanosome secretion has previously been suspected due to roles of recycling 
endosomal Rab17, and potentially Rab11a/b, in secretion of melanosomes (22), and results 
presented here suggest that these functions also involve Myosin Vb (Figure 3.3A, 3.7E, 3.8).   
Colocalization of Myosin Va, Myosin Vb, and Myosin Vc in the perinuclear area of cells 
occurs at recycling endosomal structures where the transferrin-receptor is also present (Figure 
3.7D, 3.7F, 3.7J, 3.7K, 3.7L).  A single perinuclear cluster with Myosin Vb, Myosin Vc, and 
transferrin-receptor is observed in each cell, and in this area the highest colocalization of Myosin 
Vb and Myosin Vc occur (Figure 3.7J, 3.7K, 3.7L).  The function of this perinuclear cluster is 
unclear as little colocalization with melanosomal proteins is observed in this area (Figure 3.8).  




Figure 3. 7 
Sub-cellular distribution of human class V Myosins.  Confocal immunofluorescence microscopy images 
of untreated MNT-1 cells. (A) Myosin Vc is present primarily in perinuclear regions of cells in small and 
large punctuate structures. (B) Myosin Vb is found in small and large structures in perinuclear areas, and 
also in large structures at the ends of dendrite tips. (C) Myosin Va is found enriched along dendrites, it 
dendrite tips, and in some perinuclear clusters. (D) Merge of Myosin Vc, Vb, and Va. Colocalization 
occurs between Myosin Vb and Va at dendrite tips (E), which do not contain Myosin Vc (purple arrows).  
In perinuclear areas (D and F), Myosin Vc, Vb, and Va are observed to colocalize in punctuate clusters 
(white arrows). Some perinuclear structures with Myosin Vc (G) and Myosin Vb (H) also colocalize with 
transferrin-receptor (I, J, K, and L), but do not colocalize in more peripheral localizations (J, K, and L). A 
single, large cluster of Myosin Vc, Vb, and transferrin-receptor is present in each cell (J). (M) Analysis of 





Figure 3. 8 
Myosin Vc and Myosin Vb display similar localization to melanosome markers.  Confocal microscopy 
images of immunolabeled Myosin Vc (Alexa 488)(A,C,E,G), Myosin Vb (Alexa 488) (B,D,F,H) and 
melanosome markers Pmel17, Tyrp-1, Tyrp-2, and Rab27a (Alexa 546).  Both Myosin Vc (A,C,E,G) and 
Myosin Vb (B,D,F,H) show partial colocalization with early, Pmel17-labeled, melanosomes (A,B) and 
with more mature, pigmented melanosomes with Tyrp-1, Tyrp-2, and Rab27a labeling (C-H).  
Differences in the subcellular staining patterns and colocalization of Tyrp-2 with Myosin Vc and Myosin 
Vb suggest that it may utilize a different trafficking pathway, which is dependent on Myosin Vc and 






and Vc are present (Figure 3.8E, 3.8F), underlying previous reports that the trafficking of Tyrp-2 
may utilize a recycling endosomal pathway (40).  Overall, the cellular distribution of Myosin Vc 
strongly resembles Myosin Vb (Figure 3.7), and both motors colocalize with melanosome 
markers to a similar degree (Figure 3.8).  Myosin Vc exhibits only partial colocalization with 
melanosome markers Tyrp-1, Tyrp-2, Pmel17, and Rab27a (Figure 3.8), but sucrose gradient 
fractionation suggests that Myosin Vc is present primarily in vesicles at steady-state (Figure 3.6).  
Based on interaction with multiple melanosome-associated Rabs (Figure 3.1A) and the 
phenotypic connection of Myosin Vc with multiple Rabs (Figure 3.4A, 3.5), it is unclear if these 
Rabs function with Myosin Vc in a redundant or independent fashion.  The degree of 
colocalization of Myosin Vc with Rab7a, Rab8a, Rab32, and Rab38 suggests that Myosin Vc 
functions with each of these Rabs to some degree (Figure 3.9J).  Interestingly, Myosin Vc 
colocalizes with Rabs in two distinct cellular areas: perinuclear clusters of Myosin Vc at which 
Rab7a and Rab8a are present (Figure 3.9A, 3.9C, 3.9D, 3.9E) and the transition from cell body 
to dendrite extension where colocalization with Rab7a, Rab32, and Rab38 is observed (Figure 
3.9A, 3.9C, 3.9F, 3.G, 3.9H, 3.9I).  Despite strong binding and a functional connection with 
Rab8a (Figure 3.1A, 3.1D, 3.5), Myosin Vc colocalizes least with Rab8a and is found to 
colocalize most with Rab32 and Rab38 (Figure 3.9E, 3.9G, 3.9I, 3.9L).   The degree of 
colocalization observed between Myosin Vc with Rab32 and Rab38 is similar to the degree of 
colocalization observed between Rab32 and Rab38 with early endosomal vesicle budding sites 
(labeled by AP-3, AP-1, BLOC-2, and clathrin) or melanosomal cargoes Tyrp-1 and Tyrp-2 (17).  
The colocalization with Rab7a, Rab8a, Rab32, and Rab38 is consistent with Myosin Vc function 





Figure 3. 9 
Localization of melanosome-associated Rabs with Myosin Vc.  Confocal immunofluorescence images of 
Myosin Vc (Alexa 488) and Rab7a, Rab8a, Rab32, Rab38, and melanosome SNARE VAMP7 (Alexa 
546) (A-J).  Myosin Vc is observed to colocalize more strongly with Rab38, Rab32, and Rab7a than 
Rab8a (A-I).  Colocalization with Rab7a and Rab8a occur often in perinuclear areas (A-E).  Rab7a is also 
found in beginnings of dendrite extensions, as are Rab38 and Rab32 (A-C, F-I).  (J) Analysis of 












We demonstrate that Myosin Vc directly binds the active form of Rab7a, Rab8a, Rab32, 
and Rab38 and colocalizes with these Rabs in MNT-1 melanocyte cells (Figure 3.1, 3.2, 3.9).  
Myosin Vc likely functions as an effector of several of these Rabs in melanosome biogenesis as 
knockdown of each of these Rabs does not mimic the phenotypes observed in Myosin Vc 
knockdown (Figure 3.5).  Myosin Vc knockdown causes a dramatic increase in the number of 
pigmented melanosomes in MNT-1 cells, and these melanosomes do not shown any obviously 
altered localization compared to control (Figure 3.3).  Myosin Vc serves an important role in the 
trafficking of melanin-synthesizing enzymes to melanosomes, but mature melanosomes are still 
formed in cells with Myosin Vc knockdown (Figure 3.3, 3.4).  Myosin Va and Myosin Vc have 
different subcellular localization in MNT-1 cells, and Myosin Vc is found primarily in vesicles 
and does not strongly colocalize with sites of melanosome secretion (Figure 3.7, 3.6, 3.8).  
Notably, Myosin Vb also localizes to sites of melanosome secretion, is present in 
melanosome fractions in sucrose gradients, and shows a similar enrichment upon Myosin Vc 
knockdown as with several other melanosomal proteins (Figure 3.3, 3.6, 3.7).  However, Myosin 
Vb does not strongly colocalize with melanosome markers, and may function downstream of 
Myosin Va in the secretion of melanosomes (Figure 3.8).  A role for recycling endosomes has 
been suggested in the secretion of melanosomes, but to date no role for Myosin Vb in 
melanosome secretion has been suggested (22).  Localization of Myosin Vb at dendrite tips, 
where Myosin Va is enriched, and in some sites with Rab27a suggests that Myosin Vb and 
recycling endosomes serve a role in mature melanosome secretion (Figure 3.7, 3.8).   
The function and location of Myosin Vc on vesicles or organelles in melanosome 
biogenesis is not yet resolved.  Interactions of Myosin Vc with Rab7a, Rab32, and Rab38 - all 
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demonstrated to be present on non-melanosomal structures and on less mature melanosomes – 
are consistent with a role of Myosin Vc in melanosome biogenesis, rather than in melanosome 
secretion (19, 42).  Rab32 and Rab38 are established components in the vesicle, or perhaps 
tubular, trafficking between early endosomes and melanosomes (16, 17, 43).  Rab8a has been 
implicated in the non-Myosin Va dependent, actin-dependent movement of melanosomes (20, 
21), but it is unclear if these are functions of Myosin Vc, Myosin Vb, or both.  The localization 
of Rab8a on specific stages of melanosomes has not been determined, and may act in 
melanosome secretion.   
Complicating the understanding of Myosin Vc functions in this pathway are the 
interactions and colocalization with multiple Rabs in different cellular locations (Figure 3.1, 3.9).  
Does Myosin Vc serve different functions in different cellular locations with different Rabs?  Or 
do Rabs function redundantly to recruit Myosin Vc to membranes?   Unanswered questions also 
remain about the regulation of Myosin Va, Myosin Vc, and potentially Myosin Vb in this 
pathway.  How are the interactions of multiple Myosins with a single Rab regulated, and do 
different motors use the same Rab in this pathway?   Knockdown of Myosin Va and Myosin Vc 
have distinct phenotypes, suggesting that little functional overlap between these motors exist.  
What are the functions of Myosin Vb in this pathway? Outstanding questions about the function 
and redundancy of Rabs and class V myosins in melanosome biogenesis and secretion will 




Yeast 2-hybrid experiments were performed using PGBT9 and PGAD424 vectors 
(Clontech) using AH109 s. cerevisiae cells grown on Synthetic Dropout media lacking leucine 
and tryptophan as selection markers, as previously described (44).  3-amino-1,2,4-triazole (Alfa 
Aesar) was used to test for higher binding stringency.   Expression and purification of GST-Rabs 
and His-Myosin Vc were performed as previously described (17,44). In vitro GST-pulldowns 
were performed as previously described (17,44) using 50µg GST-Rab and 250µg His-Myosin 
Vc.  Transfection of MNT-1 cells was performed as previously described (17) using 
Nucleofector kit NHEM-Neo (Lonza).  Briefly, 1.5x106 cells were transfected with universal 
negative control siRNA (Sigma-Aldrich, SIC001), Myosin Vc siRNA (Sigma-Aldrich, 
SASI_Hs01_00184026), Rab7a (Sigma-Aldrich, SASI_Hs01_00104357), Rab8a (Sigma-
Aldrich, SASI_Hs02_00339466), Rab27a (Sigma-Aldrich, SASI_Hs01_00172591), Rab32 
(Sigma-Aldrich, SASI_Hs02_00342400), Rab38 (Sigma-Aldrich, SASI_Hs01_00247037) on 
days 1 and 4 as previously described (17).  Cells here harvested on day 7 for melanin assay as 
previously described (17), electron microscopy, or immunoblotting.  Total cell extracts were 
prepared using as previously described (17).  Antibodies used: Rabbit a-Myosin Va and Chicken 
a-Myosin Vb were the generous gifts of Richard Cheney (29), Mouse a-Myosin Va (Sigma-
Aldrich, G-4), Rabbit a-Myosin Vc (SDIX), Mouse a-tyrosinase (Santa Cruz, T311), Mouse a-
Tyrp-1 (Santa Cruz, clone MEL5), Mouse a-Tyrp-2 (Santa Cruz,  C-9), Mouse a-Pmel17 (Dako, 
HMB45), Rabbit a-Varp (Abcam), Mouse a-VAMP7 (Abcam, SYBL1), Mouse a-Rab7a (Sigma-
Aldrich, Rab7-117), Mouse a-Rab8a (BD, 610845), Mouse a-Rab27a (Santa Cruz, E12A-1), 
Rabbit a-Rab11a (Invitrogen, 71-5300), Mouse a-Rab32 (Sigma-Aldrich, 1C7) and Mouse a-
Rab38 (Santa Cruz, 11B-7) used for immunofluorescence, Rabbit a-Rab32 and Rabbit a-Rab38 
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used for immunoblotting (17), Mouse a-Transferrin-receptor (Invitrogen, 136800), and Mouse a-
$Tubulin (Sigma-Aldrich, T9026).  For immunofluorescence, cells were grown on matrigel 
coated coverslips and fixed in a 50/50 mixture of cold (-20C) methanol/acetone at room 
temperature for 10 minutes, allowed to dry, and stored in PBS + 0.1% azide at 4C.  Cells were 
permeabilized and blocked (17), incubated with primary antibody for 1 hour, and incubated with 
species specific secondary antibodies conjugated to Alexa-488, Alexa-546, or Alexa-647 
(Invitrogen).  Images were acquired on a spinning disc confocal microscope (3i, Denver) and 
analyzed using Slidebook software (3i).  Degree of colocalization was performed as previously 
described (17).  Tyrp-1 recycling assay performed as previously described (17). Fixation for 
electron microscopy, immunogold labeling, and electron micrographs were performed as 
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CONCLUSIONS AND IMPLICATIONS FROM STUDIES ON RAB32, RAB38, AND 
MYOSIN VC IN MELANOSOME BIOGENESIS 
 
4.1 Summary 
My studies on Rab32, Rab38 and Myosin Vc have helped to address the molecular 
mechanisms of trafficking from the early endosome to the melanosome and expand the 
knowledge of melanosome biogenesis.  My results also establish roles for multiple motor 
proteins in melanosome biogenesis, which acts as an interesting model system to study the 
coordination of distinct trafficking steps.  Below I discuss the implications of my findings in 
detail. 
 
4.2 Rab32 and Rab38 are a tissue-specific bridge underlying trafficking to melanosomes 
Prior to the start of this dissertation, one of the major questions in melanosome 
biogenesis was how ubiquitous lysosomal biogenesis machinery is used in melanosome 
biogenesis.  Some of the ubiquitous machinery had been established, and parallel pathways 
formed by AP-3, A-1 and BLOC-2 were known to serve critical functions in the trafficking of 
melanosomal cargoes at early endosomes (1, 2).  These complexes are critical for the formation 
of vesicles at early endosome exist sites, but, as AP-3, AP-1, and BLOC-2 also direct trafficking 
to the lysosomes, it was not clear how separate melanosome trafficking could co-exist (1, 2).  
Rab32 and Rab38 had been shown to function in melanosome trafficking downstream of the 
early endosome and were implicated in the formation of other lysosome-related organelles (3).  
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Therefore, Rab32 and Rab38 were candidates that might serve as the functional links between 
the ubiquitous lysosomal trafficking machinery and specialized melanosome traffic (3-7).   
My studies on interactions of Rab32 and Rab38 with ubiquitous trafficking machinery 
have served to functionally connect these Rabs to AP-3, AP-1, and BLOC-2 in melanosome 
trafficking.  Rab32 and Rab38 physically interact with AP-3, AP-1, and BLOC-2 in membrane 
fractions that can be stably co-immunoprecipitated (Figure 2.1).  These interactions occur with 
Rab32 and Rab38 when they are in the active, GTP-bound form only on membranes; and the 
presence of Rab38 and Rab32 on membranes is co-dependent with the presence of AP-3 and 
BLOC-2 (Figure 2.2, 2.3).  The membrane stability and cellular abundance of Rab38 is highly 
dependent on interactions with AP-3 and BLOC-2, but Rab32 is only mildly impacted by 
depletion of BLOC-2 or AP-3 (Figure 2.3).   The interactions of active Rab32 and Rab38 with 
early endosomal trafficking components is consistent with a function for these Rabs as factors 
that direct trafficking to melanosomes, instead of lysosomes. 
These findings highlight differences between Rab32 and Rab38 in both the degree of 
membrane localization of each Rab and in the functional dependence on AP-1, AP-3, and 
BLOC-2.  Rab32 is found to be associated with membranes to a much higher degree than Rab38, 
and does not seem to be impacted significantly by depletion of these early endosomal trafficking 
components (Figure 2.3). In contrast, Rab38 has a lower degree of membrane localization at 
steady state and the membrane stability of Rab38 is much more sensitive to depletion of AP-3 or 
BLOC-2 (Figure 2.3).  The functional connection between Rab38 and BLOC-2 is quite strong, as 
depletion of Rab38 results in decreased BLOC-2 membrane localization (Figure 2.3).  This 
interdependence of Rab38 and BLOC-2 on membranes is indicative of a transient complex, and 
suggests that BLOC-2 functions somewhat differently than AP-1 or AP-3 (1).  These differences 
160 
!
between Rab38 and Rab32 could reflect differences in sites of action, where Rab32 functions 
more downstream of early endosomes, or that Rab32 interacts with different early endosomal 
components that are responsible for recruitment and maintenance of Rab32 at specific early 
endosomal exit sites.   
In the MNT-1 melanocyte cell line, a well-established system of melanosome biogenesis, 
studies on the localization of Rab38 and Rab32 have also shown a function connection to the 
early endosome (Figure 2.3, 2.6, 2.7) (3).  Rab38 and Rab32 strongly colocalize with AP-3, AP-
1, and BLOC-2 on membranes (Figure 2.6, 2.7).  Colocalization of Rab38 and Rab32 with the 
coat protein clathrin suggests that these structures are vesicle budding sites (Figure 2.6, 2.7).  As 
AP-3, AP-1, and BLOC-2 have all been shown to function at early endosomal budding sites, this 
implicates Rab38 and Rab32 with early endosomal trafficking (1, 2).  The localization of Rab38 
and Rab32 to specific early endosomal subdomains labeled by AP-3, AP-1, and BLOC-2, but not 
to other endosomal domains that function in distinct trafficking pathways, suggests that these 
Rabs function in melanosome specific trafficking (Figure 2.6, 2.7, 2.10). 
My experiments show that Rab38 and Rab32 also localize to melanosomes and to other 
smaller structures containing tyrosinase and Tyrp-1, two enzymes necessary for melanosome 
synthesis.  Tyrosinase and Tyrp-1 are known to traffic through AP-3, AP-1, and BLOC-2 
dependent pathways in early endosomes, but are primarily enriched in melanosomes at steady 
state (Figure 2.10, 2.11, 3.6).  Notably, Rab38 and Rab32 do not localize to ubiquitous 
lysosomes, but are present on intermediate maturity stage II-IV melanosomes, demonstrating that 
these Rabs localize to a melanosome specific trafficking pathway (Figure 2.11)(3).  A previous 
study observed localization of over-expressed Rab38 to melanosomes and non-pigmented 
organelles by electron microscopy, and demonstrated that Rab38 partially colocalizes with 
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pigmented melanosomes (3).  My findings refine the localization of endogenous Rab38 and 
Rab32 to both early endosomes trafficking sites and to melanosomes, and show that Rab32 and 
Rab38 are not present at other early endosomal subdomains or lysosomes.  Based on these 
results, Rab32 and Rab38 appear to function in a trafficking step between early endosomes and 
melanosomes. 
Do Rab32 and Rab38 serve functions in vesicle trafficking or melanosome trafficking 
events?  A study published in recent years has compared the presence of Rab32, Rab38, and 
Rab27a on pigmented melanosomes, and observed that Rab32 and Rab38 are abundant on less 
mature, faster moving melanosomes that are associated with microtubule dependent transport 
(8).  However more mature, slower moving melanosomes, associated with Myosin Va dependent 
tethering in cortical actin, were found to contain Rab27a but very little Rab32 or Rab38 (8).  This 
result suggests that Rab32 and Rab38 are removed from melanosomes prior to Rab27a-
dependent functions, and that they define trafficking between early endosomes and stage II 
melanosomes (3, 8).  Therefore, the main function of Rab32 and Rab38 may be in the vesicle 
trafficking to melanosomes, but these Rabs may also serve some undefined functions on 
melanosomes themselves.   
 
4.3 Function for Rab32 and Rab38 in early endosome to melanosome cargo trafficking 
Consistent with Rab38 and Rab32 dependent vesicle trafficking pathways, I found that 
Rab38 and Rab32 are functionally important for the trafficking of tyrosinase family proteins 
(Figure 2.12, 2.13 2.14).  These Rab proteins serve partially redundant roles in the trafficking of 
tyrosinase and Tyrp-1, but not in the trafficking of Tyrp-2 (Figure 2.13).  Earlier studies had 
shown that depletion of Rab38 or Rab32 altered the distribution of tyrosinase and Tyrp-1, but 
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had not assessed where the trafficking defect occurred (3).  I show that the mistrafficking of 
these tyrosinase family proteins resulting from Rab38 or Rab32 depletion is caused by 
diminished trafficking from the early endosome (Figure 2.12, 2.13 2.14).  The partial redundancy 
of Rab38 and Rab32 in the trafficking of these enzymes matches extremely well with previous 
data on the redundancy of AP-3, AP-1, and BLOC-2 in trafficking from the early endosome (1, 
2).  My studies on the redundancy of Rab32 and Rab38 also provide a better explanation for the 
partial hypopigmentation observed in Rab38 mutant models, implying that Rab32 is able to 
partially compensate for the loss of functional Rab38 in these animals (5, 6). 
Rab32 and Rab38, however, are not fully redundant in melanosome biogenesis as 
demonstrated by the trafficking of Tyrp-2 (Figure 2.13, 2.14).  The trafficking of tyrosinase and 
Tyrp-1 are defined by early endosomal pathways dependent on AP-1, AP-3, and BLOC-2 (1, 2). 
The trafficking of Tyrp-2 has been suggested to utilize an alternate route from tyrosinase and 
Tyrp-1, one that involves sorting through the plasma membrane.  The necessity for AP-1, AP-3, 
or BLOC-2 in Tyrp-2 trafficking has not been tested (9, 10).  Interestingly, Tyrp-2 is not 
necessary for regulation of normal pigmentation, and functions in only one pathway of 
eumelanin synthesis (Figure 1.2), so it is difficult to predict if any of the hypo-pigmented animal 
models have Tyrp-2 trafficking defects.   The necessity of Rab32 in an alternative pathway for 
the trafficking of Tyrp-2, which does not utilize Rab38, suggests that Tyrp-2 may not trafficking 
through AP-1-, AP-3-, or BLOC-2-dependent pathways.  Consistent with additional Rab38-
independent functions for Rab32, knockdown of Rab32 causes more severe hypopigmentation 
than Rab83 knockdown (Figure 2.13).  Our results demonstrate that Rab32 and Rab38 function 
in parallel or redundant pathways for the trafficking of some cargoes, but that Rab32 may also 
function in separate trafficking pathways to melanosomes.   
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4.4 Interacting partners of Rab32 and Rab38 
When I performed these studies, there was only a poor understanding of the functions of 
Rab38 and Rab32 in melanosome trafficking (3).  The one known interacting partner of Rab38 
and Rab32, Varp, was also discovered very close to the time I began work in this project (11, 
12).  Two studies have demonstrated that Varp functions in the trafficking of Tyrp-1 and 
VAMP7, a SNARE, to melanosomes and that Varp is dependent on interactions with Rab38 and 
Rab32 (12).  VAMP7 is likely to be recruited to specific early endosomal subdomains through 
interactions with AP-3 and Varp, which facilitate loading into vesicles bound for melanosomes 
(13).  VAMP7 is important for the fusion of vesicles trafficked to lysosomes, and it is likely that 
it is also important for the fusion of vesicles with melanosomes, which explains why a defect in 
Tyrp-1 trafficking to melanosomes would also occur in cells in which VAMP7 was not present 
(13).  A mechanism for the trafficking of VAMP7 by Rab38 and Rab32 is still not fully 
understood, despite interesting work on the interactions between Rab38 and Rab32 with Varp 
that has occurred since I began working on this project (14, 15).  My studies on the function of 
Rab38 and Rab32 at endosomes have served to expand knowledge of the trafficking functions of 
Varp, which is thought to utilize the vesicle trafficking pathways dependent on Rab32 and 
Rab38.   
The mechanism used to recruit Rab32 and Rab38 to endosomal sites to function with AP-
3, AP-1, and BLOC-2 was not known until recently (16).  Initially, we suspected that Rab38 and 
Rab32 might be recruited to membranes directly by interactions with AP-3 and BLOC-2 (Figure 
2.3).  The finding that Rab38 and Rab32 bound to AP-3, AP-1, and BLOC-2 only when in the 
active, GTP-bound form suggested that other proteins were responsible for the recruitment and 
activation of Rab38 and Rab32 (Figure 2.4).  In our experiments, we observed that knockdown 
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of BLOC-3 resulted in a similar trafficking defect of Tyrp-2 as observed by Rab32 knockdown, 
which we suggested was a specific result of disruption of a Rab32-BLOC-3 dependent pathway 
(Figure 2.16, Appendix 2) (Chapter 2).  Recently, it was discovered that BLOC-3 functions as 
the GEF that is responsible for the recruitment of Rab38 and Rab32 to membranes, and for the 
GTP-loading of these Rabs (16).  Our previous findings regarding defects in the trafficking of 
Tyrp-1 were repeated in this study, and it was found that knockdown of BLOC-3 reproduced 
these trafficking defects (16).  BLOC-3, however, is not likely to be the only GEF that functions 
with Rab38 and Rab32 as BLOC-3 knockdown samples do not have as severe of trafficking 
defects as observed for Rab32 or Rab38 alone (16). BLOC-3 mutant mice are less severely hypo-
pigmented than Rab38 mutant mice (17, 18), suggesting that other mechanisms exist for Rab38 
and Rab32 recruitment and activation in this pathway.  Simultaneous knockdown of Rab32 and 
Rab38 results in more severe defects in the trafficking of tyrosinase and Tyrp-1 than either 
knockdown alone (Figure 2.12, 2.13), and if BLOC-3 acted as the lone GEF for Rab32 and 
Rab38 in this pathway we expect a severe hypopigmentation resulting from BLOC-3 
knockdown.  
 
4.5 Interaction of Myosin Vc with melanosomal Rab proteins 
My work on the functions of Rab32 and Rab38, and other work published in the field 
since I began this project, has expanded understanding of how Rab32 and Rab38 function at 
early endosomes in the trafficking to melanosomes.  It is still unclear, however, how Rab32 and 
Rab38 function in the trafficking of cargoes after vesicle budding from early endosomes.  
Therefore, the discovery that Myosin Vc functions as an effector of Rab32 and Rab38 in 
melanosome biogenesis is an important expansion of the field.   Myosin Vc was discovered as an 
165 
!
interacting partner for Rab38 in a screen against the active, GTP-bound mutant of the protein, 
and the interaction with only the constitutively-active, GTP-locked mutant suggest that Myosin 
Vc is a Rab effector protein.  I discovered that Myosin Vc also acts an effector of Rab32, and 
furthermore that Myosin Vc is also an effector protein of other Rabs associated in melanosome 
biogenesis, Rab7a and Rab8a (Figure 3.1) (19-25).  Direct interaction between Myosin Vc and 
Rabs with different functions in melanosome biogenesis implicates Myosin Vc in melanosome 
biogenesis and is a novel function for Myosin Vc. 
The finding that Myosin Vc interacts with multiple melanosomal Rabs raises interesting 
questions about the specificity of these interactions: are these Rabs non-specifically binding to 
any class V myosin?  I found that while Rab7a and Rab8a bound to Myosin Va or Myosin Vb, 
Rab32 and Rab38 bind only to Myosin Vc (Figure 3.1B).  Additionally, Rab32 and Rab38 bind 
more strongly to Myosin Vc than either Rab8a or Rab7a, which may have functional 
implications on the ability of Rab-Myosin Vc interactions to occur in vivo (Figure 3.1C).  Even if 
Rab-Myosin Vc interactions are low affinity, binding to multiple Rabs would increase the avidity 
of Myosin Vc interactions, and the ability to bind multiple Rab proteins may be crucial to the 
function of Myosin Vc in these cells.   
Experiments to map the binding sites of Rab7a, Rab8a, Rab32, and Rab38 show that 
some of these Rabs have partially overlapping binding sites within the coiled-coil tail of Myosin 
Vc.  Additionally, Rab7a binding to Myosin Vc is dependent on both the coiled-coil and globular 
tail domains, suggesting that Rab7a either has multiple binding sites in the two tail domains or 
that it binds the coiled-coil and globular tail simultaneously (Figure 3.1C, 3.1E, 3.1F).  To date, 
numerous studies have been performed about the necessity for specific coiled-coil regions for the 
binding to Rab proteins, but no studies have investigated simultaneous binding of multiple Rabs 
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(26-28).  Notably, interaction between Rabs and effectors can also occur using Rab dimers that 
interact with effectors in a 2:2 ratio, and raises possibility of hetero- or homo-dimers of Rabs 
interacting with Myosin Vc, which functions as a dimer (29).  Based on these studies, it is 
unclear if these binding sites would be compatible with simultaneous binding to multiple Rabs, 
or perhaps certain pairs of Rabs that do not have overlapping binding sites (Figure 3.1E).  The 
binding of Rab7a, Rab8a, Rab32, and Rab38 to Myosin Vc serves as an excellent case to 
investigate the mechanisms used by class V myosins that are able to bind multiple Rabs. 
In addition to mapping the binding of Rabs to Myosin Vc, I also investigated the sites on 
Rab32 and Rab38 used for binding to Myosin Vc (Figure 3.2).  I found that mutation of specific 
tyrosine residues in the switch II region of Rab32 or Rab38 disrupted interaction with Myosin Vc 
(Figure 3.2B).  The finding that the switch II region is required for effector binding is consistent 
with previous findings that have shown effector binding in regions that undergo conformational 
change between in-active, GDP-bound Rabs and active, GTP-bound Rabs (29-35).  The 
interaction of Varp with Rab32 and Rab38 was also recently mapped to the switch II region of 
the Rabs, and is dependent specifically on a valine residue that is directly adjacent to the tyrosine 
that is required for Myosin Vc binding (14).  Interestingly, Varp binding to Rab32 and Rab38 is 
very specific, as other residues in the switch II region were not required for the binding of Varp, 
but the necessity of the tyrosine residue for binding to Varp was not tested in this study (14).  
Mutation of valine residue in the switch II region of Rab32 and Rab38, important for binding to 
Varp, does not significantly diminish binding to Myosin Vc unless the valine and tyrosine 
residues are both mutated (Figure 3.2C, 3.2D).  Mutation of both valine and tyrosine residues 
reduces the degree of binding to Myosin Vc, and the degree of growth observed in yeast 2-hybrid 
assays (Figure 3.2C, 3.2D).  This finding that the only known effectors of Rab32 and Rab38, 
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Varp and Myosin Vc, bind to the same site on Rab32 and Rab38 raises questions about the 
mechanisms that control Rab-effector binding.  Do these two effectors compete for binding to 
Rab32 and Rab38?  Or do they function in distinct trafficking steps in melanosome biogenesis? 
 
4.7 Functions of Myosin Vc in melanosome trafficking 
Experiments investigating the effects of Myosin Vc knockdown in MNT-1 cells suggest 
that Myosin Vc and Varp may function in similar trafficking steps to melanosomes.  I show that 
Myosin Vc knockdown results in defects in both the trafficking of Tyrp-1 and Tyrp-2 to 
melanosomes, but also causes a major defect in melanosome secretion (Figure 3.3, 3.4).  The 
efficiency of Tyrp-1 trafficking from early endosomes to melanosomes is reduced by Myosin Vc 
knockdown, such that Tyrp-1 accumulates in early endosomes and is present on the plasma 
membrane of cells (Figure 3.4B).  This effect has been shown to occur when the early endosomal 
exit sites are disabled by knockdown of AP-3, AP-1, BLOC-2, and Rab32 or Rab38 (Figure 
2.12) (1).  This result is consistent for a trafficking function of Myosin Vc that depends on 
Rab32 and Rab38.  The defect in Tyrp-1 resulting from Myosin Vc is more severe than Rab32 
and Rab38 combined knockdown, and suggests that Myosin Vc serves functions in the 
trafficking of cargoes beyond those facilitated by interactions with Rab32 and Rab38 (Figure 
2.13, 3.4).  Varp also functions in the trafficking of Tyrp-1, and Myosin Vc and Varp may 
function in the same steps of trafficking to melanosomes.   
The defect in melanosome secretion that occurs from Myosin Vc knockdown suggests 
that Myosin Vc also serves Rab32- and Rab38-independent trafficking functions.  The 
accumulation of mature, pigmented melanosomes is quite distinct from the effect observed upon 
knockdown of Rab32 or Rab38 (Figure 2.12, 2.13, 3.3, 3.4).  Rab32 and Rab38 knockdown 
168 
!
causes a reduction in pigment production, and likely represent an increase in the ratio of non-
pigmented : pigmented melanosomes (Figure 2.13).   Myosin Vc knockdown does not cause an 
increase in the number of immature or striated melanosomes, and only causes an increase in the 
number of pigmented melanosomes (Figure 3.3).  The fact that melanosome are still formed by 
Myosin Vc knockdown, which shows defects in the trafficking of cargoes to melanosomes, 
reflects that some trafficking of tyrosinase and Tyrp-1 occurs.  This suggests that Myosin Vc is 
not absolutely required for the trafficking of tyrosinase and Tyrp-1, but that Myosin Vc is critical 
for other functions in melanosome biogenesis.   
The function of Myosin Vc in multiple pathway of melanosome biogenesis is also 
suggested by a comparison of Myosin Vc knockdown to knockdown of different melanosomal 
Rabs (Figure 3.5).  Knockdown of Myosin Vc shows some of the cargo trafficking defects 
observed by Rab32 or Rab38 knockdown, but also shows an accumulation of melanosomal 
proteins that does not occur in Rab32 or Rab38 knockdown (Figure 3.5).  Knockdown of Rab7a 
and Rab8a show some of the same changes in abundance of melanosomal proteins, but only 
Rab8a shows the increase in Pmel17 abundance that suggests a defect in secretion (Figure 3.5).  
A melanosome secretion defect by Rab8a knockdown may be consistent with previous studies 
that have shown functions for Rab8a in melanosome movement, independent of Rab27a (24, 25).   
The colocalization of Myosin Vc with Rab7a, Rab8a, Rab32, and Rab38 suggests that Myosin 
Vc serves multiple functions in melanosome biogenesis (Figure 3.9).  Colocalization of Myosin 
Vc with Rab7a or Rab8a is observed in large, perinuclear clusters (Figure 3.9).  Conversely, 
Myosin Vc is observed to colocalize with Rab7a, Rab32, or Rab38 in smaller structures in more 
distal regions of cells, in the transition from cell body to dendrite projection (Figure 3.9).  The 
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distinct sites of colocalization with melanosome associated Rab proteins are consistent with the 
conclusion that Myosin Vc serves multiple functions in melanosome biogenesis and trafficking. 
In MNT-1 cells, Myosin Vc is not shown to co-fractionate with Rab7a, Rab8a, Rab32, or 
Rab38 in melanosomal or other endosomal fractions (Figure 3.6).  The lack of co-fractionation 
with melanosomal markers suggests that Myosin Vc is not abundant on melanosomes, and may 
function instead in vesicle trafficking events (Figure 3.6).  The low degree of colocalization of 
Myosin Vc with melanosomal markers in immunofluorescence microscopy experiments also 
reflects that Myosin Vc is not abundant on mature melanosomes (Figure 3.8).  Notably, Myosin 
Vc does interact with some structures labeled by Tyrp-2, which may reflect a Tyrp-2 trafficking 
pathway (Figure 3.8).  The fact that knockdown of only some Rabs results in defects in Tyrp-2 
trafficking, further indicates that Myosin Vc functions in distinct trafficking steps (Figure 3.5).  
Different colocalization patterns with different Rabs may be indicative of different sites of 
function, and different functions of Myosin Vc in melanosome trafficking. 
Defects in trafficking of Tyrp-1 and Tyrp-2 suggest a function for Myosin Vc in vesicle 
trafficking to melanosomes.  How does Myosin Vc function in melanosome secretion?  As 
Myosin Vc is not abundant on melanosomes it is unlikely that Myosin Vc is directly associated 
with melanosome secretion (Figure 3.4, 3.6).  At least two models could explain these divergent 
functions of Myosin Vc in melanosome trafficking and secretion.  The first model would suggest 
that Myosin Vc functions primarily in the trafficking of cargoes to melanosomes, and that a 
defect in melanosome trafficking is an indirect effect of defects in cargo trafficking.  Perhaps 
other components of melanosomes, necessary for secretion, may also be trafficked along the 
same pathway as Tyrp-2; and that lacking Myosin Vc these melanosome components do not 
reach melanosomes resulting in decreased melanosome secretion.  Rab32 may serve non-
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redundant trafficking functions for this pathway, which would explain the similarity of lack of 
Tyrp-2 by knockdown of Myosin Vc or Rab32 (Figure 2.12, 2.13, 3.4, 3.5).  However, Rab32 
knockdown does not result in any obvious defect in melanosome secretion, suggesting that 
Myosin Vc functions in Rab32-independent functions upstream or downstream of Rab32-
dependent trafficking steps (Figure 2.13).   
The trafficking of Tyrp-2 is not clearly established, but appears to be different from 
tyrosinase and Tyrp-1 (9,10).  Tyrp-2 is likely to be directly transported from the golgi to plasma 
membrane, and subsequently endocytosed and trafficked through recycling endosomes where it 
may intersect with the tyrosinase and Tyrp-1 trafficking pathways (9, 10).  Specific trafficking 
defects in Tyrp-2 could occur in the golgi to plasma membrane, endocytic, or recycling 
trafficking of the protein, but previously established function of Myosin Vc at recycling 
endosomes suggests that knockdown of Myosin Vc would cause a recycling endosomal defect 
(38).  Recycling endosomal functions of Myosin Vc are consistent with the colocalization of 
Myosin Vc with Myosin Vb and Transferrin-receptor (Figure 3.7).  Sites of colocalization with 
Myosin Vb or Transferrin-receptor appear similar to perinuclear sites where colocalization of 
Myosin Vc with Rab7a and Rab8a occurs (Figure 3.7).  Further, Rab8a is implicated in recycling 
endosomal trafficking functions with Myosin Vb in other cell types, suggesting that it might 
serve a cargo trafficking function at recycling endosomes for melanosome trafficking (39).  
Therefore, the first model would suggest that Myosin Vc functions in both recycling endosomal 
and early endosomal steps in cargo trafficking to melanosomes using different Rab proteins for 
distinct trafficking steps. 
Some of my experiments provide evidence to support the first model to explain functions 
of Myosin Vc in melanosome secretion.  As previously discussed, knockdown of Myosin Vc 
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results in an increase in most melanosomal proteins, but also causes defects in the trafficking of 
Tyrp-2 (Figure 3.4).  Notably, Myosin Vc also changes the abundance of Varp and VAMP7, but 
in quite distinct ways (Figure 3.4).  Myosin Vc knockdown causes a significant decrease in the 
abundance of Varp, which we would expect would cause defects in the trafficking of VAMP7 to 
melanosomes (Figure 3.4) (12, 14, 15).  The mechanisms by which Myosin Vc knockdown 
would cause loss of Varp are not clear, but may reflect a functional collaboration of Varp and 
Myosin Vc in melanosome trafficking (Figure 2.5).   
In contrast, we observe a large accumulation of VAMP7 as a result of Myosin Vc 
knockdown (Figure 3.4).  It is unclear if the accumulation of VAMP7 represents proteins present 
on mature melanosomes, and thus is reflective of the defect in melanosome secretion, or if 
VAMP7 accumulation reflects a defect in trafficking to melanosomes (Figure 3.4).  A role for 
VAMP7 in melanosome secretion has not been established, but loss of a critical SNARE for 
melanosome secretion could explain the melanosome secretion defect observed in Myosin Vc 
knockdown. It is possible that the functions of Varp and Myosin Vc are functionally connected 
in some way, and establishing a connection between the two Rab32 and Rab38 effectors 
represents an interesting new direction for research projects.  The effects that Myosin Vc 
knockdown have on Varp and VAMP7 are striking, and this connection is potential mechanism 
to explain the function of Myosin Vc in melanosomes. 
A second model to explain the trafficking defects observed in Myosin Vc knockdown 
would also explain defects in melanosome secretion.  In this second model, Myosin Vc functions 
at early endosomes for the trafficking of some cargoes to melanosomes through interactions with 
Rab32 and Rab38, but the melanosome secretion is a direct function of Myosin Vc, rather than 
an indirect effect resulting from cargo mistrafficking suggested by the first model.  Myosin Vc 
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may still function in recycling endosomes, but for the purposes of melanosome secretion.  A 
previous study investigating melanosome secretion has shown that recycling endosomal Rab17 
and Rab11a/b are important for melanosome secretion (38).   A direct role for recycling 
endosomes in melanosome secretion that depends on Myosin Vc could occur, but this model 
would likely not involve a direct interaction of Myosin Vc and Rab11a, as these proteins are not 
seen to physically interact in conditions we tested (Figure 3.1).  Myosin Vc, therefore, could 
function with Rab17 or Rab8a in recycling endosome dependent melanosome secretion.  It is 
also possible both of these models occur, and that Myosin Vc functions with recycling 
endosomes in cargo trafficking and melanosome secretion.  However, it is not possible to draw 
conclusions about these models based on the currently known information about melanosome 
secretion. 
 
4.8 The role of multiple class V myosins in melanosome trafficking 
Myosin Va has been well-classified with specific functions in melanosome movement, 
and my experiments demonstrating that Myosin Vc functions in melanosome biogenesis provide 
the first direct evidence of multiple class V myosin motors functioning in the same pathway (40).   
A comparison of Myosin Va knockdown or knockout cells and Myosin Vc knockdown cells 
demonstrates that the two motor proteins serve distinct functions in melanosome trafficking 
(Figure 3.3, 3.4) (40-42).  Myosin Va knockdown cells demonstrate a perinuclear clustering of 
melanosomes, with no obvious defects in melanosome formation or a dramatic increase in the 
number of melanosomes (41).  In contrast, Myosin Vc knockdown cells have normal distribution 
of melanosomes, but defects in melanosome cargo trafficking and secretion, with a significant 
increase in the amount of pigmented melanosomes (Figure 3.3, 3.4).  The subcellular localization 
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of Myosin Va and Myosin Vc also appears to be quite distinct, and the two proteins are only 
observed to strongly colocalize in some large perinuclear structures (Figure 3.7).  The absence of 
Myosin Vc from the tips of dendrite extensions, where Myosin Va is abundant, further suggests 
that Myosin Va and Myosin Vc have different functions with melanosomes (Figure 3.7).  Myosin 
Vc is primarily found in sucrose gradient fractions corresponding to the cytosol and vesicles 
while Myosin Va is found to be primarily associated with melanosomal markers in dense 
fractions (Figure 3.6).  Myosin Va and Myosin Vc appear to serve distinct functions in 
melanosome biogenesis and trafficking. 
In my experiments, however, I also find evidence for a role of Myosin Vb in melanosome 
trafficking (Figure 3.3, 3.6, 3.7, 3.8).  First, Myosin Vb strongly colocalizes with Myosin Va in 
dendrite projections, a known site of melanosome secretion (42).  Previous work about 
melanosome secretion implies that these sites are specific to melanosome secretion, and 
localization of Myosin Vb to these sites suggests a direct function with melanosomes (42).  
Second, in Myosin Vc knockdown experiments an enrichment of melanosomal proteins is 
observed, including Myosin Va, and Myosin Vb is also enriched by Myosin Vc knockdown 
(Figure 3.3).  This enrichment could represent a compensation for the loss of Myosin Vc by up 
regulation of Myosin Va and Myosin Vb, but that would not explain other data suggesting 
Myosin Vb functions with melanosomes.  Third, Myosin Vb co-fractionates with melanosomal 
markers in sucrose gradients (Figure 3.6).  The presence of Myosin Vb on these fractions with 
mature melanosome markers is not likely to represent the ubiquitous, recycling endosomal 
functions of Myosin Vb, but rather implies a role for Myosin Vb directly with melanosomes.  
Finally, Myosin Vb partially colocalizes with Rab27a, a marker of mature melanosomes (Figure 
3.8).  As Rab27a is not present on melanosomes directly before secretion, this result would be 
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consistent with a localization of Myosin Vb to a subset of mature melanosomes (38).  What 
functions would be predicted for Myosin Vb in melanosome trafficking? 
A function for Myosin Vb in melanosome trafficking would be consistent with the 
function of recycling endosomal Rab17 and Rab11a/b in melanosome secretion (38), and with 
some of the observed localization of Myosin Vc in cells.  Notably, Myosin Vb and Myosin Vc 
are observed to strongly colocalize with specific structures that contain the transferrin-receptor 
and are likely to be recycling endosomes (Figure 3.7).  Also, Myosin Vb and Myosin Vc have 
similar colocalization with melanosome markers, and both Myosin Vb and Myosin Vc are 
present in some structures that also contain accumulated Tyrp-2 (Figure 3.8). Based on the 
previous discussion of Tyrp-2 trafficking, it is likely that these structures are recycling 
endosomes through which Tyrp-2 is trafficked (9, 10).  Alternatively, the presence of Myosin Vb 
at the tips of dendrite tips, where Myosin Va is also present, could represent the functions of 
Myosin Vb at recycling endosomes in melanosome secretion (Figure 3.7).   
Investigations of the function of Rab17 and Rab11a/b in melanosome secretion has 
demonstrated that Rab27a is not critical for melanosome secretion, and suggested that 
melanosome secretion occurs using mechanisms downstream of Rab27a and Myosin Va that are 
dependent on Rab17 and Rab11a/b (38).  Melanosome secretion functions downstream of 
Rab27a could explain the modest colocalization of Myosin Vb with Rab27a labeled 
melanosomes (Figure 3.8).  The low-degree of colocalization of Myosin Vb with melanosome 
markers could also be explained by ubiquitous functions for Myosin Vb in melanocytes, or that 
the Myosin Vb associates with mature melanosomes only briefly before melanosome secretion 
(Figure 3.8).  However, Rab8a and Myosin Vc are not found in dendrite tips, suggesting that 
such a role for the recycling endosome in melanosome secretion would be independent of 
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Myosin Vc (Figure 3.7, 3.9).  The sub-cellular localization of Myosin Vb has similarities with 
both Myosin Va and Myosin Vc, and notably there are some perinuclear structures in MNT-1 
cells where all three motors are present (Figure 3.7).  The identity and function of these 
perinuclear clusters is unclear, but may represent clusters of melanosomes at the perinuclear 
microtubule-organizing center or clustered recycling endosomes.  No direct role for Myosin Vb 
in melanosome trafficking has been established, but evidence from my experiments and recent 
publications strongly suggest a role for recycling endosomes and Myosin Vb in melanosome 
secretion. 
What are the functional implications of Rabs that are capable of interacting to different 
class V myosins? Some melanosomal Rabs show interaction with only specific class V myosins: 
Rab27a interacts with Myosin Va, Rab11a interacts only with Myosin Vb, and Rab32 and Rab38 
bind only to Myosin Vc (Figure 3.1).  The use of these Rabs to recruit specific Myosins for 
functions in melanosome trafficking is easy to interpret.  Are Rab proteins that interact with 
multiple Myosins, such as Rab7a with Myosin Va, Myosin Vb, and Myosin Vc, able to 
functionally bind to each of these motors in melanosome trafficking (Figure 3.1)?  The 
localization of Rab7a and Rab27a to distinct melanosomes suggests that Rab7a is not enriched 
on melanosomes that contain Myosin Va (22).  Rab7a is associated more with functions in 
melanosome biogenesis, but is also implicated with fast, microtubule-based melanosome 
movement (19-23).  It is, therefore, unclear if Rab7a is able to function with Myosin Vb and 
Myosin Vb in melanosome trafficking, but it is unlikely that Rab7a functions with Myosin Va. 
Colocalization of Rab7a and Myosin Vc is observed at both perinuclear clusters and more 
distal structures, so it is possible that Myosin Vc functions in some trafficking pathways with 
Rab7a (Figure 3.9).  Based on the fractionation of Myosin Vc in sucrose gradients, these 
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functions would likely involve vesicle trafficking steps (Figure 3.6). The trafficking defects in 
Rab7a knockdown are similar to defects caused by Rab32 or Rab38 knockdown (Figure 3.5).  
And these three Rab proteins have similarities in their subcellular distribution (Figure 3.9).  It is 
possible that Myosin Vc functions with Rab7a, Rab32, and Rab38 in some cargo trafficking 
steps.  However, not enough is known about the functions of these Rabs in melanosome 
biogenesis and a careful comparison of the functions of Rab7a, Rab32, and Rab38 in 
melanosome biogenesis is needed.   
Rab8a is able to bind to both Myosin Vb and Myosin Vc, but does it function with both 
motors in melanosome trafficking?  Rab8a functions with Myosin Vb in polarized trafficking 
from the recycling endosome in polarized cell types, and in the recycling of glucose-receptors in 
muscle cells (37, 43, 44).  Rab8a also functions with Myosin Vc in secretion of secretory 
vesicles in certain cell types (45, 46).  Rab8a has been shown to function in Rab27a-independent, 
actin-based movement of melanosomes (24).  In melanosome biogenesis, some of the functions 
of Myosin Vc may be dependent on interactions with Rab8a, as suggested by comparison of the 
phenotypes for Rab8a and Myosin Vc knockdown (Figure 3.3, 3.4, 3.5).  In MNT-1, 
colocalization of Rab8a and Myosin Vc occurs on structures that would be consistent with 
recycling endosomes, and not melanosomes (Figure 3.9).  This would suggest that that Myosin 
Vc is not responsible for the Myosin Va-independent, Rab8a-dependent actin-based movement 
of melanosomes (24).  Perhaps these functions are dependent on Myosin Vb.  Myosin Vb is 
found to localize to dendrite tips, where actin-based movement of melanosomes is known to 
occur, and this could be a site where Rab8a and Myosin Vb could functionally interact in 
melanosome trafficking.  The ability, however, for Rabs to bind to multiple class V myosin 
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motors, and the ability for motors to interact with multiple Rabs in melanosome biogenesis, 
makes it difficult to dissect the functions of these Rabs and Myosins in melanosome trafficking. 
 
4.9 Concluding remarks 
Experiments that I have performed investigating the functions of Rab32 and Rab38 in 
melanosome biogenesis have addressed outstanding questions about the mechanism used to 
recruit ubiquitous lysosome trafficking machinery for melanosome specific trafficking.  Results 
on the redundant and non-redundant functions of Rab32 and Rab38 also match the known 
parallel pathways established by AP-3, AP-1, and BLOC-2 (1, 2).  The presence of Rab38-
independent functions for Rab32 for the trafficking of Tyrp-2 suggests that another trafficking 
pathway is also important for melanosome biogenesis.  Analysis of the redundant and non-
redundant functions of Rab32 and Rab38 will be certain to yield interesting information about 
the molecular mechanisms that regulate these two similar Rabs in melanosome biogenesis. 
The discovery that Myosin Vc is an effector of multiple Rabs in melanosome biogenesis 
is an important finding, but one that raises numerous questions about the function of this motor 
in melanosome trafficking.  Outstanding questions about the ability for Rab32 and Rab38 to 
interact with two effectors in the same trafficking pathway will certainly yield better understand 
of Rab – effector interactions in general.  The combination of ubiquitous and cell-type specific 
Rabs in melanosome biogenesis serves as a model to investigate the collaboration of multiple 
Rabs in specialized trafficking pathways.  How are the membrane localization and function of 
these Rabs regulated, and how are interactions with a shared effector, such as Myosin Vc, 
controlled?  The function of Myosin Vc in melanosome biogenesis is undefined.  Does Myosin 
Vc function in multiple trafficking steps in melanosome biogenesis, or do we observe a 
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combination of ubiquitous and melanosome specific trafficking functions in MNT-1 cells?  
Additional experiments will be required to define the functions of Myosin Vc, and define the 
molecular mechanisms that control Myosin Vc in melanosome trafficking.   
The presence of multiple class V myosin motors in melanosome trafficking raises 
questions about the functions of these motors.  Do all of these motors serve specific trafficking 
functions in melanosome trafficking or does an overlap of ubiquitous and cell-type specific 
trafficking occur?  Do these motors function in distinct or redundant steps in melanosome 
trafficking?  And ultimately, what are the mechanisms that are able to regulate the functions of 
so many Rab proteins and Myosin V motors in melanosome trafficking?  Melanosome 
biogenesis serves as an excellent model to study the complicated cell biology and biochemical 
















1. Di Pietro SM, et al (2006) BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate 
protein trafficking on endosomes. Mol Biol Cell. 17(9):4027-38. 
2. Theos AC, et al (2005) Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from 
endosomes to melanosomes. Mol Biol Cell 16(11):5356-5372. 
3. Wasmeier C, et al (2006) Rab38 and Rab32 control post-Golgi trafficking of melanogenic 
enzymes. J Cell Biol. 175(2):271-81.  
4. Ninkovic I, White JG, Rangel-Filho A, Datta YH (2008) The role of Rab38 in platelet dense 
granule defects. J Thromb Haemost. 6(12):2143-51.  
5. Brooks BP, et al (2007) Analysis of ocular hypopigmentation in Rab38cht/cht mice. Invest 
Ophthalmol Vis Sci. 48(9):3905-13. 
6. Lopes VS, Wasmeier C, Seabra MC, Futter CE (2007) Melanosome maturation defect in Rab38-
deficient retinal pigment epithelium results in instability of immature melanosomes during 
transient melanogenesis. Mol Biol Cell. 18(10):3914-27.  
7. Park M, Serpinskaya AS, Papalopulu N, Gelfand VI (2007) Rab32 regulates melanosome 
transport in Xenopus melanophores by protein kinase A recruitment. Curr Biol. 17(23):2030-4 
8. Hume AN, Wilson MS, Ushakov DS, Ferenczi MA, Seabra MC (2011) Semi-automated analysis 
of organelle movement and membrane content: understanding rab-motor complex transport 
function. Traffic. 12(12):1686-701 
9. Negroiu G, Dwek RA, Petrescu SM (2005) Tyrosinase-related protein-2 and -1 are trafficked on 
distinct routes in B16 melanoma cells. Biochem Biophys Res Commun. 328(4):914-21. 
10. Negroiu G, Dwek RA, Petrescu SM (2003) The inhibition of early N-glycan processing targets 
TRP-2 to degradation in B16 melanoma cells. J Biol Chem. 278(29):27035-42.  
11. Wang F, et al (2008) Varp interacts with Rab38 and functions as its potential effector. Biochem 
Biophys Res Commun. 372(1):162-7.  
12. Tamura K, et al (2009) Varp is a novel Rab32/38-binding protein that regulates Tyrp-1 
trafficking in melanocytes. Mol Biol Cell. 20(12):2900-8.  
13. Salazar G, et al (2006) BLOC-1 complex deficiency alters the targeting of adaptor protein 
complex-3 cargoes. Mol Biol Cell. 17(9):4014-26.  
14. Tamura K, Ohbayashi N, Ishibashi K, Fukuda M (2011) Structure-function analysis of VPS9-
ankyrin-repeat protein (Varp) in the trafficking of tyrosinase-related protein 1 in melanocytes. 
J Biol Chem. 286(9):7507-21.  
15. Schäfer IB, et al (2012) The binding of Varp to VAMP7 traps VAMP7 in a closed, fusogenically 
inactive conformation. Nat Struct Mol Biol. 19(12):1300-9.  
16. Gerondopoulos A, Langemeyer L, Liang JR, Linford A, Barr FA. (2012) BLOC-3 mutated in 
Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide exchange factor. Curr Biol. 
22(22):2135-9.  
17. Nazarian R, Falcón-Pérez JM, Dell'Angelica EC. (2003) Biogenesis of lysosome-related 
organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome 
(HPS) proteins HPS1 and HPS4. Proc Natl Acad Sci U S A. 100(15):8770-5 
18. Loftus SK, et al (2002)  Mutation of melanosome protein RAB38 in chocolate mice. Proc Natl 
Acad Sci U S A. 99(7):4471-6.  
19. Hirosaki K, Yamashita T, Wada I, Jin HY, Jimbow K (2002) Tyrosinase and tyrosinase-related 
protein 1 require Rab7 for their intracellular transport. J Invest Dermatol. 119(2):475-80. 
20. Hida T, et al (2011) Rab7 is a critical mediator in vesicular transport of tyrosinase-related protein 
1 in melanocytes. J Dermatol. 38(5):432-41.  
21. Kawakami A, et al (2008) Rab7 regulates maturation of melanosomal matrix protein 
gp100/Pmel17/Silv. J Invest Dermatol. 128(1):143-50.  
180 
!
22. Jordens I, et al (2006) Rab7 and Rab27a control two motor protein activities involved in 
melanosomal transport. Pigment Cell Res. 19(5):412-23. 
23. Jordens I, et al (2001) The Rab7 effector protein RILP controls lysosomal transport by inducing 
the recruitment of dynein-dynactin motors. Curr Biol. 11(21):1680-5. 
24. Chabrillat ML, et al (2005) Rab8 regulates the actin-based movement of melanosomes. Mol Biol 
Cell. 16(4):1640-50.  
25. Chakraborty AK, Funasaka Y, Araki K, Horikawa T, Ichihashi M (2003) Evidence that the small 
GTPase Rab8 is involved in melanosome traffic and dendrite extension in B16 melanoma cells. 
Cell Tissue Res. 314(3):381-8.  
26. Roland JT, Lapierre LA, Goldenring JR (2009) Alternative splicing 
in class V myosins determines association with Rab10. J Biol Chem.  284(2):1213-23 
27. Lambert J, Naeyaert JM, Callens T, De Paepe A, Messiaen L (1998) Human myosin V gene 
produces different transcripts in a cell type-specific manner. Biochem Biophys Res Commun. 
252(2):329-33. 
28. Westbroek W, et al (2003) Interactions of human Myosin Va isoforms, endogenously expressed 
in human melanocytes, are tightly regulated by the tail domain. J Invest Dermatol. 120(3):465-
75. 
29. Kawasaki, M., Nakayama, K. and Wakatsuki, S. (2005) Membrane recruitment of effector 
proteins by Arf and Rab GTPases. Curr. Opin. Struct. Biol. 15, 681–689 
30. Overmeyer JH, Wilson AL, Erdman RA, Maltese WA (1998) The putative "switch 2" domain of 
the Ras-related GTPase, Rab1B, plays an essential role in the interaction with Rab escort 
protein. Mol Biol Cell. 9(1):223-35. 
31. Grosshans BL, Ortiz D, Novick P. (2006) Rabs and their effectors: achieving specificity in 
membrane traffic. Proc Natl Acad Sci U S A. 103(32):11821-7. 
32. Kloer DP, et al (2010) Assembly of the biogenesis of lysosome-related organelles complex-3 
(BLOC-3) and its interaction with Rab9. J Biol Chem. 285(10):7794-804.  
33. Sultana A, et al (2011) The activation cycle of Rab GTPase Ypt32 reveals structural determinants 
of effector recruitment and GDI binding. FEBS Lett. 585(22):3520-7.  
34. Fernandes H, et al (2009) Structural aspects of Rab6-effector complexes. Biochem Soc 
Trans. 37(Pt 5):1037-41. 
35. Pereira-Leal JB, Seabra MC (2000) The mammalian Rab family of small GTPases: definition of 
family and subfamily sequence motifs suggests a mechanism for functional specificity in the 
Ras superfamily. J Mol Biol. 301(4):1077-87. 
36. Rodriguez OC, Cheney RE (2002) Human myosin-Vc is a novel class V myosin expressed in 
epithelial cells. J Cell Sci. 115(Pt 5):991-1004. 
37. Roland JT, et al (2011) Rab GTPase-Myo5B complexes control membrane recycling and 
epithelial polarization. Proc Natl Acad Sci U S A. 108(7):2789-94. 
38. Beaumont KA, et al (2011) The recycling endosome protein Rab17 regulates melanocytic 
filopodia formation and melanosome trafficking. Traffic. 12(5):627-43.  
39. Van Gele M, Dynoodt P, Lambert J (2009) Griscelli syndrome: a model system to study vesicular 
trafficking. Pigment Cell Melanoma Res. 22(3):268-82. 
40. Van Gele M, Geusens B, Schmitt AM, Aguilar L, Lambert J (2008) Knockdown of myosin Va 
isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes. J 
Invest Dermatol. 128(10):2474-84.  
41. Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD (2009) A review of genetic disorders of 
hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 18(9):741-
9.  
42. Wu XS, et al (2012) Melanoregulin regulates a shedding mechanism that drives melanosome 
transfer from melanocytes to keratinocytes. Proc Natl Acad Sci U S A. 109(31):E2101-9.  
181 
!
43. Roland JT, Kenworthy AK, Peranen J, Caplan S, Goldenring JR (2007) Myosin Vb interacts with 
Rab8a on a tubular network containing EHD1 and EHD3. Mol Biol Cell. 18(8):2828-37.  
44. Ishikura S, Klip A (2008) Muscle cells engage Rab8A and myosin Vb in insulin-dependent 
GLUT4 translocation. Am J Physiol Cell Physiol. 295(4):C1016-25.  
45. Jacobs DT, Weigert R, Grode KD, Donaldson JG, Cheney RE (2009) Myosin Vc is a molecular 
motor that functions in secretory granule trafficking. Mol Biol Cell. 20(21):4471-88.  
46. Xu XF, Chen ZT, Gao N, Zhang JL, An J (2009) Myosin Vc, a member of the actin motor family 







CELL-TYPE SPECIFIC RAB32 AND RAB38 COOPERATE WITH THE UBIQUITOUS 
LYSOSOME BIOGENESIS MACHINERY TO SYNTHESIZE SPECIALIZED LYSOSOME-
RELATED ORGANELLES $"$"3 
 
A.1.1 Summary 
Lysosome-related organelles (LROs) exist in specialized cells to serve specific functions 
and typically co-exist with conventional lysosomes.  The biogenesis of LROs is known to utilize 
much of the common protein machinery used in the transport of integral membrane proteins to 
lysosomes. Consequently, an outstanding question in the field has been how specific cargoes are 
trafficked to LROs instead of lysosomes, particularly in cells that simultaneously produce both 
organelles.  One LRO, the melanosome, is responsible for the production of the pigment melanin 
and has long been used as a model system to study the formation of specialized LROs.  
Importantly, melanocytes, where melanosomes are synthesized, are a cell type that also produces 
lysosomes and must therefore segregate traffic to each organelle. Two small GTPases, Rab32 
and Rab38 are key proteins in the biogenesis of melanosomes and were recently shown to 
redirect the ubiquitous machinery – BLOC-2, AP-1, and AP-3 – to traffic specialized cargoes to 
melanosomes in melanocytes.  In addition, the study revealed Rab32 and Rab38 have both 
redundant and unique roles in the trafficking of melanin-producing enzymes and overall 
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melanosome biogenesis. Here we review these findings, integrate them with previous knowledge 
on melanosome biogenesis, and discuss their implications for biogenesis of other LROs. 
 
A.1.2 Introduction 
In humans, the pigment melanin is responsible for pigmentation of hair, skin, and eyes 
and serves to minimize the damage caused by exposure to the UV radiation from sunlight.  
Melanin is produced in a specialized organelle, the melanosome, which is found in melanocyte 
cells, in skin and hair follicles, and retinal and iris pigmented epithelial cells in the eyes (1-4).  
The formation of melanosomes has been heavily studied both because of disease implications 
caused by defects in melanosome formation and because the melanosome is a prototype of the 
specialized class of organelles called Lysosome-related organelles (LROs) (1, 3-6).  Lysosome-
related organelles are found in specialized cell types such as melanocytes, platelets, lung alveolar 
type II cells, and some innate and adaptive immune cells and have critical roles in pigment 
production, blood clotting, lung surfactant production, lytic activity of the innate immune system 
and antigen-processing of the adaptive immune system, respectively (4-8).  LROs are so called 
because of shared acidic lumen, protein components and because LROs utilize similar biogenesis 
pathways as lysosomes (4-6).  Melanosome maturation is characterized by four morphologically 
distinct phases as observed in electron micrographs (1, 9).  Stage I melanosomes are formed by 
the delivery of the transmembrane, structural protein Pmel17 to vacuolar early endosomes, most 
likely after rapid transit through the cell surface, and subsequent sorting to intraluminal vesicles 






Figure A. 1 
Model of melanosome biogenesis.  Schematic diagram of the four stages of melanosome maturation (I-
IV), endosomal organelles, and biosynthetic transport pathways followed by the cargo integral 
membrane proteins Pmel17, tyrosinase, tyrosinase-related protein-1 (Tyrp-1) and Tyrp-2. Melanosomal 
cargoes derive from the Golgi complex and traverse early/recycling endosomal domains either directly 
or through the cell surface. Sorting of Pmel17 to intraluminal vesicles from the limiting membrane of 
vacuolar early endosomal domains mark Stage I melanosomes. This process initiates the segregation of 
pre-melanosomes from the degradative late endosome/Multi Vesicular Body (MVB) pathway to 
lysosomes. Formation of Pmel17 fibrils across the length of the organelle characterizes stage II 
melanosomes. Tyrosinase and Tyrp-1 reach the maturing melanosome from specialized tubular 
domains of early/recycling endosomes and catalyze the synthesis of the melanin pigment observed in 
stage III and IV melanosomes. Rab32 and Rab38 interact with AP-1, AP-3, and BLOC-2 on 
early/recycling endosome tubules where cargo such as tyrosinase and Tyrp-1 are loaded into vesicles or 
transport intermediates. This trafficking machinery is organized into at least two parallel or alternate 
routes for transport of cargo to the maturing melanosome such that deficiency of one component 
typically causes a partial defect rather than complete failure of melanosome biogenesis. Rab32, Rab38, 
and possibly BLOC-2 remain associated with the vesicles or transport intermediates to promote their 
motility, tethering and fusion with the maturing melanosome.  The pathway taken by Tyrp-2 is not 
known, but it is at least partially different from that of tyrosinase or Tyrp-1 and it depends strictly on 
Rab32 – not on Rab38 – and BLOC-3.  
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This Pmel17 sorting is independent of the Endosomal Sorting Complex Required for 
Transport (ESCRT), the machinery that mediates formation of intraluminal vesicles in Multi 
Vesicular Bodies (MVBs)/late endosomes and defines the ubiquitous degradative/lysosome 
pathway (Figure A1.1) (1, 11). Stage I melanosomes are also differentiated from MVBs by the 
presence of large, flat, clathrin-containing coats on their limiting membrane (9, 12). Pmel17 is 
then cleaved in the luminal region of the protein by a proprotein convertase and the luminal 
Pmel17 fragments form amyloid fibrils across the length of the organelle, thus characterized as 
stage II melanosomes (Figure A1.1) (1, 9, 11, 13). Stage I and II melanosomes are occasionally 
referred to as pre-melanosomes and they do not yet contain the melanin pigment. Delivery of the 
transmembrane enzymes tyrosinase and tyrosinase-related proteins-1 and -2 (Tyrp-1 and Tyrp-
2), the main proteins responsible for melanin synthesis, is required to drive maturation from 
stage II to stage III melanosomes (Figure A1.1) (1, 12).  Tyrosinase, Tyrp-1, and Tyrp-2 form 
large melanin polymers that are deposited upon Pmel17 fibrils to form partially pigmented stage 
III melanosomes (1, 9, 14).  Further melanin synthesis produces mature stage IV melanosomes 
which are fully pigmented and are transported to the cell periphery for transfer to keratinocytes, 
in the case of skin melanocytes, or long-term storage, in the case of retinal pigmented epithelial 
cells in the eye (2, 15). 
Transport of newly synthesized tyrosinase and Tyrp-1 to the maturing melanosome 
requires a sorting step at specialized tubular domains of early/recycling endosomes, rather than 
direct transport from the trans-Golgi network (Figure A1.1) (1, 16-18). Packaging of the 
tyrosinase family proteins into transport vesicles at early/recycling endosome associated tubules 
is dependent on ubiquitous Adaptor Protein complex (AP)-1 and AP-3, and Biogenesis of 
Lysosome-related Organelles Complex (BLOC)-1 and BLOC-2 (16, 17). Furthermore, AP-3 and 
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BLOC-2 define parallel pathways for melanosome biogenesis, thus deficiency of both complexes 
causes a more severe defect in Tyrp-1 transport and overall pigmentation than either single 
deficiency (Figure A1.1) (17).  Analogously, AP-1 and AP-3 provide alternate routes for 
transport of tyrosinase and possibly other cargoes to maturing melanosomes (Figure A1.1) (16). 
While it has not been established if the AP-3 independent pathways – i.e. BLOC-2- and AP-1-
dependent, respectively – are separate or the same trafficking route, it is clear that the 
early/recycling endosomal system is a key sorting station for delivery of cargo to maturing 
melanosomes (1).  Remarkably, lysosome integral membrane proteins such as LAMPs reach the 
lysosome limiting membrane from analogous early/recycling endosome tubules in vesicles 
formed by the same AP and BLOC complexes (17, 19-21). It is therefore puzzling how 
specialized cells such as the melanocyte simultaneously produce and maintain lysosomes and 
specialized LROs such as the melanosome. How does the cell define separate early/recycling 
endosomal tubular domains and utilize at least partially overlapping machinery to mediate 
distinct integral membrane protein transport to different organelles (1, 6, 21)?  What other factors 
are involved in the biogenesis to allow for the separate, but concurrent existence of the two 
pathways and organelle types? 
One possible mechanism to facilitate the production and existence of both lysosomes and 
LROs is the expression of cell-type specific proteins that function in LRO biogenesis and not in 
lysosome biogenesis (22).  Two closely related small GTPases of the Rab family, Rab32 and 
Rab38 are expressed in selected cell types such as melanocytes and other cells where LROs are 
present (23-25). Rab32 and Rab38 have been shown to work on melanosome biogenesis and to 
mediate transport of tyrosinase and Tyrp-1 by an unknown mechanism (23). Rab38 deficient 
mice and rats are hypopigmented and Rab32 silencing in melanocytes isolated from Rab38 
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mutant mice further enhances the melanosome biogenesis defect (23, 26, 27). This cooperation 
between Rab32 and Rab38 for melanosome biogenesis resembles that of BLOC-2, AP-3, and 
AP-1 described above. These Rabs could therefore be the cell-type specific factors that interact 
with the ubiquitous trafficking machinery to mediate transport to maturing melanosomes (22). 
Such a scenario would be in agreement with the known functions of the Rab family proteins, 
which belong to the Ras superfamily and operate as elegant “switches” that regulate vesicular 
trafficking through interactions with effector proteins (28-30).  However the specific function 
and partners of Rab32 and Rab38 in the biogenesis of melanosomes or other LROs had remained 
poorly characterized (23, 31).  
 
A.1.3 Rab32 and Rab38 interact physically and colocalize with BLOC-2, AP-1, and AP-3 
To study endogenous Rab32 and Rab38 using biochemical and immunofluorescence 
microscopy approaches, antibodies against the Rabs were produced and validated (31).  In 
immuno-precipitation experiments, endogenous Rab32 and Rab38 were found to interact with 
BLOC-2, AP-1, and AP-3 in membrane, but not cytosolic fractions of MNT-1 melanocyte cells 
(31).  These results suggest a specific interaction with BLOC-2, AP-1, and AP-3 on membranes, 
where the adaptors are known to function.  In GST-Rab pulldown assays, Rab32 and Rab38 
showed preferential binding to BLOC-2, AP-1, and AP-3 when bound to GTP instead of GDP 
(31).  This GTP-bound specificity is consistent with the idea that Rab32 and Rab38 have an 
active, functional role in the trafficking pathway mediated by BLOC-2, AP-1, and AP3.  The 
exciting possibility emerges that Rab32 and Rab38 may function with the ubiquitous machinery 
in trafficking cargoes to maturing melanosomes and could be the cell-type specific factors that 
differentiate trafficking pathways to melanosomes instead of lysosomes. 
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Adaptor proteins orchestrate the formation of membrane coats that mediate cargo 
selection and vesicle budding (32-34). Adaptor proteins are recruited to membranes through 
interactions with membrane lipids, the cytoplasmic tails of transmembrane cargoes and, at least 
in some cases, ARF proteins – another family of GTP-binding proteins of the Ras superfamily 
(32-34).  While it was initially suspected that AP-3 may be clathrin-independent, subsequent 
research has shown that AP-3 and AP-1 act as clathrin-binding adaptor proteins, and it is also 
possible that BLOC-2 functions as a clathrin-binding adaptor (19, 35-41).  Clathrin is a structural 
component that defines one of the major classes of transport vesicle coats (34).  Adaptor proteins 
also help recruit a host of proteins involved in downstream vesicle functions such as motility 
through motor protein-cytoskeleton interactions, and vesicle tethering and fusion with the target 
organelle (32). An RNAi approach was used to determine if the recruitment or stabilization of 
Rab32 and Rab38 on membranes is dependent on the presence of AP-1, AP-3, or BLOC-2 (31).  
Depletion of AP-3 or BLOC-2 causes a significant decrease in the percentage of Rab38 that is 
associated with membranes at steady state, but has a modest effect on Rab32 membrane 
association. Depletion of AP-1 has no effect on either Rab32 or Rab38 membrane association. 
Furthermore, depletion of BLOC-2, but not AP-1 or AP-3, causes a large reduction in the total 
amount of Rab38 in cells, but modest reduction of total amounts of Rab32, which is likely due to 
Rab protein destabilization. Given the strong effect that depletion of BLOC-2 has on Rab38 
membrane association and stability, RNAi depletion of Rab32 and Rab38 was performed to 
determine if there is any effect on BLOC-2 membrane association.  Depletion of Rab38 
significantly decreases the membrane association of BLOC-2, but Rab32 depletion has no effect 
on BLOC-2 levels. These results indicate that while both Rab32 and Rab38 interact physically 
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with BLOC-2, AP-1, and AP-3 on membranes, the association may be functionally stronger 
between Rab38 and AP-3 and even stronger between Rab38 and BLOC-2 (31). 
Confocal immunofluorescence microscopy experiments show that a significant 
percentage of structures labeled with endogenous AP-1, AP-3, and BLOC-2 co-localize with 
endogenous Rab32 and Rab38 in many locations throughout MNT-1 melanocytes (31).  A larger 
percentage of structures labeled by AP-1, AP-3, or BLOC-2 co-localize with Rab38 than with 
Rab32.  This is consistent with the stronger membrane association defects observed with Rab38 
compared to Rab32 upon depletion of AP-3 and BLOC-2.  The localization of Rab32 and Rab38 
is likely to specific tubular domains of early/recycling endosomes that contain AP-1, AP-3, or 
BLOC-2 (16, 17).  In support of that idea, Rab32 and Rab38 do not colocalize with the early 
endosome vacuolar domain marker EEA1 or tubular domains involved in the retrieval pathway 
to the trans-Golgi network labeled by the retromer complex (31). Interestingly, both Rab38 and 
Rab32 partially co-localize with the coat protein clathrin (31). Upon vesicle budding, the clathrin 
coat and adaptors disassemble and return to the cytosolic pool so they can be reutilized in further 
rounds of traffic (Figure A1.1).  Therefore, Rab32 and Rab38 are probably loaded onto the 
transport vesicles on endosomal tubular domains during the budding process or soon after vesicle 
release, but before vesicle uncoating.  Rab32 and Rab38 likely remain bound to vesicles upon 
disassembly of AP-1, AP-3, and clathrin from vesicles (Figure A1.1).  It has been suggested that 
BLOC-2 may also be present in downstream vesicles or transport intermediates and may not 
undergo quick dissociation as is expected for AP-1, AP-3, and clathrin (1).  This possibility 
would be consistent with the stronger Rab38-BLOC-2 membrane association described above. 
Rabs are ideal candidates to serve as mediators of trafficking between endosomal tubules and 
downstream organelles through interactions with specific effector proteins (28-30).  The 
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specificity of Rab32 and Rab38 function in endosome to melanosome trafficking is demonstrated 
by their localization to stage III and IV melanosomes and not to lysosomes (Figure A1.1) (23, 
31).  These results indicate that Rab32 and Rab38 operate in the same pathways previously 
defined for AP-1, AP-3, and BLOC-2 and suggest they are the specific proteins that divert AP-1, 
AP-3, and BLOC-2 dependent cargoes to maturing melanosomes and away from lysosomes. 
   
A.1.4 Rab32 and Rab38 serve critical functions in the trafficking of melanin-producing 
enzymes 
If Rab32 and Rab38 are redirecting protein trafficking from early/recycling endosomal 
domains to melanosomes instead of lysosomes, then depletion of these Rab proteins should cause 
mis-trafficking of the cargo proteins.  RNAi depletion of Rab32 or Rab38 causes incorrect 
trafficking of the melanin-producing enzyme Tyrp-1 to the plasma membrane in MNT-1 
melanocytes (31). The same phenotype is produced by deficiency of either of AP-1, AP-3, or 
BLOC-2 (17, 31), consistent with the idea that Rab32 and Rab38 participate in a transport step 
mediated by AP-1, AP-3, and BLOC-2. This mistrafficking likely represents a blockage in 
transport to compartments downstream the early/recycling endosomes, which results in 
accumulation of cargo in early endosomes and leakage into the recycling pathway to the plasma 
membrane (Figure A1.1). Simultaneous depletion of Rab32 and Rab38 elicits a more severe 
trafficking defect for Tyrp-1, thus suggesting partially redundant roles for Rab32 and Rab38 
(31).   
Examination of the total abundance of tyrosinase and Tyrp-1 further demonstrates the 
importance of Rab32 and Rab38 for correct, functional trafficking.  Independent depletion of 
either Rab32 or Rab38 causes a significant decrease in overall tyrosinase abundance, but only 
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modest decrease in Tyrp-1 abundance (31).  However, simultaneous depletion of both Rab32 and 
Rab38 further reduces the abundance of tyrosinase and Tyrp-1 (31).  Inhibition of lysosomal 
hydrolases partially restores tyrosinase and Tyrp-1 to steady-state levels even with simultaneous 
depletion of Rab32 and Rab38. These results demonstrate that Rab32 and Rab38 are critical to 
direct trafficking of melanosome-specific cargoes to maturing melanosomes, instead of the 
default trafficking to lysosomes (Figure A1.1).  These results also resemble those obtained with 
melanocytes deficient for AP1-, AP3, or BLOC-2, reinforcing the notion of functional 
cooperation with Rab32 and Rab38 in the traffic of cargo to melanosomes (17, 42, 43). 
 It appears that Rab32 and Rab38 function in parallel roles for the trafficking of 
tyrosinase and Tyrp-1 and are able to partially compensate for the loss of the other Rab.  Such a 
result is also observed upon depletion of AP-1, AP-3, or BLOC-2, where each protein can 
partially compensate for the loss of the other (16, 17).  As mentioned above, this observation has 
been interpreted as evidence of parallel AP-1, AP-3, or BLOC-2 dependent pathways in the 
trafficking of tyrosinase and Tyrp-1.  Given the physical interaction and colocalization of Rab32 
and Rab38 with AP-1, AP-3, and BLOC-2, these Rabs likely serve all of the AP-3, AP-1, and 
BLOC-2 dependent pathways in the trafficking of tyrosinase, Tyrp-1, and possibly additional 
cargoes required for melanosome biogenesis (Figure A1.1) (31).  
 
A.1.5 Evidence for Rab32 unique roles in melanosome biogenesis 
In contrast with the cooperation displayed between Rab32 and Rab38 in the transport of 
tyrosinase and Tyrp-1, the Rabs do not appear to have redundant or compensatory roles in the 
trafficking of Tyrp-2 (31).  Depletion of Rab32, but not Rab38, causes a dramatic loss of Tyrp-2 
within MNT-1 melanocytes, which is likely due to mistrafficking to lysosomes (31).  What is 
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more, depletion of Rab32 or Rab38 causes a reduction in the total amount of melanin within 
MNT-1 melanocytes, an indication of deficient melanosome biogenesis (31).  However, Rab32 
depletion has a much more severe effect than depletion of Rab38, and simultaneous depletion of 
both Rabs elicits similar melanin levels as depletion of Rab32 alone.  These results imply there 
are key Rab32 roles in melanosome biogenesis, such as Tyrp-2 transport, that Rab38 cannot 
carry out. Rab32 and Rab38 appear to have partial functional redundancy, but differ in the 
membrane association dependency with BLOC-2 and AP-3, the extent of co-localization with 
AP-3 and AP-1, trafficking of Tyrp-2, and overall function in melanin production.  Both Rab32 
and Rab38 are present at similar levels within MNT-1 cells, demonstrating that non-redundant 
functions of Rab32 are not secondary to overall protein abundance (31). Ultimately, Rab32 and 
Rab38 have some redundant functions, but some unique function of Rab32 is required to 
maintain normal pigmentation within melanocytes. 
In stark contrast with the transport of tyrosinase and Tyrp-1, the trafficking pathway 
followed by Tyrp-2 to reach maturing melanosomes is unknown. The above results suggest it 
may use a distinct pathway that requires Rab32 but not Rab38. Provocatively, depletion of 
BLOC-3, but not BLOC-1, both components of the machinery involved in melanosome 
biogenesis, also causes substantial loss of Tyrp-2 within MNT-1 melanocytes, suggesting a 
possible independent role for Rab32 in the trafficking of Tyrp-2 through a BLOC-3 dependent 
pathway (31).  The function of BLOC-3 and its localization in specialized LRO-producing cells 
are unknown, although it has been shown to impact the localization of late endosomes/lysosomes 





A.1.6 Implications for other Lysosome-related organelles and future directions 
Several genetic disorders exist with simultaneous defects in the production of 
melanosomes and other LROs, consistent with the idea that LROs share a common biogenesis 
mechanism (1, 3, 4, 6, 46, 47). For example, Hermansky-Pudlak Syndrome (HPS) patients and 
the corresponding animal models have abnormal melanosomes, platelet dense granules, and 
lamellar bodies of lung type II epithelial cells. These defects produce partial oculocutaneous 
albinism, bleeding diathesis, and lung disease, respectively (1, 3, 4, 6, 46-48).  Mutations in 
subunits of AP-3, BLOC-1, BLOC-2, and BLOC-3 underlie many forms of HPS (4, 20, 49). 
Importantly, Rab38 deficiency in rodent disease models causes biogenesis defects in 
melanosomes, platelet dense granules, and lamellar bodies (25-27, 50-52).  Therefore it is likely 
that the cooperation between Rab38 and the ubiquitous transport machinery uncovered in 
melanocytes also functions in the biogenesis of other LROs such as platelet dense granules and 
lamellar bodies. In future studies it will be important to assess the potential contribution of 
Rab32 to the biogenesis of other LROs in addition to melanosomes. 
Recruitment of the Rabs occurs at specific early/recycling endosome tubular domains but 
they are also present on melanosomes, suggesting that they remain bound to vesicles until fusion 
with the downstream melanosome (23, 31).  These results constitute a step forward in our 
understanding of these pathways but also open other questions. What are the functions of Rab32 
and Rab38?  What are the effectors of Rab32 and Rab38 that facilitate trafficking to and fusion 
with melanosomes? What proteins are important for the regulation of Rab32 and Rab38? Little is 
known about the protein effectors of Rab32 and Rab38 beyond interaction with the protein Varp, 
which is implicated in the recruitment of the v-SNARE VAMP-7/TI-VAMP and Tyrp-1 traffic 
(15, 53, 54).  This Rab-Varp interaction is likely important for the vesicle-melanosome fusion 
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event.  Potential interactions of Rab32 and Rab38 with tethering proteins such as the HOmotypic 
fusion and Protein Sorting (HOPS) complex could also facilitate trafficking or fusion of vesicles 
with melanosomes (55-57).  Supporting this possibility, mutation of the HOPS complex subunit 
Vps33a results in deficient melanosome biogenesis in the buff mouse (55). However, the precise 
mechanisms that control the movement and targeting of vesicles remain unclear.  The 
mechanisms used by Rab32 and Rab38 in the trafficking of transmembrane cargoes to 
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LIST OF ABBREVIATIONS 
 
ADP: Adenosine diphosphate 
AP-1: Adaptor Protein -1 
AP-3: Adaptor Protein -3 
ATP: Adenosine triphosphate 
BLOC-1: Biogenesis of Lysosome-related organelle complex -1 
BLOC-2: Biogenesis of Lysosome-related organelle complex -2 
BLOC-3: Biogenesis of Lysosome-related organelle complex -3 
CHS: Chediak-Higashi syndrome 
CORVET: class C core vacuole/endosome tethering 
DHI: 5,6-dihydroxyindole 
DHICA: 5,6-dihydroxyindole-2-carboxylic acid 
DOPAquinone: ortho-quinone of 3,4-dihydroxyphenylalanine 
EEA1: Early endosome antigen 1 
ER: Endoplasmic reticulum 
ERK kinase: extracellular-signal-regulated kinases 
ESCRT: Endosomal Sorting Complex Required for Transport 
GAP: GTPase-activating proteins 
GDI: Guanine-dissociation inhibitory proteins  
GDP: Guanosine diphosphate 
GEF: GTP/GDP-exchange factor 
GLUT4: high affinity insulin-regulated glucose transporter 
GS: Griscelli syndrome 
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GST: glutathione S-transferase 
GTP: Guanosine-5'-triphosphate 
HOPS: homotypic fusion and vacuole protein sorting 
HPS: Hermansky-Pudlak syndrome 
ILV: intralumenal vesicles 
IP(3): inositol 1,4,5-trisphosphate 
LAMP: Lysosome-associated membrane protein 
L-DOPA: L-3,4-dihydroxyphenylalanine 
LRO : Lysosome-related organelle 
MAP kinase: Mitogen-activated protein kinase 
MHC-II: major histocompatibility-complex type II 
MNT-1: highly pigmented human melanoma cells 
mRNA: messenger RNA 
MVB/MVE: multivesicular bodies/endosomes 
OCA: Oculocutaneous albinism 
PI(3)P: phosphotidylinositol-3-phosphate 
PI(3,5)P2: phosphotidylinositol-3,5-bisphosphate 
PMEL: premelanosome protein 
Rab: small GTPases of the Ras superfamily 
RNAi: RNA interference  
RPE: retinal pigmented epithelial cells 
siRNA: Small interfering RNA / short interfering RNA /silencing RNA 
SNARE: Soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
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SNX1: Sorting nexin-1 
TfR: transferrin-receptor 
t-SNARE: target SNARE 
Tyrp-1: Tyrosinase-related protein -1; 5,6-dihydroxyindole-2-carboxylic acid oxidase 
Tyrp-2: Tyrosinase-related protein -2; dopachrome tautomerase 
VAMP7: Vesicle-associated membrane protein 7 
Varp: VPS9-ankyrin-repeat protein 
V-ATPase: Vacuolar-type H+ pumps ATPases 
v-SNARE: vesicle SNARE 
$-MSH: melanocyte-stimulating hormone 
 
